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a b s t r a c t 
There is growing worry that drinking water can be affected by contaminants of emerging concern (CECs), 
potentially threatening human health. In this study, a wide range of CECs ( n = 177), including pharma- 
ceuticals, pesticides, perfluoroalkyl substances (PFASs) and other compounds, were analysed in raw water 
and in drinking water collected from drinking water treatment plants (DWTPs) in Europe and Asia ( n = 
13). The impact of human activities was reflected in large numbers of compounds detected ( n = 115) and 
high variation in concentrations in the raw water (range 15-7995 ng L −1 for 177 CECs). The variation was 
less pronounced in drinking water, with total concentration ranging from 35 to 919 ng L −1 . Treatment 
efficiency was on average 65 ± 28%, with wide variation between different DWTPs. The DWTP with the 
highest CEC concentrations in raw water had the most efficient treatment procedure (average treatment 
efficiency 89%), whereas the DWTP with the lowest 177 CEC concentration in the raw water had the low- 
est average treatment efficiency (2.3%). Suspect screening was performed for 500 compounds ranked high 
as chemicals of concern for drinking water, using a prioritisation tool (SusTool). Overall, 208 features of 
interest were discovered and three were confirmed with reference standards. There was co-variation be- 
tween removal efficiency in DWTPs for the target compounds and the suspected features detected using 
suspect screening, implying that removal of known contaminants can be used to predict overall removal 
of potential CECs for drinking water production. Our results can be of high value for DWTPs around the 
∗ Corresponding author at: Rikard Tröger, Swedish University of Agricultural Sciences (SLU), Box 7050, SE-75007 Uppsala, Sweden. 
E-mail address: rikard.troger@slu.se (R. Tröger). 
https://doi.org/10.1016/j.watres.2021.117099 
0043-1354/© 2021 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ) 
R. Tröger, H. Ren, D. Yin et al. Water Research 198 (2021) 117099 
globe in their planning for futu  
posure to unknown CECs prese












































































































Large amounts of synthetic organic chemicals are used world- 
ide in products, goods and daily life ( Richardson and Ternes 
014 ; Benotti et al. 2009a ; Geissen et al. 2015 ; Ruff et al. 2015 ;
chwarzenbach et al. 2006 ; Stuart et al. 2012 ; Padhye et al. 
014b; Sörengård et al. 2019 ). These chemicals can poten- 
ially reach water bodies used for production of drinking wa- 
er and compromise raw water quality ( Tröger et al., 2018, 
020 ). Major point sources of chemicals include wastewa- 
er treatment plants (WWTPs), industries and hospitals ( Gago- 
errero et al. 2017 ; Sörengård et al. 2019 ; Loos et al. 2013 ). In-
ufficient removal of contaminants of emerging concern (CECs) 
uring drinking water treatment could pose a risk to human ex- 
osure ( Falconer et al. 2006 ), e.g. to pesticides ( Petrovic, Gon- 
alez, and Barcelo 2003 ; Badach, Nazimek, and Kaminska 
007 ; Mekonen et al. 2016 ; Fava et al. 2010 ), pharmaceuticals 
nd personal care products (PPCPs) ( Stackelberg et al. 2007 ; 
ebb et al. 2003 ) and flame retardants ( Garcia-Lopez, Rodriguez, 
nd Cela 2010 ; Wang, Liu, and Yin 2011 ). Another pressing matter 
s potential human exposure to per- and polyfluoroalkyl substances 
PFASs) via drinking water ( Hu et al. 2016 ; Sharma et al. 2016 ;
afeiraki et al. 2015 ), due to the occasional high concentra- 
ions, high persistence, bioaccumulation and potential toxic char- 
cteristics of these substances ( Gebbink, Glynn, and Berger 2015 ; 
yllenhammar et al. 2015 ). 
Conventional drinking water treatment processes (e.g. sand 
ltration and flocculation) are usually efficient in removing 
athogens, but inefficient in removing CECs ( Margot et al. 2013 ; 
tackelberg et al. 2007 ; Ternes et al. 2002 ; Tröger et al. 2018 ;
örengård et al. 2019 ). There is therefore a need to complement 
xisting treatment efficiency studies with investigations specifically 
ocusing on CECs. Treatment through sorption materials, such as 
ranular activated carbon (GAC), has been shown to remove CECs 
 Margot et al. 2013 ; Stackelberg et al. 2007 ; Ternes et al. 2002 ;
röger et al., 2020 ), but complete removal is commonly not 
chieved ( McCleaf et al. 2017 ; Tröger et al. 2018 ) because of weak
inding of some CECs ( McCleaf et al. 2017 ), decreasing removal ef- 
ciency for CECs with increasing operating time of the GAC mate- 
ial ( Kennedy et al. 2015 ; McCleaf et al. 2017 ; Tröger et al., 2020 )
nd co-sorption of dissolved organic matter ( Lavonen et al. 2015 ; 
cCleaf et al. 2017 ; Golovko et al. 2020 ; Ullberg et al. 2021 ). Most
EC removal efficiency studies to date have been conducted with a 
elected number of CECs and little is known about the removal of a 
road range of CECs in current full-scale drinking water treatment 
lants (DWTPs). 
The most common approach when screening for CECs in en- 
ironmental samples is target screening using reference standards 
or quantification and confirmation (Benotti et al. 2009b; Gago- 
errero et al. 2017 ; Padhye et al. 2014a ; Ren et al. 2020 ; Togola and
udzinski 2008 ; Tröger et al. 2018 ). A complementary approach 
s suspect screening, where features detected using high resolu- 
ion mass spectrometry (HRMS) are compared against a list of sus- 
ects containing the compounds of interest ( Andres-Costa, Andreu, 
nd Pico 2016 ; Bade, Bijlsma, et al. 2015 ; Gago-Ferrero et al. 2018 ;
ago-Ferrero et al. 2015 ; Hug et al. 2014 ; Schymanski et al. 2015 ).
 suspect list relevant for drinking water can be created by pri- 
ritising compounds based on their physicochemical properties 2 re treatment strategies to meet the increasing concern about human ex-
nt in their drinking water. 
© 2021 The Authors. Published by Elsevier Ltd. 
icle under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
 Dürig et al., 2019 ) and/or exposure indices and usage quantities 
erived from regulatory databases ( Gago-Ferrero et al. 2018 ). To 
uild confidence in the identification, mass accuracy, fragmenta- 
ion and isotopic profiles can be considered, leading to different 
evels of confidence ( Schymanski et al. 2014 ). Suspect screening 
pproaches have been applied to search for CECs in surface wa- 
er and groundwater ( Andres-Costa, Andreu, and Pico 2016 ; Gago- 
errero et al. 2015 ), but there is a lack of suspect screening studies 
ocusing on drinking water quality. 
This study addressed the lack of international studies on CECs 
nd their behaviour in full-scale DWTPs. A wide-scope screening of 
ECs in raw and drinking water samples from 13 different DWTPs 
n 11 countries across Europe and Asia was performed, to better 
nderstand the presence and behaviour of CECs during different 
rinking water treatment processes. The aim was to investigate the 
elationship between treatment efficiency of target analytes and 
he presence of unknown CECs in water in a screening study. Spe- 
ific objectives were I) to investigate the occurrence of a large vari- 
ty of CECs ( n = 177) including pharmaceuticals, PFASs, pesticides 
including metabolites) and other compounds in raw water and 
rinking water, II) to assess their removal efficiency in a number 
f case studies, III) to perform a suspect screening of 500 com- 
ounds prioritised using SusTool ( Dürig et al., 2019 ) and compare 
heir removal with target compounds, and IV) to identify a selected 
umber of unknown CECs using reference standards. 
. Materials and methods 
.1. Sampling sites and sample collection 
In total, 13 DWTPs located in 11 different European ( n = 8) and 
sian ( n = 3) countries were selected for the study ( Table 1 ). The
elected case study objects only comprised DWTPs that use sur- 
ace water as raw water, as previous studies have indicated that 
urface water is more strongly impacted by CECs than groundwa- 
er ( Stuart et al. 2012 ; Cahill et al. 2004 ). The 13 DWTPs employed
ifferent treatment according to their needs, while some DWTPs 
id not implement advanced treatments at all. Reverse osmosis 
as incorporated as a treatment step in one of the DWTPs inves- 
igated. All DWTPs except two employed GAC filtration and eight 
mployed advanced oxidation through ozonation ( Table 1 ). Several 
f the DWTPs studied used some type of chlorination as a final 
isinfection step. Quenching of the residual chlorine in those sam- 
les was not performed, in order to keep sample pre-treatment 
onsistent and not alter the sample nature, since reducing agents 
ay also interfere with other chemicals present in the water. Exact 
ocations of the DWTPs are not given, to maintain confidentiality. 
nstead, the sites are referred to by the country name and an in- 
ex where more than one plant was studied ( Table 1 ). It should
e noted throughout the paper that the selected DWTPs are rep- 
esentative of one type of treatment standard in their respective 
ountry, not an average standard for that country. 
Grab samples of raw water and finished drinking water were 
ollected at each DWTP using 1-L polypropylene (PP) bottles that 
ere filled directly from available taps. Triplicate samples of each 
atrix were collected at the same time at each location, by se- 
uentially filling up three 1-L bottles (i.e. six bottles in total from 






































Information about the 13 different drinking water treatment plants (DWTPs) from which samples were collected 























































































































































































































Belgium Surface water N/A 150 750 K N N Y Y Y Y N Y Y Y N N N Flotation 
China #1 Qing Reservoir 
- Yangtze River 
N/A 40 100 K N N N Y Y Y N Y N Y Y N N 
China #2 Jin Reservoir - 
Huangpu River 
N/A 30 35 K N N N Y Y Y N Y N Y Y N N Ozone 
pre- 
treatment 
Czech Republic River Úhlava 0 -1.5 
m 






86 190 K N N Y Y N N Y N N Y N N N Auto 
catalytic 
filtration 
Italy #1 Lake water 40 m 35 N/A N N N Y N Y N Y N N Y N N pH ad- 
justment 
Italy #2 Po River water 5 m 86 250 K N N N Y Y N N Y N Y Y N N 
Japan Surface water 0-1 m 60 190 K N N Y Y Y N N Y N Y Y N N 




270 N/A N Y Y N Y Y N Y N Y Y Y Y 
Sweden Lake Mälaren 4-28 m 140 700 K N N Y Y Y Y N Y Y Y N N N 







36 200 K 
River 
Bank 
N N N N Y N Y Y N N N N Carry- 
over 
filter 
Vietnam Saigon River 4 m 300 240 K N Y Y Y Y Y N N N Y N N N pH ad- 
justment 
GAC = granular activated carbon; Y = Yes; N = No; N/A = not available; 
∗shut down on the day of sampling due to technical problems 
3
 




















































































































oxes to our laboratory at the Swedish University of Agricultural 
ciences (SLU), where they were stored at 4 °C until extraction. 
.2. Chemicals and reference standards 
The target method included 177 CECs from a wide range 
f compound categories, comprising pesticides ( n = 74), phar- 
aceuticals ( n = 66), PFASs ( n = 14), phthalates ( n = 3),
ood additives ( n = 2), flame retardants ( n = 4), hormones 
 n = 6), industrial chemicals ( n = 6), drug ( n = 1) and
iloxane ( n = 1) ( Table A1 in the Appendix). The CECs 
ere selected based on previous detection in drinking wa- 
er ( Petrovic, Gonzalez, and Barcelo 2003 ; Xindi C. Hu 2016; 
vancev-Tumbas 2014 ; Westerhoff et al. 2005 ; Webb et al. 2003 ; 
ekonen et al. 2016 ; Benotti et al. 2009a ; Kumar and Xagoraraki 
010 ; Segura et al. 2011 ; Padhye et al. 2014a ) and on availabil-
ty of reference standards. In total, 37 isotopically labelled internal 
tandards (ISs) were used, representing most compound groups in- 
luded in the method. The IS mixture was prepared in methanol 
t a concentration of 500 ng mL −1 of each IS per compound. The 
ative compounds were assigned to their corresponding IS if avail- 
ble, or otherwise assigned to an IS based on expert judgment con- 
idering retention time, molecular structure and ionisation charac- 
eristics ( Table A1 in the Appendix). 
All PFAS standards were purchased from Wellington Laborato- 
ies (Guelph, Canada) and all pesticide standards were purchased 
rom Teknolab Sorbent (Kungsbacka, Sweden). Remaining stan- 
ards were purchased from Sigma Aldrich (Buchs, Switzerland). All 
uffers, acids and bases were of LC-MS grade purity and purchased 
rom Sigma Aldrich (Buchs, Switzerland). The solvents acetonitrile 
LC-MS grade) and methanol (LC-MS grade) were purchased from 
erck (Darmstadt, Germany), and ethanol (AnalaR purity) from 
WR International (Fontenay-sous-Bois, France). Ultrapure water 
Milli-Q) was generated in-house by a water purification system 
Millipore; Bedford, USA). 
.3. Extraction of water samples 
All triplicate samples were extracted separately using a SPE- 
EX semi-automated extraction system (4790 SPE-DEX®; Hori- 
on Technology, Salem, New Hampshire, USA) previously used by 
 Tröger et al., 2020 ). Instead of conventional solid phase extraction 
SPE) cartridges, this device uses HLB SPE disks (47 mm, Atlantic 
LB-M, Horizon Technology). In brief, 1 L from each PP bottle was 
ransferred to a glass bottle and 40 μL of IS mixture (20 ng of each
S) were added to each sample. An in-line 1-μm glass fibre filter (1 
icron - Fine, Fast Flow Sediment Pre-Filters Horizon Technology) 
as placed before the SPE disk, to protect it from clogging. The 
ystem, including the sorbent and the filter, was pre-conditioned 
sing 25 mL Milli-Q water, followed by 25 mL methanol twice 
nd twice with 25 mL Milli-Q water. After pre-conditioning, the 
ample was applied through the filter and onto the SPE disk and 
he system was washed twice using 25 mL Milli-Q water with 5% 
ethanol. The system was then air-dried at room temperature for 
0 min before elution using 25 mL methanol followed by 25 mL of 
cetonitrile (for details, see Table A2 in the Appendix). The eluate 
as stored at -20 °C and later reduced to ~1 mL using a TurboVap 
lassic II (Biotage, USA). The extract was then transferred to a 12 
L glass tube, followed by two rinsings of the TurboVap tube using 
thanol (4 mL), where the rinse portions were combined with the 
ample extract. The extract was reduced to ~0.5 mL and transferred 
o an amber glass LC-MS vial. The glass tube was rinsed twice with 
.5 mL of ethanol, which was added to the vial. The extract in the 
ial was reduced further to < 0.5 mL and finally diluted to 1 mL 
ith Milli-Q water. The extracts were stored at -20 °C until instru- 
ental analysis. 4 .4. Instrumental analysis and software 
All analyses were performed using a quadrupole-time-of-flight 
QToF) mass spectrometer (Xevo G2-S, Waters, Manchester, UK) 
oupled to a ultra-performance liquid chromatography (UPLC) sys- 
em (Acquity H-Class with FTN injector, Waters, Milford, USA). The 
olumns used were an Acquity UPLC BEH-C18 (Waters, 2.1 × 100 
m, 1.7 μm particle size) for the negative ionisation mode and a 
cquity UPLC HSS T3-C18 (Waters, 2.1 × 100 mm, 1.8 μm parti- 
le size) for the positive mode analysis. The liquid chromatography 
LC) flow consisted of a linear gradient of Milli-Q water and ace- 
onitrile. The mobile phases used in negative mode were Milli-Q 
ater with 5 mM ammonium acetate and 0.01% of ammonium hy- 
roxide added to both the water and acetonitrile. In positive mode, 
.01% of formic acid was added to both the water and acetonitrile 
hases and 5 mM of ammonium formate were added to the wa- 
er phase. The same linear gradient was used in both ionisation 
odes, with a flow rate of 0.5 mL min −1 . The gradient started at 
% acetonitrile and increased to 99% acetonitrile with a total run 
ime of 21 min. The injection volume was set to 10 μL. The main 
nstrument settings were: 350V capillary voltage in positive mode, 
00 V in negative mode, 4 V low collision energy and 10 to 45 eV
or high collision energy (ramping). Data were collected using MS E - 
ode and the resolution was ~30 0 0 0 at 556.28 m/z , with leucine
nkephalin used as lock spray (for lock mass correction). The soft- 
are used for both data collection and evaluation was UNIFI v1.8.2. 
ore details of the instrumental analysis are given in Tröger et al. 
 Tröger et al. 2018 ). 
The samples were analysed using a target method with the 
ompounds described in section 2.2 ( Table A1 in the Appendix) 
nd by suspect screening for a list of 500 compounds created using 
usTool ( Dürig et al., 2019 ) (see section 2.5 ). 
.5. Suspect list creation 
The suspect list created using SusTool ( Dürig et al., 2019 ) in- 
luded in total 500 compounds. SusTool uses a database com- 
rising of > 30 0 0 0 compounds, which are relevant for human 
nd/or environmental exposure, and a scoring system to priori- 
ise suspects based on physicochemical properties, environmental 
ate characteristics, endocrine disruption potential, usage quantity 
nd exposure indices. Although SusTool includes a large database, 
t is not exhaustive and could be complemented with even more 
ompounds (e.g. CEC transformation products and disinfection by- 
roducts) as well as more toxicological parameters. The parame- 
ers used to prioritise the compounds were log D (pH adjusted 
ctanol/water partition coefficient), log K oc (organic carbon/water 
artition coefficient), log S w (water solubility), log BCF (bioconcen- 
ration factor), biodegradation, QI (quantity index), EI (exposure 
ndex) for water, EI for sewage treatment and EI for consumers. 
ach parameter was assigned a weight between 1-5 according to 
ts relevance for a suspect list focused on surface water and drink- 
ng water (see Table 2 ). A high final score means high ranking on 
he suspect list. The database was sorted based on the total score, 
nd only compounds deemed to be LC compatible (log K ow < 5 (oc- 
anol/water partition coefficient)) were selected for further consid- 
ration. The top 500 compounds were selected for suspect screen- 
ng. The full list is given in Table A6 in the Appendix and the full
usTool Excel file, with all details, can be downloaded from the 
upporting information in ( Dürig et al., 2019 ). 
.6. Quality assurance and method performance 
All compounds were identified using accurate mass screening 
ith a 10 ppm mass error data extraction window and retention 
R. Tröger, H. Ren, D. Yin et al. Water Research 198 (2021) 117099 
Table 2 
Weighting factors used to create the suspect list for screen- 
ing of contaminants of emerging concern (CECs). 
Parameter Weight 
log D 4 
log K oc 2 
log S w 5 
Log BCF 1 
Biodegradation 1 
log K oa 0 
ED potential for ER 5 
ED potential for AR 5 
ED potential for TTR 5 
EI Air 0 
EI Water 4 
EI Soil 0 
EI Sewage treatment 2 
EI Consumer 3 
QI 3 
ED: Endocrine disruption, ER: oestrogen receptor, AR: androgen 
receptor, TTR: transthyretin transport protein, for other abbre- 



















































































ime using a one-minute time window. Isotope patterns and frag- 
entation spectra were also considered for the identification. The 
oftware (UNIFI) performs an in silico fragmentation of all com- 
ounds and searches for matching fragments in the high-collision 
nergy spectra for each identified peak. If a matching fragment is 
ound, it increases the identification certainty. The ±H adduct was 
sed for quantification in all cases, and all target compounds were 
uantified using an external 8-point calibration curve, in 50:50 
ethanol:Milli-Q, with concentrations ranging from 0 to 120 ng 
 
−1 . 
The method detection limit (MDL, ng L −1 ) for the 177 target 
ompounds was calculated from the detection limit (DL) as: 
DL = DL+ 
(
3 ∗ RS D spiked ∗DL 
)
L = C spiked ∗R cutoff / 
(
R spiked −R blank 
)
C spiked : nominal concentration in the spiked sample (50 ng L 
−1 ) 
R cutoff: minimum detector counts (100) used to not discard a 
peak 
R spiked : average detector counts in spiked sample 
R blank : average detector counts (if detected) in blank sample 
RSD spiked : relative standard deviation in the spiked sample 
A cut-off value of 100 counts for discarding a peak was applied, 
ased on expert judgment in accordance with normal noise con- 
itions during a typical analytical run. For quality control, a trip- 
icate of 1 L drinking water (tap water from the laboratory, SLU, 
ppsala, Sweden) was spiked with 50 ng of each target compound 
 n = 177), and a triplicate of the same drinking water was anal-
sed unspiked as a blank for blank subtraction. The average MDL 
as 2.6 ng L −1 , with a median of 0.24 ng L −1 . For more details,
ee Table A1 in the Appendix. The MDL was also used as the 
uantification limit. The recovery from SPE extraction was calcu- 
ated by dividing the average response (peak area) in three spiked 
ontrol samples (drinking water spiked with 50 ng) by the aver- 
ge response in another set of three control samples spiked af- 
er extraction (drinking water spiked with 50 ng). Any response 
n the three unspiked blank control sample was subtracted from 
ll spiked samples. The average recovery was 82%, with a median 
f 90% (for details, see Table A1 in the Appendix). Matrix effects 
uring the analysis were calculated by comparing the average re- 
ponse from the three control samples spiked after extraction with 
he response for two calibration points (from the external calibra- 
ion curve) at a similar concentration (but without matrix). Any 5 esponse observed for the unspiked control sample was subtracted 
rom the spiked triplicate. The average matrix effect was -22%, 
ith a median of -30% (for details, see Table A1 in the Appendix). 
To compensate for any deviation in accuracy when determining 
he final concentration of the samples, a correction factor (CF) was 
alculated for each compound by dividing 100 by the accuracy. The 
ccuracy was calculated by dividing the average measured concen- 
ration in the three spiked control samples by the nominal added 
oncentration (50 ng L −1 ) and then multiplying by 100. 
The final concentration in the sample was calculated as: 
 F inal = C Sample ∗ CF 
C Final : corrected concentration 
C Sample : measured concentration in the sample 
CF : correction factor calculated from the control samples 
Ideally, CF should be 1.00 for all compounds, but there are 
wo main circumstances that can cause deviation from the ideal 
alue: a difference in recovery between the selected IS and the 
ative compound being quantified, or a difference in ion suppres- 
ion/enhancement between the IS and the measured compound. 
he average CF was 1.24, with a median of 1.08. For more details, 
ee Table A1 in the Appendix. 
All reported concentrations of individual compounds are given 
s the average concentration for the triplicate samples. If a com- 
ound was only detected in one or two of the triplicate sam- 
les, the concentration was considered zero in any replicate with 
oncentration < MDL in calculation of the average concentration. 
rincipal component analysis (PCA) was conducted using SIMCA 
16.0.1, and the analyses were performed with the default settings 
n the software (i.e. unit variance and mean centring). 
.7. Removal efficiency 
The removal efficiency of each target CEC was calculated for 
ach DWTP by dividing the drinking water concentration by the 
aw water concentration, subtracting this ratio from 1 and multi- 
lying by 100 to get the removal percentage. This was done for all 
ompounds detected in the raw water at concentrations above the 
DL. If the concentration in the corresponding drinking water was 
elow MDL, MDL/2 was used for the calculation of removal effi- 
iency. Any negative removal efficiencies was considered zero for 
he calculation of the averages removal. 
. Results and discussion 
.1. CECs in raw water 
In total, 115 out of the 177 target compounds were detected in 
t least one water sample ( Table A3 in the Appendix). The aver- 
ge ( ± standard deviation) number of detected compounds for all 
3 different DWTPs was 44 ( ±16). The number of detected com- 
ounds varied substantially between the different case study sites 
nd reflected local CEC contamination profiles. It should again be 
ighlighted that the study objects are named after country origin, 
ut should not be considered typical representatives of DWTPs for 
hat country, but rather as examples of DWTPs located in vari- 
us European and Asian countries. Samples from Germany had the 
owest number of detected compounds (6), while samples from 
pain had significantly higher numbers of detected compounds 
71). The high number of detected compounds in samples from 
he Spanish DWTP can be explained by their source water being 
ighly impacted by wastewater discharges ( Bade et al., 2015 ; Gago- 
errero et al. 2017 ). 
For further discussion and visualisation, the compounds were 
ivided into four categories: pesticides ( n = 45), pharmaceuticals 





























































































































 n = 47), PFASs ( n = 11) and other CECs ( n = 11), with the ex-
eption of sucralose, which was clearly the dominant compound 
t all sites (except in Germany) and was therefore considered sep- 
rately ( Fig. 1 ). In addition to sucralose, on average 15 ( ±6) pes-
icides, 6 ( ±2) PFASs, 17 ( ±10) pharmaceuticals and 4 ( ±3) other 
ECs were detected at the 13 different sites. In raw water samples 
rom China #1, China #2, The Netherlands, Germany and Vietnam, 
esticides was the most frequently detected compound group. In 
amples from Japan, equal numbers of pesticide ( n = 19) and phar- 
aceutical ( n = 19) compounds were detected. At the remaining 
WTPs, pharmaceuticals was the most frequently detected com- 
ound group ( n = 8 to n = 39) (for details, see Table A3 in the
ppendix). 
There was large variation in the raw water concentrations of 
ECs between the different sites (range 15-7995 ng L −1 ) ( Fig. 1 a,
able A3 in the Appendix). Samples from Spain generally showed 
he highest sum concentrations of each compound category, except 
or PFASs, where samples from China #2 showed the highest to- 
al concentration (143 ng L −1 ). Samples from Sweden, Germany, 
taly #1 and Switzerland had relatively low total CEC concentra- 
ions (15-247 ng L −1 ) in comparison with those from Spain, China 
2 and Japan (2466-7995 ng L −1 ). The CEC concentrations in raw 
ater are highly influenced by the population impacting the source 
ater ( Nguyen et al. 2017 ; Gago-Ferrero et al. 2017 ), land uses in
he catchment area ( Ren et al. 2020 ; You et al. 2015 ), treatment
tandards for wastewater and industrial wastewater discharges, 
hemical/pharmaceutical usage patterns ( Kot-Wasik, Jakimska, and 
liwka-Kaszynska 2016 ) and untreated wastewater discharges to 
eceiving waters. Pharmaceuticals are commonly discharged with 
unicipal and hospital wastewater effluent, due to insufficient re- 
oval in WWTPs ( Bade et al., 2015 ; Gago-Ferrero et al. 2017 ;
ot-Wasik, Jakimska, and Sliwka-Kaszynska 2016 ; Loos et al. 2013 ; 
örengård et al. 2019 ). The level of pesticide pollution is strongly 
inked to the fraction of agricultural land, the intensity of agri- 
ultural activities and pesticide use patterns by farmers and the 
urface runoff in the catchment area ( Reichenberger et al. 2007 ; 
ereecken 2005 ; Zalidis et al. 2002 ). PFASs have a relatively dif- 
use dispersal pattern in surface waters ( Gago-Ferrero et al. 2017 ; 
röger et al., 2020 ), but show elevated concentrations near point 
ources, such as fire-fighting fields and airports that formerly used 
queous film-forming foams ( Ahrens et al. 2015 ; Backe, Day, and 
ield 2013 ; Hu et al. 2016 ) or water bodies affected by manufac-
uring of fluorinated chemicals ( Hu et al. 2016 ; Wang et al. 2018 ). 
To further elucidate differences in raw water quality between 
ites, PCA was employed using the CEC concentration data from 
ll DWTPs ( n = 13) ( Fig. A1 in the Appendix). For improved site
eparation and a better possibility to interpret relations between 
WTPs, Spain was excluded from the PCA plot ( Fig. 1 ). The first
wo principal components (PCs) jointly explained 49% (PC1: 29%, 
C2: 20%) of the total variation ( Fig. 1 b). In the biplot with all
WTPs included ( Fig. A1 in the Appendix), Spain was the site that 
ontributed most to the variation along PC1, while China #2 was 
lotted far from the other DWTPs along PC2. These separations 
ere driven by higher levels of pharmaceuticals in the Spanish 
WTP samples and higher levels of pesticides and PFASs in the 
hinese #2 DWTP samples. With Spain removed ( Fig. 1 b), most 
WTPs were still clustered around origo, but China #2 separated 
rom the rest along PC1, driven by higher levels of pesticides and 
FASs. Japan and Czech Republic were separated from the other 
WTPs along PC2, due to their higher levels of pharmaceuticals. 
.2. CECs in drinking water 
In total, 58 out of the 177 target compounds were detected in 
t least one drinking water sample, compared with 115 in the raw 
ater ( Table A4 in the Appendix). The number of detected com- 6 ounds varied between 11 CECs in sample Italy #2 and 35 CECs 
n China #2. The average number of detected compounds was 19 
 ±8) for the 13 different sites, compared with 44 ( ±16) in the raw
ater. 
There was large variation in the CEC concentrations in drinking 
ater (range 35-919 ng L −1 ) between sites ( Table A4 in the Ap-
endix). The sample from China #2 had the highest overall con- 
entration (919 ng L −1 ), with sucralose concentration remaining 
igh after treatment in China #1, China #2, Spain and Japan (302- 
97 ng L −1 ). Although found at high concentrations, sucralose is 
n approved food additive. Assuming a per capita drinking water 
onsumption of 2 L per day and a body weight of 60 kg, the in-
ake dose of sucralose from drinking water (~0.02 μg/day//kg body 
eight) would be orders of magnitude below the safe daily in- 
ake (50 0 0 μg/day/kg body weight) ( Soh et al. 2011 ). Apart from
ucralose, samples from Spain had low concentrations of CECs in 
he finished drinking water (79 ng L −1 ) considering the high con- 
entration of CECs measured in the raw water (4573 ng L −1 ). 
his can be explained by the use of reverse osmosis as an ad- 
anced treatment method at the Spanish DWTP, which has pre- 
iously been shown to have high performance for CEC removal 
 Radjenovic et al. 2008 ). 
The relationship between DWTPs and their respective CEC con- 
entrations was evaluated by PCA ( Fig. A2 in the Appendix). For 
mproved site separation, China #2 was excluded in a subsequent 
CA ( Fig. 2 b), where the two first PCs jointly explained 46% (PC1: 
4%, PC2: 22%) of the total variation. In the biplot including all 
WTPs ( Fig. A2 in the Appendix), China #2 was separated from 
he rest of the DWTPs along PC1, driven by high levels of most 
ECs, while Vietnam stood out along PC2 due to its higher lev- 
ls of pesticides. With China #2 removed ( Fig. 2 b), China #1 and
ietnam were separated from the other DWTPs, with Vietnam still 
ue to higher pesticide levels and China #1 due to high levels of 
ucralose and PFASs. 
Although sucralose was by far the largest contributor (mainly 
ue to high concentrations in raw water) to the total CEC con- 
entration in drinking water (average 160 ± 170 ng L −1 ) at all 
WTPs except Germany, Italy #2 and Vietnam, it only made up, 
n average, 54% ( ±30%) of the total CEC concentration in sam- 
les from the 13 DWTPs. This demonstrates that there also are 
ther substances which might be of concern for human exposure. 
FASs showed the highest number of detected compounds out of 
ll categories in eight of the DWTPs, with an average of six com- 
ounds per plant detected when considering all DWTPs. In Swe- 
en, the drinking water guideline value is 90 ng L −1 for 11 PFASs 
 Gobelius et al. 2018 ). This limit was only exceeded in the drinking
ater from China #2, where a total of 150 ng L −1 of PFASs was de-
ected. The second highest concentration was in China #1 (27 ng 
 
−1 ). At least three individual PFASs (e.g. PFOA and PFHpA) were 
etected in all drinking water samples, and thus removal of PFASs 
rom the raw water is shown to be problematic for all DWTPs 
tudied. In Sweden, pharmaceuticals was the compound category 
ith the highest number of detected compounds, but due to the 
ow concentrations in the raw water, the total detected concentra- 
ion was only 36 ng L −1 . In China #1, China #2, Czech Republic 
temporarily suspended ozonation could be the cause in this case) 
nd Vietnam, pesticides was the category with the highest num- 
er of detected compounds. The Swedish drinking water guide- 
ine (and the parametric value in the “Proposal for a Directive of 
he European Parliament and of the Council on the quality of wa- 
er intended for human consumption” ( Livsmedelsverket 2014 )) al- 
ows a total concentration of pesticides of 500 ng L −1 , or 100 ng
 
−1 for an individual pesticide compound. No sample exceeded 
he Swedish total pesticide concentration limit, although Vietnam 
ame close (336 ng L −1 ). However, the individual concentration of 
,4-dichlorophenoxyacetic acid in the sample from Vietnam (302 
R. Tröger, H. Ren, D. Yin et al. Water Research 198 (2021) 117099 
Fig. 1. a) Concentrations of contaminants of emerging concern (CECs) detected in raw water used by the 13 drinking water treatment plants (DWTPs), divided by compound 
category. b) Principal component analysis (PCA) biplot for raw water concentrations of individual CECs at all DWTPs except Spain. The first two principal components (PCs) 
jointly explained 49% of the total variation (PC1: 29%, PC2: 20%). 
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Fig. 2. a) Concentrations of contaminants of emerging concern (CECs) detected in drinking water at the 13 drinking water treatment plants (DWTPs), shown per compound 
category. b) Principal component analysis (PCA) biplot for drinking water levels of individual CECs at all DWTPs except China #2. The first two principal components (PCs) 
jointly explained 46% of the total variation (PC1: 24%, PC2: 22%). 
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g L −1 ) exceeded the guideline value for individual pesticides by 
hreefold. Pesticide pollution is thus another compound group of 
oncern for DWTPs, especially in countries heavily influenced by 
gricultural activities, as shown in previous studies ( Badach, Naz- 
mek, and Kaminska 2007 ; Fava et al. 2010 ). 
.3. Overall removal efficiency of micropollutants 
DWTPs have many parameters to consider in regards to main- 
aining a high standard for their drinking water, where the re- 
oval of CECs is only one of them. Other parameters to consider 
n the overall treatment process include the removal of dissolved 
rganic carbon (DOC), metals and pathogens. All parameters need 
o be considered together and affects decisions on which barriers 
microbial and chemical) to use. Our case study on removal effi- 
iencies of CECs showed that the average efficiency across all de- 
ected compounds and all DWTPs was 65% ( ±28%) with the value 
anging from 2.3% (Germany) to 89% (Spain) ( Fig. 3 a). The Ger- 
an DWTP showed low removal efficiency; however, likely suffi- 
ient treatment as only a few ( n = 6) compounds at low levels
ere detected in the raw water. The DWTP in Germany, with treat- 
ent based only on coagulation-flocculation, rapid sand filtration 
nd final chlorine disinfection, is able to use powdered activated 
arbon (PAC) as a treatment step in cases where it is considered 
ecessary (but was not applied before the sampling in this study). 
he second lowest removal efficiency was shown by the Swedish 
WTP, with an average removal efficiency of 9.1% for 22 detected 
ompounds, demonstrating that GAC filtration is not guaranteed to 
chieve good CEC removal. The high removal efficiency of CEC in 
he Spanish DWTP can be attributed to the use of reverse osmosis, 
hich has previously been shown to work well for removing CECs 
 Boleda, Galceran, and Ventura 2011 ). All removal efficiency data 
re given in Table A5 in the Appendix. 
It should be noted that the removal efficiencies are based on 
he detected target compounds analysed ( Table A5 in the Ap- 
endix), representing a wide-scope screening approach. Still, it is 9 ot an exhaustive list of all potential CECs in the analysed wa- 
er samples. Potentially present CECs representing more hydropho- 
ic compounds and compounds with other functional groups than 
hose included in our target list may react differently to the treat- 
ent steps employed by the DWTPs. Additionally, applying chlo- 
ination, ozonation or ultraviolet disinfection can transform natu- 
al organic matter (NOM) or other organic compounds into haz- 
rdous disinfection by-products potentially also classified as CECs 
 Postigo et al. 2021 ; Zhang et al. 2020 ), but not targeted in this
tudy. Moreover, it cannot be excluded that differences in the 
reatment efficiencies between DWTPs ( Fig. 3 ) to some extent 
ight be due to differing levels of NOM in the raw water. High 
evels of NOM is known to pose a challenge for several drinking 
ater technologies ( Sillanpää et al. 2018 ). 
Of all compound groups, PFASs showed the lowest removal ef- 
ciency, of on average 18 ±18% in the 13 different DWTPs, indicat- 
ng that PFASs is a problematic compound group for drinking water 
roducers, as reported previously ( Belkouteb et al. 2020 ). Pharma- 
euticals were removed most efficiently during the drinking wa- 
er treatment, with an average removal of 83 ±26%, whereas the 
ther groups had an average removal efficiency of 62-69%. Previ- 
us studies have also observed lower removal of PFASs compared 
ith other CECs ( Tröger et al., 2020 ). Even the Spanish DWTP, with
he highest overall removal efficiency, only achieved an average re- 
oval of 37% for PFASs. However, despite the overall low removal 
fficiencies for PFASs, the sum of concentrations of PFASs was gen- 
rally low in finished drinking water (0.8-27 ng L −1 ), except for 
hina #2 (151 ng L −1 ). 
Environmental mobility of individual CECs is mainly governed 
y their sorption to hydrophobic materials ( Reemtsma et al. 2016 ). 
heoretically, partition coefficients could be expected to predict the 
emoval behaviour of individual CECs in a DWTP, with sorption 
o GAC as one major retention mechanism. The relationship be- 
ween two physicochemical properties (log K oc and log D ) of the 
ndividual CECs and their removal efficiencies (found in this study) 
 Table A5 in the Appendix) was investigated through linear regres- 
R. Tröger, H. Ren, D. Yin et al. Water Research 198 (2021) 117099 






































































ion analyses. No relevant predictive relationships, where an in- 
rease in log K oc or log D corresponded to an increase in removal 
fficiency, were found ( Figs. A3 and A4 in the Appendix). The pos- 
ibility of detecting significant relationships would likely be higher 
n controlled pilot- or laboratory-scale experiments. 
.4. Suspect screening 
To investigate a broader set of compounds, suspect screening 
as performed by searching for 500 suspects in both positive 
nd negative ionisation mode in all raw and drinking water trip- 
icate samples. A database was created in UNIFI with the molec- 
lar structures for all 500 compounds prioritised by SusTool (see 
ection 2.5 ). This database was later used to perform in silico frag- 
entation of the compounds. To be considered a detected feature 
o match a suspect, a maximum ±2 mDa mass error was required. 
o increase confidence in the assigned suspects, only features that 
ad at least one detected in silico fragment with a maximum mass 
rror of ±4 mDa were considered. The next step was to manu- 
lly check all suggested candidates and judge their peak shapes, in 
rder to classify them as real peak or noise integration. A subset 
f the suspects, only containing peaks (and their retention times) 
hat passed the quality criteria, was then created and these sus- 
ects were re-analysed as if target compounds. To readily compile 
he data from the 26 different triplicate samples analysed with the 
ew semi-target list, a custom R-script was applied to determine 
he number of detections for each feature in each triplicate sam- 
les (0-3 detections). The output was compiled ( Table A7 in the 
ppendix), together with some basic mass spectrometry (MS) pa- 
ameters for all detected features. In total, 208 features were de- 
ected in all triplicates of at least one sample, with some detected 
oth in positive and negative ion mode and/or at different reten- 
ion times, resulting in a number of 175 unique detected suspects. 
To examine the behaviour of the detected features in the DWTP 
rocesses, the removal was calculated in a similar way as for the 
arget compounds, with the exception that peak response (area) for 
ach feature was used instead of concentration. Non-detects in the 
rinking water were substituted with the response cut-off (100) 10 or peak rejection in the data processing method instead of MDL/2 
 Table A8 in the Appendix). It should be noted that this approach 
ssumes the same response in raw water and drinking water for 
he same amount of a compound. The number of features detected 
n samples from each DWTP varied from 15 (Switzerland) to 65 
Spain). The average removal estimate for each individual feature in 
ach DWTP was then compared against the removal of the target 
ompounds ( Fig. 4 ). To check for common trends, the DWTPs were 
orted according to declining average removal of the suspects and 
rend lines were added for targets and suspects. These trend lines 
or targets and suspects agreed relatively well. The average removal 
f suspects differed by between -15% and + 48% from the aver- 
ge removal of target compounds, with the largest differences ob- 
erved for samples from Germany (48%) and Sweden (19%). Spain, 
ith the highest average removal of target compounds, also had 
he highest removal of suspect features, while Sweden, which had 
he second worst removal of targets (after Germany), had the worst 
emoval of suspect features. Germany showed a relatively large dis- 
repancy between removal of the targets and the suspects. This can 
otentially be explained by high uncertainty in the calculated tar- 
et removal efficiency of Germany, because of the availability of 
nly six data points, compared with 32 for suspect features. Given 
ost DWTPs followed a common trend, removal of a broad range 
f known compounds can be used as an indication of removal of 
nknown compounds. This observation may be of high value for 
WTPs around the globe in their planning for future treatment 
trategies to meet the increasing concern about human exposure 
o unknown CECs present in their drinking water. Still, the findings 
n this study also highlight the potential for unknown, potentially 
azardous compounds to slip through the treatment processes at 
WTPs if their attributes are similar to those of target compounds 
nown to slip through. 
.5. Identification of suspects 
To identify the most relevant CECs for the DWTPs out of the 
08 suspect features detected, further prioritisation was needed. 
n this process, only suspects detected in the finished drinking wa- 











































































































er, since humans are unavoidably exposed to these features were 
elected. This prioritisation decreased the number of suspect fea- 
ures to 86. Next, features present in only one DWTP were re- 
oved, to increase relevance for the drinking water sector in gen- 
ral rather than information for an individual DWTP. The remain- 
ng 39 features were then evaluated manually from an analyti- 
al chemistry point of view, by judging whether the suspect fea- 
ure had a realistic retention time (as judged from the molecu- 
ar structure) and whether it was detected in an appropriate ion 
ode (as judged from the molecular structure). This manual dese- 
ection reduced the list down to 27 potential detected suspects. Of 
hose, 19 were available to purchase as reference standards from 
ur main supplier, with two (sucralose and triisopropanolamine) 
lready analysed using the target method and considered con- 
rmed suspects. Consequently, a total of 17 reference compounds 
ere purchased: D-( −)-salicin, 4-hydroxyphenylpyruvic acid, sero- 
onin, salidroside, ginkgolide A, ginkgolide J, ginkgolide C, he- 
icin, chlorogenic acid, 5-amino-2-hydroxy-3-sulfobenzoic acid, 7H- 
odecafluoroheptanoic acid, DL-vanillactic acid lithium salt hy- 
rate, dimidium bromide, dhurrin, asperuloside, γ -glu-cys and 
,4 ′ -disulfanediylbis(2-aminobutanoic acid). 
Of these 17 compounds, dhurrin did not ionise and could not 
e analysed, while 14 showed good ionisation and chromatography 
ut their retention times did not match those of the correspond- 
ng features in the samples. Of the two remaining compounds, 
anillactic acid eluted at the same retention time as the suspect 
eature, but its fragmentation pattern did not closely match that 
f the sample feature. In the end, only 7H-dodecafluoroheptanoic 
cid was fully confirmed with matching retention time and frag- 
entation pattern. This compound is very similar to perfluorohep- 
anoic acid (PFHpA), which was found in the raw water samples 
rom all 13 DWTPs. The only difference between the two molecules 
s that 7H-dodecafluoroheptanoic acid has one F-atom substituted 
ith an H-atom. In the samples, 7H-dodecafluoroheptanoic acid 
ccurred in both raw water and drinking water from China #1, 
hina #2 and Italy #1, while it was only present in drinking wa- 
er from Spain, Czech Republic, Germany and Italy #2. Occurrence 
f a CEC in drinking water, but not in the raw water, indicates 
hat it could be a transformation product created from a parent 
FAS ( Merino et al. 2016 ) during one or several treatment steps in
he DWTP. The occurrence of this compound has previously been 
entatively confirmed using suspect screening in samples of heav- 
ly contaminated wastewater from a fluorochemical manufacturing 
lant in China ( Wang et al. 2018 ). 
. Conclusions 
Concentrations of CECs in raw water and drinking water were 
creened using comparative data on samples obtained from 13 full- 
cale DWTPs located in different countries and continents. The 
nalyses clearly showed that many known and unknown mobile 
ECs pass through artificial barriers (DWTP treatment) around the 
orld and are found in treated drinking water, although in gener- 
lly low concentrations (mostly below statutory threshold levels). 
his emphasizes the value of employing good analytical methods 
nd extensive detection workflows to detect and identify CECs in 
WTPs and to evaluate the efficiency of treatment techniques. 
The raw water used by the different DWTPs contained a wide 
ange of CECs, including PFASs, pharmaceuticals, pesticides and 
ther compounds. In total, 115 different CECs out of 177 analysed 
ere detected in at least one water sample. Detection of PFASs 
n drinking water samples gives cause for concern, due to their 11 ossible adverse effects on humans. The Swedish drinking water 
uideline value of 90 ng L −1 for 11 PFASs was exceeded in drink- 
ng water at one DWTP in China. Another problematic group is 
esticides, which can have adverse effects on human health. The 
wedish drinking water guideline value of 500 ng L −1 for total pes- 
icides was not exceeded at any site, but the limit for an individ- 
al pesticide (100 ng L −1 ) was exceeded threefold at one DWTP 
Vietnam). Apart from this, none of the measured concentrations 
xceeded national guideline values for drinking water. 
The 13 DWTPs studied applied different combinations of treat- 
ent strategies to remove CECs from the raw water, with vary- 
ng removal efficiency for the target compounds analysed in this 
tudy. Five of the treatment plants had average removal efficiency 
 80%, which can be considered very good. Spain had the most 
dvanced treatment, using reverse osmosis, which resulted in the 
ighest removal efficiency (89%) of all 13 DWTPs. DWTPs in Swe- 
en and Germany had the lowest removal of target compounds 
 < 10%), but also had the lowest concentrations of CECs in raw wa- 
er, so the finished drinking water still had similar concentrations 
o the other DWTPs, showing that poor removal does not neces- 
arily result in poor drinking water quality. Although, low removal 
ould be an issue with unknown CECs, since Sweden and Ger- 
any also had the lowest removal efficiency of the suspect com- 
ounds. Overall, there was relatively good agreement between re- 
oval of the target compounds and the suspect features. Thus, a 
elected number of target CECs can potentially be used to estimate 
he removal efficiency of CECs during drinking water treatment 
rocesses and potential exposure via drinking water in humans, 
lthough a more extensive study is needed to confirm our find- 
ngs. Three compounds detected using suspect screening were con- 
rmed using reference standards (triisopropanolamine, sucralose 
nd 7H-dodecafluoroheptanoic acid), showing that SusTool can be 
sed to suggest CECs in raw and drinking water to screen for. 
o further increase the scope in future studies, disinfection by- 
roducts formed during chlorination, UV-radiation or ozonation 
reatment could be included in the suspect screening. 
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List of all target compounds analysed, along with their descriptors and method parameters for the instrumental analysis. Method parameters include recovery (%, calculated on response), matrix effect (%, calculated on response), 
relative standard deviation (RSD; %, calculated on concentration), concentration correction factor (unitless), blank concentration (ng L −1 ), and MDLs (ng L −1 ). N/D = not detected, MDL = Method detection limit 
Compound CAS# Compound 
Category 















L −1 ) 
MDL 
(ng/L) 
10,11-Dihydro-10-hydroxycarbamazepine 29331-92-8 Pharmaceutical + H 254.1055 4.9 IS - Oxazepam -d5 95.9 27.8 6.3 1.37 N/D 0.97 
10,11-Dihydrocarbamazepine 3564-73-6 Pharmaceutical + H 238.1106 6.7 IS - Methadone - d3 99.1 -84.0 14.6 3.08 N/D 0.24 
2,4-Dichlorophenoxyacetic acid 94-75-7 Pesticide -H 219.9694 3.8 IS - Perfluorohexanoic acid 
(PFHxA)-13C2 
85.1 -6.0 11.7 1.13 N/D 20.07 
2,6-Dichlorbenzamid (BAM) 2008-58-4 Pesticide + H 188.9748 3.5 IS - DEET-d10 110.1 -32.5 6.8 0.98 N/D 2.97 
4-(Trifluoromethyl)benzenesulfonamide 830-43-3 Industrial 
Chemical 





-H 318.9908 2.5 IS - Furosemide-d5 66.2 -50.6 13.3 1.14 N/D 2.82 
4-Chloro-4 ′ -fluorobutyrophenone 3874-54-2 Industrial 
Chemical 
+ H 200.0404 7.0 IS - TCEP-d12 89.4 -12.9 4.9 1.13 N/D 0.45 
5-Amino-2-chlorotoluene-4-sulfonic acid 88-53-9 Industrial 
Chemical 
-H 220.9913 2.9 IS - Furosemide-d5 59.2 -50.3 12.9 1.15 N/D 6.50 
Acetaminophen 103-90-2 Pharmaceutical + H 151.0633 2.0 IS - Codeine-d3 76.5 -60.0 13.6 1.70 N/D 1.83 
Acetamiprid 135410-20-7 Pesticide + H 222.0672 4.8 IS - TCEP-d12 102.3 -4.3 4.7 0.90 N/D 0.10 
Alachlor 15972-60-8 Pesticide + H 269.1183 10.2 IS - DEET-d10 100.4 -44.8 3.6 1.31 N/D 0.56 
Amidosulfuron 120923-37-7 Pesticide + H 369.0413 6.3 IS - DEET-d10 46.0 46.1 19.2 1.07 N/D 0.50 
Amitryptiline 50-48-6 Pharmaceutical + H 277.1830 7.4 IS - Methadone - d3 52.5 -64.8 10.3 2.57 N/D 0.11 
Atenolol 29122-68-7 Pharmaceutical + H 266.1630 2.1 IS - Atenolol-d7 63.3 -6.0 11.1 1.26 N/D 0.22 
Atrazine 1912-24-9 Pesticide + H 215.0938 7.3 IS - DEET-d10 102.7 -39.1 2.3 1.04 N/D 0.07 
Atrazine-desethyl 6190-65-4 Pesticide + H 187.0625 4.4 IS - Citalopram-d4 101.1 -58.7 12.6 1.33 N/D 0.24 
Atrazine-desisopropyl 1007-28-9 Pesticide + H 173.0468 3.3 IS - Citalopram-d4 108.8 -54.5 16.6 1.12 N/D 0.38 
Azithromycin 83905-01-5 Pharmaceutical + H 748.5085 5.1 IS - Citalopram-d4 66.9 -13.7 6.8 1.11 N/D 0.13 
Azoxystrobin 131860-33-8 Pesticide + H 403.1168 9.5 IS - DEET-d10 90.0 -17.5 1.7 0.94 0.03 0.04 
Bentazon 25057-89-0 Pesticide -H 240.0569 2.7 IS - Irbesartan-d7 87.8 -22.8 1.9 0.90 N/D 1.38 
Benzyl butyl phthalate 85-68-7 Phthalate + H 312.1362 12.2 IS - Progesterone - 13C3 65.6 -39.4 25.9 1.50 N/D 10.67 
Bezafibrate 41859-67-0 Pharmaceutical + H 361.1081 7.8 IS - Bezafibrate-d4 96.1 25.2 1.8 1.16 N/D 0.16 
Bicalutamide 90357-06-5 Pharmaceutical -H 430.0610 8.1 IS - Oxazepam -d5 94.3 -23.2 8.2 0.91 N/D 0.08 
Bifenox-acid 53774-07-5 Pesticide -H 326.9701 5.7 IS - Oxazepam -d5 102.6 -30.2 11.4 0.92 N/D 10.02 
Bis(2-ethylhexyl) phosphate 298-07-7 Industrial 
Chemical 
-H 322.2273 8.4 IS - Irbesartan-d7 93.0 -34.2 3.7 1.08 1.03 0.48 
Bisoprolol 66722-44-9 Pharmaceutical + H 325.2253 5.4 IS - Citalopram-d4 53.9 -13.8 7.0 1.23 N/D 0.05 
Bitertanol 55179-31-2 Pesticide + H 337.1790 10.2 IS - TCEP-d12 94.5 -7.3 8.5 0.90 N/D 4.09 
Boscalid 188425-85-6 Pesticide + H 342.0327 9.6 IS - DEET-d10 92.2 -24.1 2.3 0.95 N/D 0.97 
Caffeine 58-08-2 Food Additive + H 194.0804 2.9 IS - Caffeine-13C3 94.6 -21.6 1.5 0.97 1.64 0.66 
Carbendazim 10605-21-7 Pesticide + H 191.0695 3.8 IS - Citalopram-d4 56.8 -19.4 12.8 1.25 N/D 0.16 
Cetirizine 83881-51-0 Pharmaceutical + H 388.1554 7.0 IS - Citalopram-d4 88.4 -38.2 11.6 1.09 N/D 0.07 
Chloramphenicol 56-75-7 Pharmaceutical -H 322.0123 4.6 IS - Irbesartan-d7 97.8 -40.5 8.1 1.03 N/D 0.61 
Chlorfenvinphos 470-90-6 Pesticide + H 357.9695 10.7 IS - DEET-d10 92.4 -33.8 1.5 1.20 N/D 0.10 
Chloridazon 1698-60-8 Pesticide + H 221.0356 4.4 IS - DEET-d10 99.7 -24.6 2.9 0.92 N/D 0.06 
Chlorzoxazone 95-25-0 Pharmaceutical -H 168.9931 4.4 IS - Irbesartan-d7 88.5 -14.8 4.7 0.82 N/D 2.10 
Citalopram 59729-33-8 Pharmaceutical + H 324.1638 6.2 IS - Citalopram-d4 73.6 -15.2 2.3 0.94 0.86 0.05 
Clarithromycin 81103-11-9 Pharmaceutical + H 747.4769 7.8 IS - Citalopram-d4 76.7 -36.0 7.8 1.22 0.08 0.02 
Climbazole 38083-17-9 Pharmaceutical + H 292.0979 9.0 IS - Diazepam-d5 91.4 -27.0 3.1 1.12 0.02 0.03 
Clomazone 81777-89-1 Pesticide + H 239.0713 8.4 IS - Citalopram-d4 101.0 -50.7 10.7 1.17 N/D 0.77 
Clopidogrel 113665-84-2 Pharmaceutical + H 321.0590 11.7 IS - Methadone - d3 72.2 -51.8 6.1 1.42 0.25 0.05 
Clothianidin 210880-92-5 Pesticide + H 249.0087 4.1 IS - DEET-d10 108.9 -36.3 9.2 1.04 N/D 2.97 
Codeine 76-57-3 Pharmaceutical + H 299.1521 2.7 IS - Codeine-d3 76.3 -30.4 1.1 1.05 N/D 0.08 
Cyanazine 21725-46-2 Pesticide + H 240.0890 6.3 IS - Oxazepam -d5 113.2 -5.4 27.1 1.42 N/D 0.39 
Cyazofamid 120116-88-3 Pesticide + H 324.0448 10.8 IS - DEET-d10 94.4 -18.6 4.5 1.03 N/D 4.60 








































Table A1 ( continued ) 
Compound CAS# Compound 
Category 















L −1 ) 
MDL 
(ng/L) 
Cybutryne 28159-98-0 Pesticide + H 253.1361 9.6 IS - DEET-d10 84.8 -27.9 2.0 1.05 N/D 0.03 
Cyflufenamid 180409-60-3 Pesticide + H 412.1210 12.1 IS - TPP-d21 81.4 -63.6 14.5 1.06 N/D 0.73 
Cyprodinil 121552-61-2 Pesticide + H 225.1266 10.3 IS - TPP-d21 46.5 -51.1 1.5 1.24 N/D 0.08 
DEET (N,N-Diethyl-3-methylbenzamide) 134-62-3 Pesticide + H 191.1310 7.5 IS - DEET-d10 103.9 -32.0 0.7 0.89 0.64 0.03 
Diazepam 439-14-5 Pharmaceutical + H 284.0716 8.7 IS - Diazepam-d5 87.5 -6.9 0.7 0.92 0.02 0.03 
Dibutyl phosphate 107-66-4 Industrial 
Chemical 
-H 210.1021 3.7 IS - Furosemide-d5 27.3 -33.1 9.4 2.12 N/D 6.16 
Dichlorprop 120-36-5 Pesticide -H 233.9850 4.2 IS - Irbesartan-d7 82.9 -20.7 4.7 0.92 N/D 27.26 
Diclofenac 15307-86-5 Pharmaceutical -H 295.0167 5.7 IS - Diclofenac -13C6 70.3 10.3 4.0 0.73 N/D 10.99 
Dienogest 65928-58-7 Hormone + H 311.1885 7.2 IS - Venlafaxine-d6 84.7 -30.2 4.6 1.18 N/D 0.09 
Difenoconazole 119446-68-3 Pesticide + H 405.0647 11.0 IS - Methadone - d3 82.7 -44.7 6.2 1.08 N/D 0.10 
Diflufenican 83164-33-4 Pesticide -H 394.0741 11.1 IS - Perfluoroundecanoic 
acid (PFUnDA)-13C2 
70.1 -62.5 23.4 1.04 N/D 2.63 
Dimethoate 60-51-5 Pesticide + H 228.9996 4.5 IS - TEP-d15 59.0 -53.2 1.7 1.12 N/D 0.81 
Diuron 330-54-1 Pesticide + H 232.0170 7.6 IS - Oxazepam -d5 106.9 -13.0 4.7 1.66 N/D 0.19 
Enalapril 75847-73-3 Pharmaceutical + H 376.1998 5.5 IS - Oxazepam -d5 90.8 30.5 5.1 1.29 N/D 0.07 
Fenofibrate 49562-28-9 Pharmaceutical + H 360.1128 13.1 IS - TPP-d21 52.9 -73.6 29.9 2.40 N/D 6.07 
Fenpiclonil 74738-17-3 Pesticide -H 235.9908 8.0 IS - Furosemide-d5 64.5 -39.3 8.1 0.95 N/D 0.40 
Fexofenadine 83799-24-0 Pharmaceutical + H 501.2879 7.3 IS - Oxazepam -d5 93.8 32.2 1.5 1.34 0.03 0.02 
Fluazinam 79622-59-6 Pesticide -H 463.9514 10.4 IS - Perfluoroundecanoic 
acid (PFUnDA)-13C2 
74.7 -75.7 23.2 1.54 N/D 0.34 
Fluconazole 86386-73-4 Pharmaceutical + H 306.1041 4.1 IS - TCEP-d12 96.2 2.6 6.1 0.87 N/D 0.30 
Fludioxonil 131341-86-1 Pesticide -H 248.0397 8.3 IS - Perfluorooctane 
Sulfonamide (FOSA)-13C8 
53.9 -47.3 19.2 1.00 N/D 0.25 
Flufenacet 142459-58-3 Pesticide + H 363.0665 10.3 IS - Isoproturon-d3 101.6 -27.6 6.5 1.32 N/D 0.70 
Fluopicolide 239110-15-7 Pesticide + H 381.9654 9.8 IS - Isoproturon-d3 93.9 -25.8 3.7 1.51 N/D 0.11 
Flusilazole 85509-19-9 Pesticide + H 315.1003 9.9 IS - Citalopram-d4 92.3 -36.3 6.2 0.98 N/D 0.07 
Flutriafol 76674-21-0 Pesticide + H 301.1027 7.4 IS - Isoproturon-d3 102.4 -12.7 0.3 1.08 N/D 0.12 
Foramsulfuron 173159-57-4 Pesticide + H 452.1114 6.3 IS - Citalopram-d4 30.0 81.2 16.1 1.17 N/D 0.54 
Fuberidazole 3878-19-1 Pesticide + H 184.0637 4.5 IS - DEET-d10 96.7 -30.9 1.5 1.00 N/D 0.05 
Furosemide 54-31-9 Pharmaceutical -H 330.0077 3.9 IS - Furosemide-d5 63.5 -45.2 12.7 1.02 N/D 6.98 
Gestodene 60282-87-3 Hormone + H 310.1933 8.8 IS - Isoproturon-d3 95.3 -26.5 1.3 1.38 N/D 0.53 
Glibenclamide 10238-21-8 Pharmaceutical + H 493.1438 9.8 IS - DEET-d10 88.8 -20.0 6.9 1.16 N/D 0.19 
Glimepiride 93479-97-1 Pharmaceutical + H 490.2250 10.2 IS - Isoproturon-d3 88.1 -5.4 16.2 1.32 N/D 0.34 
Hexamethylcyclotrisiloxane 541-05-9 Siloxane + H 222.0564 5.0 IS - TCEP-d12 93.9 -13.0 2.5 1.11 N/D 0.70 
Hexazinone 51235-04-2 Pesticide + H 252.1586 5.8 IS - Isoproturon-d3 100.9 -3.3 2.3 1.07 N/D 0.05 
Hydrochlorothiazide 58-93-5 Pharmaceutical -H 296.9645 1.9 IS - Furosemide-d5 75.1 -41.9 8.3 0.83 N/D 12.44 
Ifosfamide 3778-73-2 Pharmaceutical + H 260.0248 4.9 IS - Oxazepam -d5 96.4 14.3 4.3 1.53 N/D 0.05 
Imidacloprid 138261-41-3 Pesticide + H 255.0523 4.4 IS - Oxazepam -d5 101.0 110.1 3.5 0.77 N/D 0.27 
Irbesartan 138402-11-6 Pharmaceutical + H 428.2325 8.4 IS - DEET-d10 94.9 -33.8 7.8 1.07 N/D 0.05 
Isoproturon 34123-59-6 Pesticide + H 206.1419 7.6 IS - Isoproturon-d3 105.6 3.8 0.8 0.81 N/D 0.05 
Ivermectin 70288-86-7 Pharmaceutical -H 874.5079 14.7 IS - Perfluoroundecanoic 
acid (PFUnDA)-13C2 
61.0 -56.8 30.8 0.99 N/D 30.51 
Ketoprofen 22071-15-4 Pharmaceutical + H 254.0943 7.9 IS - Bezafibrate-d4 96.3 46.8 5.1 1.11 N/D 0.89 
Lamotrigine 84057-84-1 Pharmaceutical + H 255.0079 4.1 IS - Lidocaine -d10 102.4 -49.4 11.0 1.03 N/D 0.06 
Levamisole 14769-73-4 Pharmaceutical + H 204.0721 2.9 IS - Codeine-d3 88.7 -46.9 5.0 1.21 N/D 0.11 
Levonorgestrel 17489-40-6 Hormone + H 312.2089 9.4 IS - DEET-d10 96.2 -36.2 6.0 1.17 N/D 0.42 
Linuron 330-55-2 Pesticide + H 248.0119 8.9 IS - Citalopram-d4 98.9 -41.8 10.6 1.03 N/D 3.29 
Loperamide 53179-11-6 Pharmaceutical + H 476.2231 8.6 IS - Methadone - d3 66.9 -37.9 5.8 1.19 0.07 0.03 
Loratadine 79794-75-5 Pharmaceutical + H 382.1448 10.6 IS - DEET-d10 77.9 -30.8 12.7 1.28 0.15 0.03 
Losartan 114798-26-4 Pharmaceutical + H 422.1622 7.4 IS - Isoproturon-d3 104.2 -8.1 4.2 0.89 N/D 0.11 
Mandipropamid 374726-62-2 Pesticide + H 411.1237 9.7 IS - DEET-d10 94.3 -24.9 3.2 1.04 N/D 0.06 








































Table A1 ( continued ) 
Compound CAS# Compound 
Category 















L −1 ) 
MDL 
(ng/L) 
MCPA 94-74-6 Pesticide -H 200.0240 3.7 IS - Perfluorohexanoic acid 
(PFHxA)-13C2 
93.8 -4.8 12.9 1.02 N/D 22.13 
Mebendazole 31431-39-7 Pharmaceutical + H 295.0957 6.8 IS - Methadone - d3 48.7 -33.1 5.8 1.44 N/D 0.23 
Meclofenamic acid 644-62-2 Pharmaceutical -H 295.0167 6.3 IS - Furosemide-d5 43.3 -11.0 8.7 1.08 N/D 22.67 
Mecoprop 7085-19-0 Pesticide -H 214.0397 4.1 IS - Perfluorohexanoic acid 
(PFHxA)-13C2 
97.9 -8.6 15.6 1.04 N/D 31.71 
Memantine 19982-08-2 Pharmaceutical + H 179.1674 5.3 IS - TEP-d15 70.2 -72.9 18.4 1.52 N/D 4.63 
Metalaxyl 57837-19-1 Pesticide + H 279.1471 7.7 IS - Isoproturon-d3 101.4 -15.3 2.0 1.19 N/D 0.05 
Metazachlor 67129-08-2 Pesticide + H 277.0982 8.1 IS - Isoproturon-d3 99.8 -15.5 2.4 1.09 N/D 0.13 
Methabenzthiazuron 18691-97-9 Pesticide + H 221.0623 6.9 IS - DEET-d10 95.7 -27.1 2.8 1.01 N/D 0.11 
Methadone 76-99-3 Pharmaceutical + H 309.2093 7.6 IS - Methadone - d3 65.6 -32.3 0.5 1.06 N/D 0.07 
Metolachlor 51218-45-2 Pesticide + H 283.1339 10.2 IS - DEET-d10 96.4 -35.0 1.0 1.16 N/D 0.07 
Metoprolol 51384-51-1 Pharmaceutical + H 267.1834 4.3 IS - Lidocaine -d10 52.7 -13.8 4.2 1.18 N/D 0.08 
Metribuzin 21087-64-9 Pesticide + H 214.0888 6.3 IS - TEP-d15 40.2 -31.9 71.2 1.09 N/D 0.55 
Metronidazole 443-48-1 Pharmaceutical + H 171.0644 2.3 IS - Ofloxacin-d3 63.4 -46.5 18.3 1.20 N/D 0.85 
Metsulfuron methyl 74223-64-6 Pesticide + H 381.0743 6.2 IS - Oxazepam -d5 94.0 173.5 6.5 0.67 N/D 0.11 
Mirtazapine 61337-67-5 Pharmaceutical + H 265.1579 4.8 IS - Venlafaxine-d6 78.6 -25.9 2.1 1.24 N/D 0.07 
Monobenzyl Phthalate 2528-16-7 Phthalate -H 256.0736 4.0 IS - Irbesartan-d7 95.0 -35.3 1.0 0.98 N/D 3.39 
Monobutyl Phthalate 131-70-4 Phthalate -H 222.0892 3.5 IS - Furosemide-d5 57.8 -28.1 10.8 0.90 N/D 14.04 
N-Desmethylcitalopram 62498-67-3 Pharmaceutical + H 310.1481 6.1 IS - Methadone - d3 73.2 -61.3 27.1 1.65 0.33 0.09 
Nicotine 54-11-5 Drug + H 162.1157 1.2 IS - Nicotine - d4 94.2 -66.9 3.8 0.99 N/D 0.74 
Niflumic acid 4394-00-7 Pharmaceutical -H 282.0616 5.9 IS - Irbesartan-d7 95.5 -26.8 2.5 0.89 N/D 0.15 
Norethindrone 68-22-4 Hormone + H 298.1933 8.4 IS - Isoproturon-d3 97.1 -27.6 1.3 1.37 N/D 0.21 
Norfloxacin 70458-96-7 Pharmaceutical + H 319.1332 3.5 IS - Sulfamethoxazole-d4 11.3 -37.9 28.4 4.77 N/D 6.64 
Ofloxacin 82419-36-1 Pharmaceutical + H 361.1438 3.6 IS - Sulfamethoxazole-d4 48.8 -6.4 18.8 0.75 N/D 0.17 
Omeprazole 73590-58-6 Pharmaceutical + H 345.1147 6.0 IS - Sulfamethoxazole-d4 30.8 -65.4 44.2 2.95 N/D 2.96 
Oxazepam 604-75-1 Pharmaceutical + H 286.0509 6.9 IS - Oxazepam -d5 89.7 78.9 2.1 0.97 N/D 0.27 
Oxycodone 76-42-6 Pharmaceutical + H 315.1471 3.0 IS - Lidocaine -d10 72.7 -27.3 4.1 1.09 N/D 0.11 
Penconazole 66246-88-6 Pesticide + H 283.0643 10.0 IS - DEET-d10 93.8 -35.0 1.8 1.16 N/D 0.12 
Perfluoro-2-propoxypropanoic acid 
(GenX) 
13252-13-6 PFAS -H 329.9750 5.8 IS - Perfluorohexanoic acid 
(PFHxA)-13C2 
87.3 -15.4 2.3 1.12 N/D 15.39 
Perfluorobutane sulfonic acid (PFBS) 375-73-5 PFAS -H 299.9503 5.4 IS - Perfluorohexane 
sulfonic acid (PFHxS)-18O2 
103.1 -15.5 5.5 0.98 4.84 0.06 
Perfluorodecanoic acid (PFDA) 335-76-2 PFAS -H 513.9673 8.6 IS - Perfluorodecanoic acid 
(PFDA)-13C2 
92.9 -44.4 0.7 1.00 0.14 0.14 
Perfluorododecanoic acid (PFDoDA) 307-55-1 PFAS -H 613.9609 9.9 IS - Perfluorododecanoic 
acid (PFDoDA)-13C2 
85.0 -87.9 15.0 0.98 0.08 0.98 
Perfluoroheptanoic acid (PFHpA) 375-85-9 PFAS -H 363.9769 6.4 IS - Perfluorooctanoic acid 
(PFOA)-13C4 
97.7 -12.5 3.4 0.87 N/D 0.16 
Perfluorohexane sulfonic acid (PFHxS) 355-46-4 PFAS -H 399.9439 7.3 IS - Perfluorohexane 
sulfonic acid (PFHxS)-18O2 
100.5 -20.9 1.3 1.05 0.11 0.05 
Perfluorohexanoic acid (PFHxA) 307-24-4 PFAS -H 313.9801 5.5 IS - Perfluorohexanoic acid 
(PFHxA)-13C2 
98.9 -11.0 3.0 0.96 N/D 0.35 
Perfluorononanoic acid (PFNA) 375-95-1 PFAS -H 463.9705 7.9 IS - Perfluorononanoic 
acid (PFNA)-13C5 
97.4 -32.5 1.9 1.06 N/D 0.11 
Perfluorooctane sulfonamide (FOSA) 754-91-6 PFAS -H 498.9535 8.6 IS - Perfluorooctane 
Sulfonamide (FOSA)-13C8 
102.0 -72.9 3.0 1.08 N/D 0.55 
Perfluorooctane sulfonic acid (PFOS) 1763-23-1 PFAS -H 499.9375 8.8 IS - Perfluorooctane 
sulfonic acid (PFOS)-13C4 
92.6 -38.1 2.8 1.08 0.13 0.06 
Perfluorooctanoic acid (PFOA) 335-67-1 PFAS -H 413.9737 7.2 IS - Perfluorooctanoic acid 
(PFOA)-13C4 
100.8 -26.0 4.8 1.03 0.31 0.14 
Perfluoropentanoic acid (PFPeA) 2706-90-3 PFAS -H 263.9833 4.3 IS - Perfluorodecanoic acid 
(PFDA)-13C2 
46.9 3.4 10.4 1.06 N/D 1.53 
Perfluorotetradecanoic acid (PFTeDA) 376-06-7 PFAS -H 713.9545 11.1 IS - perfluorotetradecanoic 
acid (PFTeDA)-13C2 
101.2 -89.4 3.1 1.08 N/D 1.13 
Perfluoroundecanoic acid (PFUnDA) 2058-94-8 PFAS -H 563.9641 9.3 IS - Perfluoroundecanoic 
acid (PFUnDA)-13C2 
82.5 -66.9 1.9 1.06 0.07 0.34 
Picoxystrobin 117428-22-5 Pesticide + H 367.1031 11.0 IS - DEET-d10 92.2 -40.8 5.9 1.17 N/D 0.47 
Pirimicarb 23103-98-2 Pesticide + H 238.1430 6.8 IS - Methadone - d3 61.4 -36.0 11.0 1.21 N/D 0.06 
Prochloraz 67747-09-5 Pesticide + H 375.0308 10.5 IS - Progesterone - 13C3 88.9 -37.6 0.9 1.07 N/D 0.11 








































Table A1 ( continued ) 
Compound CAS# Compound 
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L −1 ) 
MDL 
(ng/L) 
Progesterone 57-83-0 Hormone + H 314.2246 10.7 IS - Progesterone - 13C3 87.7 -30.9 1.2 1.03 N/D 0.66 
Propamocarb 24579-73-5 Pesticide + H 188.1525 2.3 IS - Codeine-d3 81.6 -46.7 5.3 1.28 N/D 0.21 
Propiconazole 60207-90-1 Pesticide + H 341.0698 10.4 IS - Citalopram-d4 92.8 -36.1 12.4 1.01 N/D 0.08 
Propoxycarbazone 145026-81-9 Pesticide + H 398.0896 5.4 IS - Oxazepam -d5 105.3 200.4 8.1 0.52 N/D 0.30 
Propranolol 525-66-6 Pharmaceutical + H 259.1572 5.7 IS - Sulfamethoxazole-d4 56.1 -25.6 18.1 0.72 N/D 0.08 
Propyzamide 23950-58-5 Pesticide + H 255.0218 9.5 IS - DEET-d10 105.5 -37.3 5.7 0.97 N/D 5.10 
Prothioconazole-desthio 120983-64-4 Pesticide + H 311.0592 9.3 IS - DEET-d10 93.9 -32.1 1.4 1.08 N/D 0.10 
Pyraclostrobin 175013-18-0 Pesticide + H 387.0986 11.4 IS - TPHP-d15 72.4 -49.1 3.2 0.89 0.07 0.09 
Pyrimethamine 58-14-0 Pharmaceutical + H 248.0829 5.1 IS - TEP-d15 31.9 -32.7 7.9 1.40 N/D 0.08 
Pyroxsulam 422556-08-9 Pesticide + H 434.0620 6.8 IS - Oxazepam -d5 97.3 176.2 6.3 0.60 N/D 0.03 
Quinmerac 90717-03-6 Pesticide + H 221.0244 3.5 IS - Metronidazole-d4 4.0 15.4 30.3 7.93 N/D 5.13 
Quinoxyfen 124495-18-7 Pesticide + H 306.9967 12.3 IS - TPHP-d15 52.9 -78.7 14.8 2.82 0.26 0.23 
Ramipril 87333-19-5 Pharmaceutical + H 416.2311 7.1 IS - Isoproturon-d3 87.8 -6.0 4.2 1.27 N/D 0.05 
Roxithromycin 80214-83-1 Pharmaceutical + H 836.5246 7.9 IS - Citalopram-d4 68.7 -39.0 9.8 1.46 N/D 0.04 
Silthiofam 175217-20-6 Pesticide + H 267.1113 10.6 IS - Citalopram-d4 91.9 -42.5 12.0 1.12 N/D 0.19 
Sotalol 3930-20-9 Pharmaceutical + H 272.1195 2.1 IS - Ofloxacin-d3 48.2 -32.2 15.5 1.36 N/D 0.79 
Sucralose 56038-13-2 Food Additive -H 396.0146 3.0 IS - Losartan -d4 93.6 -33.5 3.7 0.65 N/D 18.15 
Sulfaclozine 102-65-8 Pharmaceutical -H 284.0135 2.1 IS - Furosemide-d5 46.6 -42.5 14.3 1.32 N/D 16.85 
Sulfamethoxazole 723-46-6 Pharmaceutical + H 253.0521 4.6 IS - Sulfamethoxazole-d4 29.9 37.8 2.2 0.78 N/D 0.69 
Sulfosulfuron 141776-32-1 Pesticide + H 470.0678 7.4 IS - DEET-d10 41.6 89.9 5.4 0.92 N/D 0.30 
Sulindac 38194-50-2 Pharmaceutical + H 356.0882 7.3 IS - Isoproturon-d3 94.6 -25.5 3.5 1.44 N/D 0.44 
TCEP (Tris(2-chloroethyl) phosphate) 115-96-8 Flame 
Retardant 
+ H 283.9539 6.9 IS - TCEP-d12 105.0 -13.5 6.9 0.98 N/D 1.65 
Telmisartan 144701-48-4 Pharmaceutical + H 514.2369 9.5 IS - Isoproturon-d3 90.8 -15.4 5.7 1.24 0.03 0.01 
Terbuthylazine 5915-41-3 Pesticide + H 229.1094 8.8 IS - Citalopram-d4 96.9 -34.0 10.4 0.88 N/D 0.08 
Terbutryn 886-50-0 Pesticide + H 241.1361 9.5 IS - DEET-d10 83.6 -34.5 2.5 1.20 0.02 0.04 
Testosterone 58-22-0 Hormone + H 288.2089 8.3 IS - Isoproturon-d3 100.8 -32.5 3.6 1.51 N/D 0.47 
Theobromine 83-67-0 Pharmaceutical + H 180.0647 2.3 IS - Metronidazole-d4 47.6 -32.0 5.2 1.10 N/D 4.32 
Thiabendazole 148-79-8 Pharmaceutical + H 201.0361 4.3 IS - Metronidazole-d4 16.8 -54.6 31.6 4.58 N/D 0.54 
Thiacloprid 111988-49-9 Pesticide + H 252.0236 5.5 IS - TCEP-d12 105.7 -3.0 3.0 0.88 N/D 0.08 
Thiamethoxam 153719-23-4 Pesticide + H 291.0193 3.6 IS - TCEP-d12 100.4 -2.1 12.0 0.94 N/D 0.32 
Thifensulfuron methyl 79277-27-3 Pesticide + H 387.0307 6.1 IS - Oxazepam -d5 83.4 120.3 13.1 0.94 N/D 0.19 
Tramadol 27203-92-5 Pharmaceutical + H 263.1885 4.4 IS - TCEP-d12 87.5 -19.6 6.4 1.24 0.28 0.09 
Triadimefon 43121-43-3 Pesticide + H 293.0931 9.5 IS - Isoproturon-d3 93.0 -25.1 2.3 1.39 N/D 0.30 
Triflusulfuron-methyl 126535-15-7 Pesticide + H 492.1039 9.7 IS - Bezafibrate-d4 96.4 25.6 5.1 1.30 N/D 0.11 
Triisopropanolamine 122-20-3 Pharmaceutical + H 191.1521 0.7 IS - Codeine-d3 78.9 -41.1 13.4 1.14 N/D 0.32 
Triticonazole 131983-72-7 Pesticide + H 317.1295 9.0 IS - Isoproturon-d3 107.5 -15.8 1.4 1.02 N/D 0.18 
Valsartan 137862-53-4 Pharmaceutical -H 435.2270 4.3 IS - Irbesartan-d7 90.8 -34.4 3.5 1.05 N/D 0.78 
Venlafaxine 93413-69-5 Pharmaceutical + H 277.2042 5.3 IS - Venlafaxine-d6 84.3 -21.8 1.7 1.05 N/D 0.07 
Verapamil 52-53-9 Pharmaceutical + H 454.2832 7.4 IS - Citalopram-d4 56.3 -25.5 3.2 1.35 0.67 0.03 
α-HBCD 134237-50-6 Flame 
Retardant 
-H 641.6447 13.1 IS - perfluorohexadecanoic 
acid (PFHxDA)-13C2 
48.3 -83.2 22.5 1.87 N/D 43.81 
β-HBCD 134237-51-7 Flame 
Retardant 
-H 641.6447 13.3 IS - perfluorohexadecanoic 
acid (PFHxDA)-13C2 
50.8 -81.6 9.9 1.55 N/D 10.72 
γ-HBCD 134237-52-8 Flame 
Retardant 
-H 641.6447 13.9 IS - perfluorohexadecanoic 
acid (PFHxDA)-13C2 
46.2 -81.9 15.1 1.65 N/D 14.03 
Average 81.5 -22.2 8.4 1.24 0.07 2.58 
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Table A2 
Details of the SPE-DEX 4790 extraction programme. 
PreWet cycle (conditioning) 
Solvent Soak time AirDry time 
minutes seconds minutes seconds 
Prewet5 MilliQ 0 30 0 10 
Prewet1 MeOH 0 30 0 10 
Prewet2 MeOH 0 30 0 10 
Prewet3 MilliQ 0 30 0 10 
Prewet4 MilliQ 0 30 0 10 
Sample cycle (sample application) 
Fixed step 
Wash cycle (washing step) 
Solvent Soak time AirDry time 
minutes seconds minutes seconds 
Rinse1 5% MeOH 0 10 0 10 
Rinse1 5% MeOH 0 10 0 10 




Rinse cycle (elution steps) 
Solvent Soak time AirDry time 
minutes seconds minutes seconds 
Rinse2 MeOH 1 0 0 30 







































Average CEC concentrations (ng L −1 ) obtained from analysis of triplicate raw water samples from the 13 selected DWTPs. 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
10,11-Dihydro-10- 
hydroxycarbamazepine 




51.53 < MDL < MDL 33.83 27.52 < MDL < MDL < MDL < MDL 178.01 < MDL < MDL 20.62 
4-Chloro-4 ′ - 
fluorobutyrophenone 




< MDL 106.29 < MDL 64.08 < MDL 395.66 < MDL < MDL < MDL 38.25 < MDL < MDL 41.12 
Acetaminophen < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 17.01 < MDL < MDL < MDL < MDL 
Acetamiprid 1.86 8.21 < MDL 8.10 < MDL < MDL < MDL < MDL 2.09 7.59 < MDL < MDL 1.08 
Alachlor < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 7.83 < MDL < MDL < MDL 
Amitryptiline < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.55 < MDL < MDL 
Atenolol < MDL < MDL < MDL 10.96 3.64 < MDL 1.02 < MDL 7.16 < MDL 0.92 < MDL 4.82 
Atrazine 8.66 73.96 < MDL < MDL 2.62 < MDL 0.51 < MDL 5.81 6.63 0.41 2.96 1.04 
Atrazine-desethyl 3.50 8.06 < MDL < MDL 5.96 < MDL < MDL < MDL 11.46 2.44 0.89 4.14 < MDL 
Atrazine-desisopropyl < MDL 2.39 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Azithromycin < MDL < MDL < MDL 49.04 < MDL < MDL < MDL < MDL < MDL < MDL 1.59 < MDL < MDL 
Azoxystrobin 6.85 10.55 0.12 0.68 0.16 < MDL < MDL < MDL 2.12 30.05 0.10 3.01 1.95 
Bentazon 14.87 221.35 1.49 4.34 9.98 106.28 < MDL < MDL 11.96 16.96 < MDL 8.08 70.71 
Benzyl butyl phthalate 
(BBP) 
< MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Bezafibrate < MDL < MDL < MDL 6.65 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 5.44 
Bicalutamide < MDL 0.42 8.44 5.29 4.39 < MDL 0.47 < MDL 0.91 < MDL 1.64 2.97 19.65 
Bis(2-ethylhexyl) 
phosphate 
3.15 37.37 < MDL 45.69 3.75 9.85 < MDL 1.14 5.31 13.94 1.00 4.98 1.81 
Bisoprolol < MDL < MDL < MDL 13.95 1.70 < MDL 0.91 < MDL < MDL < MDL < MDL < MDL < MDL 
Boscalid < MDL < MDL < MDL 7.85 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Caffeine 36.52 107.76 31.13 277.90 67.28 10.11 17.78 12.90 89.64 32.26 52.38 69.17 217.48 
Carbendazim 61.62 45.36 < MDL 1141.09 1.20 6.57 6.21 < MDL 6.83 97.41 0.92 3.81 58.76 
Cetirizine < MDL < MDL < MDL 23.38 20.06 < MDL < MDL < MDL 2.08 12.62 1.54 8.96 15.74 
Chloramphenicol < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.81 < MDL < MDL < MDL 
Chloridazon (Pyrazon) < MDL < MDL < MDL < MDL 0.24 20.66 < MDL < MDL 0.25 < MDL < MDL 17.92 < MDL 
Citalopram < MDL < MDL < MDL 26.98 2.07 < MDL 1.23 < MDL 0.09 < MDL < MDL < MDL < MDL 
Clarithromycin < MDL < MDL < MDL 24.06 27.75 < MDL 1.73 < MDL 3.87 < MDL 3.13 0.66 18.48 
Climbazole 0.23 0.58 < MDL 3.90 2.17 < MDL 0.48 < MDL 2.00 0.64 0.61 0.21 < MDL 
Clomazone < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 7.59 < MDL < MDL < MDL < MDL 
Clopidogrel < MDL < MDL < MDL 0.61 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Codeine < MDL < MDL < MDL 92.78 1.25 < MDL < MDL < MDL 1.13 < MDL 0.87 < MDL < MDL 
Cyanazine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 10.72 
Cybutryne < MDL < MDL 0.21 < MDL < MDL 0.11 0.11 < MDL < MDL < MDL < MDL < MDL 2.49 
Cyprodinil < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.64 < MDL < MDL 1.49 < MDL 
DEET 1.91 6.68 0.59 5.70 1.42 2.59 2.62 < MDL 0.30 8.09 0.96 1.61 7.68 
Diazepam 3.13 6.17 < MDL 18.86 < MDL 0.19 < MDL < MDL < MDL < MDL < MDL 0.11 < MDL 
Dibutyl phosphate 13.47 74.25 < MDL 72.14 < MDL 11.09 < MDL < MDL < MDL < MDL < MDL 74.24 < MDL 
Diclofenac < MDL < MDL < MDL 36.77 28.26 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Difenoconazole I < MDL 0.23 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 2.85 < MDL < MDL < MDL 
Diuron 2.44 2.73 < MDL 70.75 < MDL 9.62 7.05 < MDL < MDL 15.29 1.02 1.38 37.47 
Fexofenadine < MDL < MDL 2.70 17.64 6.94 < MDL 3.94 < MDL 2.34 7.08 9.25 3.56 437.31 







































Table A3 ( continued ) 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
Fluconazole 11.93 17.39 < MDL 204.48 < MDL < MDL < MDL < MDL < MDL < MDL 3.25 20.86 < MDL 
Fludioxonil < MDL < MDL < MDL 1.04 < MDL < MDL 0.36 < MDL 5.09 < MDL < MDL < MDL 4.35 
Flufenacet < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 3.99 < MDL < MDL < MDL < MDL 
Flusilazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 1.48 < MDL < MDL < MDL 
Flutriafol 0.63 19.14 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
FOSA (perfluorooctane 
sulfonamide) 
< MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Fuberidazole < MDL < MDL < MDL < MDL < MDL 0.29 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Furosemide < MDL < MDL < MDL 28.49 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Hexamethylcyclotrisiloxane 
62.80 91.10 < MDL < MDL < MDL 21.93 < MDL < MDL < MDL < MDL < MDL < MDL 14.22 
Hexazinone 0.89 3.73 < MDL < MDL 1.90 0.33 < MDL < MDL < MDL < MDL < MDL < MDL 6.69 
Imidacloprid 2.48 6.32 < MDL 19.86 11.53 < MDL < MDL < MDL 1.98 5.18 < MDL < MDL 1.29 
Irbesartan 2.02 33.61 < MDL 51.38 26.82 < MDL 2.20 < MDL 21.23 < MDL 1.62 1.94 26.03 
Isoproturon 4.18 93.62 < MDL 3.73 < MDL 11.61 0.53 0.26 < MDL < MDL < MDL 0.62 < MDL 
Ketoprofen < MDL < MDL < MDL 15.34 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Lamotrigine 0.34 0.45 12.02 56.65 15.52 0.59 14.73 < MDL 4.67 < MDL 2.90 22.92 14.91 
Levamisole 2.51 < MDL < MDL 14.47 < MDL < MDL < MDL < MDL < MDL 2.37 < MDL < MDL < MDL 
Loratadine < MDL < MDL < MDL 0.40 < MDL < MDL < MDL < MDL < MDL 0.04 < MDL < MDL < MDL 
Losartan < MDL 5.23 < MDL 148.28 9.21 < MDL 3.41 < MDL 4.99 4.06 1.06 3.71 9.98 
Mandipropamid < MDL 0.87 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.32 < MDL 
MCPA < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 27.39 
Mebendazole < MDL < MDL < MDL 1.86 < MDL < MDL < MDL < MDL < MDL 1.10 < MDL < MDL < MDL 
Mecoprop < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metalaxyl 1.97 2.63 < MDL 1.72 0.24 < MDL < MDL < MDL 0.30 8.36 0.16 < MDL 1.74 
Methabenzthiazuron < MDL < MDL < MDL < MDL < MDL 4.68 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Methadone < MDL < MDL < MDL 2.61 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metolachlor 2.99 12.53 < MDL < MDL 0.25 < MDL < MDL < MDL 245.92 3.83 0.72 6.86 1.81 
Metoprolol 0.64 < MDL < MDL 1.94 14.25 < MDL 2.15 < MDL 4.84 < MDL 0.75 0.72 0.37 
Metribuzin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metronidazole 6.68 < MDL < MDL 13.32 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metsulfuron methyl 0.38 11.44 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.39 < MDL 
Mirtazapine < MDL < MDL < MDL 7.18 1.17 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Monobutyl Phtha- 
late (MBP) 
114.56 362.17 < MDL < MDL < MDL 94.84 < MDL < MDL < MDL < MDL 15.40 68.82 24.46 
N-Desmethylcitalopram < MDL < MDL < MDL 3.74 1.25 < MDL 0.49 < MDL 0.42 < MDL < MDL < MDL < MDL 
Nicotine < MDL < MDL < MDL 14.88 < MDL 36.30 < MDL < MDL < MDL < MDL < MDL 4.45 < MDL 
Niflumic acid < MDL < MDL < MDL < MDL < MDL 1.47 < MDL < MDL 1.68 0.47 1.28 2.45 < MDL 
Ofloxacin < MDL < MDL < MDL 23.33 < MDL < MDL < MDL < MDL 0.82 < MDL 0.31 < MDL < MDL 
Oxazepam < MDL < MDL 2.00 50.17 2.87 < MDL 1.82 < MDL < MDL < MDL < MDL 7.10 < MDL 
Oxycodone < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 3.01 < MDL < MDL 
PFBS (perfluorobutane 
sulfonic acid) 
1.47 7.65 < MDL 2.79 < MDL 13.65 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
PFDA (perfluorodecanoic 
acid) 
< MDL 0.85 < MDL 0.29 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
PFHpA 
(perfluoroheptanoic acid) 
1.05 3.94 0.79 3.28 0.30 1.24 0.37 0.24 0.26 0.45 0.54 2.12 1.87 
PFHxA 
(perfluorohexanoic acid) 
6.89 10.30 1.60 5.89 0.68 2.85 0.87 < MDL 0.68 0.91 0.75 3.42 4.44 
PFHxS (perfluorohexane 
sulfonic acid) 
0.77 82.47 1.14 0.73 < MDL 1.28 0.27 < MDL 0.06 < MDL 0.24 0.63 0.36 








































Table A3 ( continued ) 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
PFNA (perfluorononanoic 
acid) 
0.31 2.03 0.24 0.52 < MDL 0.26 0.15 < MDL 0.12 0.16 0.30 0.27 1.66 
PFOA (perfluorooctanoic 
acid) 
11.98 29.55 0.79 3.49 0.17 3.74 0.46 < MDL 0.19 1.08 0.79 2.70 2.12 
PFOS (perfluorooctane 
sulfonic acid) 
0.69 4.15 1.45 18.58 < MDL 2.79 0.96 0.12 0.13 < MDL 0.90 1.33 0.90 
PFPeA 
(perfluoropentanoic acid) 




< MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Prochloraz 0.48 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Progesterone < MDL < MDL < MDL 8.20 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Propamocarb < MDL 6.85 < MDL < MDL < MDL < MDL < MDL < MDL 0.87 < MDL < MDL 1.37 < MDL 
Propiconazole I 2.18 11.69 0.77 4.95 0.73 < MDL 1.15 < MDL 0.45 16.09 < MDL 4.22 1.02 
Propranolol < MDL < MDL < MDL 3.19 < MDL < MDL 0.12 < MDL 0.14 < MDL < MDL < MDL < MDL 
Prothioconazole-desthio < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 2.53 < MDL 
Pyraclostrobin < MDL < MDL < MDL 0.21 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Pyroxsulam < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.14 < MDL < MDL 0.32 < MDL 
Roxithromycin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 2.82 
Sotalol < MDL < MDL < MDL < MDL 10.55 < MDL < MDL < MDL 2.67 < MDL < MDL < MDL < MDL 
Sucralose 949.71 682.82 171.30 3421.67 328.48 184.08 66.24 < MDL 66.06 67.19 37.71 404.79 1139.40 
Sulfamethoxazole < MDL 3.93 < MDL 53.18 13.76 < MDL 6.85 < MDL 3.16 5.77 2.38 6.88 16.69 
TCEP 23.30 112.80 < MDL < MDL < MDL 23.89 1.87 < MDL < MDL < MDL 3.28 < MDL 56.45 
Telmisartan 2.36 8.90 0.48 42.43 163.67 0.02 1.44 < MDL 14.52 1.03 4.73 11.12 85.63 
Terbuthylazine 0.52 7.80 < MDL < MDL 0.37 < MDL 0.82 0.39 202.85 < MDL 1.99 3.88 < MDL 
Terbutryn 2.36 47.77 0.17 17.33 0.35 0.62 0.58 < MDL 0.60 3.14 0.12 0.51 0.05 
Theobromine < MDL < MDL < MDL < MDL 167.64 < MDL < MDL < MDL 77.09 138.74 < MDL 52.81 194.96 
Thiabendazole < MDL < MDL < MDL 34.14 2.13 < MDL < MDL < MDL 1.24 < MDL < MDL 63.64 31.73 
Thiamethoxam 6.69 4.75 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 9.18 < MDL < MDL 3.23 
Tramadol < MDL < MDL 7.20 747.30 41.88 0.61 45.95 < MDL 2.26 4.32 2.41 37.04 14.28 
Triadimefon < MDL < MDL < MDL < MDL < MDL 6.52 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Triflusulfuron-methyl < MDL 0.99 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 1.84 < MDL 
Triisopropanolamine 4.47 11.67 0.86 118.44 11.01 13.93 12.95 < MDL 11.76 27.81 6.17 9.70 85.18 
Valsartan 4.07 50.30 < MDL 386.72 13.69 2.21 6.35 < MDL 41.86 < MDL 3.96 23.55 22.31 
Venlafaxine < MDL < MDL 1.57 100.51 11.85 < MDL 4.59 < MDL 2.31 1.02 1.38 9.06 1.27 
Total concentration 1444.1 2465.7 247.0 7995.2 1092.5 1005.7 221.7 15.1 917.2 791.5 177.9 1007.6 2798.1 
Pesticides 179.0 609.6 3.3 1321.2 64.5 169.9 19.9 0.7 511.2 420.4 7.3 67.3 260.1 
PFASs 23.2 142.9 6.0 38.7 1.2 29.0 3.1 0.4 1.4 2.6 5.5 14.8 14.1 
Pharmaceuticals 38.4 138.7 35.3 2547.9 605.5 19.0 112.8 0.0 243.5 207.9 55.3 290.0 1007.6 
Other CECs 253.8 891.7 31.1 665.8 92.9 603.7 19.6 14.0 95.0 93.4 72.1 230.8 376.9 
Sucralose 949.7 682.8 171.3 3421.7 328.5 184.1 66.2 0.0 66.1 67.2 37.7 404.8 1139.4 
Number of detected 
compounds 









































Average CEC concentrations (ng L −1 ) obtained from analysis of triplicate drinking water samples from the 13 selected DWTPs 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
10,11-Dihydro-10- 
hydroxycarbamazepine 




< MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 301.59 < MDL < MDL < MDL 
4-Chloro-4 ′ - 
fluorobutyrophenone 




< MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Acetaminophen < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Acetamiprid 0.60 4.14 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 2.85 < MDL < MDL < MDL 
Alachlor < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Amitryptiline < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Atenolol < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Atrazine 7.94 44.50 < MDL < MDL 0.41 < MDL < MDL < MDL 1.33 4.85 0.39 0.29 0.24 
Atrazine-desethyl 7.07 17.16 < MDL < MDL 2.32 < MDL < MDL < MDL 23.24 4.41 0.82 3.72 < MDL 
Atrazine-desisopropyl 2.14 7.59 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 1.27 < MDL < MDL 
Azithromycin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Azoxystrobin 0.07 0.14 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 1.98 < MDL < MDL < MDL 
Bentazon < MDL < MDL < MDL < MDL < MDL 2.78 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Benzyl butyl phthalate 
(BBP) 
< MDL < MDL < MDL < MDL < MDL < MDL 14.82 < MDL < MDL < MDL < MDL 42.61 < MDL 
Bezafibrate < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Bicalutamide < MDL < MDL 8.49 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.20 < MDL 0.60 
Bis(2-ethylhexyl) 
phosphate 
< MDL 6.43 1.05 1.88 1.37 < MDL < MDL 4.54 < MDL 6.14 < MDL < MDL 0.96 
Bisoprolol < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Boscalid < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Caffeine 10.71 < MDL 39.68 24.75 6.95 8.98 0.89 14.31 8.67 47.18 2.26 14.64 11.48 
Carbendazim 0.97 1.16 < MDL < MDL 1.21 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Cetirizine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Chloramphenicol < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Chloridazon (Pyrazon) < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.57 < MDL 
Citalopram < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Clarithromycin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Climbazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.22 < MDL < MDL < MDL 
Clomazone < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Clopidogrel < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Codeine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Cyanazine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 1.25 
Cybutryne < MDL < MDL 0.21 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Cyprodinil < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
DEET 0.70 3.72 0.57 0.07 < MDL < MDL < MDL 0.12 < MDL 1.94 0.21 0.61 0.47 
Diazepam 1.28 2.83 < MDL 0.13 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Dibutyl phosphate < MDL 33.20 < MDL 8.10 < MDL < MDL < MDL 25.15 < MDL < MDL < MDL < MDL < MDL 
Diclofenac < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Difenoconazole I < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 1.23 < MDL < MDL < MDL 
Diuron < MDL < MDL < MDL 0.90 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 








































Table A4 ( continued ) 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
Fexofenadine < MDL < MDL 2.20 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Fluconazole 7.07 13.76 < MDL 10.17 < MDL < MDL < MDL < MDL < MDL < MDL 1.23 7.33 < MDL 
Fludioxonil < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Flufenacet < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Flusilazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Flutriafol 1.08 7.41 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
FOSA (perfluorooctane 
sulfonamide) 
< MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Fuberidazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Furosemide < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Hexamethylcyclotrisiloxane 
< MDL < MDL < MDL < MDL 3.37 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Hexazinone 0.64 1.97 < MDL < MDL 0.60 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.82 
Imidacloprid 1.28 4.05 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 2.36 < MDL < MDL < MDL 
Irbesartan 0.33 6.10 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.08 < MDL 0.51 
Isoproturon < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.26 < MDL < MDL < MDL < MDL < MDL 
Ketoprofen < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Lamotrigine 0.09 < MDL 11.91 < MDL < MDL < MDL 0.35 < MDL < MDL < MDL 0.25 0.42 < MDL 
Levamisole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Loratadine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Losartan < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Mandipropamid < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
MCPA < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Mebendazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Mecoprop < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metalaxyl 0.86 1.18 < MDL 0.09 < MDL < MDL < MDL < MDL < MDL 3.06 < MDL < MDL 0.15 
Methabenzthiazuron < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Methadone < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metolachlor 1.28 3.84 < MDL < MDL < MDL < MDL < MDL < MDL 7.16 0.73 < MDL 0.30 0.48 
Metoprolol < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metribuzin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metronidazole 2.83 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metsulfuron methyl 0.31 12.64 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Mirtazapine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Monobutyl Phtha- 
late (MBP) 
< MDL 63.21 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
N-Desmethylcitalopram < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Nicotine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Niflumic acid < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Ofloxacin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.46 < MDL < MDL 
Oxazepam < MDL < MDL 1.87 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Oxycodone < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
PFBS (perfluorobutane 
sulfonic acid) 
2.11 9.37 < MDL 3.19 < MDL 10.33 < MDL < MDL < MDL < MDL < MDL 0.22 < MDL 
PFDA (perfluorodecanoic 
acid) 
< MDL 0.78 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
PFHpA 
(perfluoroheptanoic acid) 
1.08 4.17 0.75 2.55 0.30 1.02 0.53 0.41 0.47 0.26 0.58 1.83 1.36 
PFHxA 
(perfluorohexanoic acid) 
7.55 11.44 1.58 5.63 0.65 2.95 1.46 0.54 1.06 < MDL 0.80 3.65 3.61 








































Table A4 ( continued ) 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
PFHxS (perfluorohexane 
sulfonic acid) 
0.88 85.20 1.27 0.23 < MDL 0.39 0.46 < MDL < MDL < MDL 0.28 0.27 0.24 
PFNA (perfluorononanoic 
acid) 
0.30 1.92 0.26 0.33 < MDL < MDL 0.15 0.11 0.11 0.13 0.34 0.16 1.20 
PFOA (perfluorooctanoic 
acid) 
11.88 30.22 0.72 1.88 0.30 2.04 0.54 0.17 0.31 0.42 0.97 1.76 1.48 
PFOS (perfluorooctane 
sulfonic acid) 
0.70 4.07 1.63 4.14 < MDL 0.23 0.87 0.11 < MDL < MDL 0.99 0.09 0.49 
PFPeA 
(perfluoropentanoic acid) 




< MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Prochloraz < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Progesterone < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Propamocarb < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Propiconazole I 1.50 5.75 0.81 < MDL < MDL < MDL < MDL < MDL < MDL 7.31 < MDL < MDL < MDL 
Propranolol < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Prothioconazole-desthio < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Pyraclostrobin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Pyroxsulam < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Roxithromycin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Sotalol < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Sucralose 497.05 389.80 148.19 377.06 109.83 40.75 31.70 < MDL 35.04 < MDL 22.86 148.17 301.85 
Sulfamethoxazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
TCEP 24.06 112.36 < MDL < MDL < MDL 5.42 < MDL < MDL < MDL < MDL < MDL < MDL 19.01 
Telmisartan 0.02 0.16 0.61 < MDL 0.77 0.09 < MDL < MDL < MDL 0.07 < MDL 0.04 0.09 
Terbuthylazine 0.56 5.08 < MDL < MDL 0.49 < MDL 0.21 0.37 50.60 < MDL 1.14 0.65 < MDL 
Terbutryn < MDL < MDL 0.16 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Theobromine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Thiabendazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 1.05 < MDL 
Thiamethoxam 4.54 3.49 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 4.13 < MDL < MDL < MDL 
Tramadol < MDL < MDL 8.02 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 0.09 0.30 
Triadimefon < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Triflusulfuron-methyl < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Triisopropanolamine < MDL < MDL 1.20 2.03 2.51 < MDL < MDL < MDL < MDL < MDL < MDL 1.17 < MDL 
Valsartan < MDL 16.58 < MDL 6.01 1.45 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 6.16 
Venlafaxine < MDL < MDL 1.60 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Total concentration 601.5 919.4 232.8 456.1 132.5 78.4 54.0 48.3 131.0 390.9 35.1 236.1 356.2 
Pesticides 31.6 123.8 1.8 1.1 5.0 2.8 0.2 0.8 82.3 336.4 3.8 6.1 3.4 
PFASs 26.6 151.2 6.2 24.9 1.2 20.4 6.1 3.6 5.0 0.8 4.0 14.4 11.8 
Pharmaceuticals 11.6 39.4 35.9 18.3 4.7 0.1 0.3 0.0 0.0 0.3 2.2 10.1 7.7 
Other CECs 34.8 215.2 40.7 34.7 11.7 14.4 15.7 44.0 8.7 53.3 2.3 57.2 31.4 
Sucralose 497.0 389.8 148.2 377.1 109.8 40.8 31.7 0.0 35.0 0.0 22.9 148.2 301.9 
Number of detected 
compounds 









































Removal efficiency (%) of all target compounds in the 13 selected DWTPs. 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
10,11-Dihydro-10- 
hydroxycarbamazepine 




67.7 49.5 < MDL 99.4 < MDL < MDL < MDL < MDL 97.7 62.4 < MDL < MDL 95.5 
4-Chloro-4 ′ - 
fluorobutyrophenone 





8.3 39.8 < MDL < MDL 84.5 < MDL 93.0 < MDL 77.0 27.0 5.4 90.1 76.9 
Acetaminophen < 0 < 0 < MDL < MDL 61.1 < MDL < MDL < MDL < 0 < 0 7.7 10.2 < MDL 
Acetamiprid < MDL < 0 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Alachlor 99.0 98.7 84.1 97.3 88.5 < MDL < MDL < MDL 99.1 93.4 81.0 99.4 99.0 
Amitryptiline 95.4 99.7 53.6 84.1 93.1 97.4 < MDL < MDL 94.2 95.9 < MDL 91.4 99.0 
Atenolol < MDL < MDL < MDL 93.8 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Atrazine 98.4 97.5 < MDL 100.0 < 0 98.8 98.7 < MDL 98.9 99.9 91.6 98.0 99.9 
Atrazine-desethyl < MDL < MDL < MDL < MDL 88.4 99.9 < MDL < MDL 89.0 < MDL < MDL 96.8 < MDL 
Atrazine-desisopropyl < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 94.9 < MDL < MDL < MDL < MDL 
Azithromycin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 88.4 
Azoxystrobin < MDL < MDL 0.2 < MDL < MDL 84.6 84.7 < MDL < MDL < MDL < MDL < MDL 99.3 
Bentazon < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 93.9 < MDL < MDL 97.4 < MDL 
Benzyl butyl phthalate 63.2 44.3 2.9 98.8 98.8 99.3 99.3 < MDL 94.2 76.0 78.3 62.4 93.9 
Bezafibrate < MDL 79.0 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 56.6 < MDL < MDL < MDL 
Bicalutamide 96.1 96.5 < MDL 98.7 < MDL 99.0 98.7 < MDL < MDL 99.4 90.7 93.1 99.7 
Bis(2-ethylhexyl) 
phosphate 
< MDL < MDL < MDL 88.1 < MDL < MDL 65.2 < MDL 97.6 < MDL < MDL < MDL 97.2 
Bisoprolol < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 91.2 < MDL < MDL < MDL < MDL 
Boscalid < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 97.7 < MDL < MDL < MDL 
Caffeine < 0 61.3 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Carbendazim < MDL < MDL < MDL < MDL < MDL 92.2 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Cetirizine 28.3 47.1 < MDL < MDL 68.4 92.4 < MDL < MDL < MDL < MDL < MDL < MDL 87.8 
Chloramphenicol 48.2 35.8 < MDL 99.3 98.8 < MDL < MDL < MDL 93.1 54.5 < MDL < MDL 89.4 
Chloridazon 99.4 100.0 < MDL 99.4 < MDL 99.8 95.6 0.7 < MDL < MDL < MDL 96.3 < MDL 
Citalopram < MDL 96.3 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 90.0 < MDL 
Clarithromycin < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 59.6 
Climbazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Clomazone 56.6 55.0 < MDL 95.0 90.5 < MDL < MDL < MDL 92.4 63.4 85.8 < MDL 91.3 
Clopidogrel < MDL < MDL < MDL < MDL < MDL 98.8 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Codeine 57.2 69.4 < MDL < MDL 86.8 < MDL < MDL < MDL 97.1 81.0 95.4 95.7 73.4 
Cyanazine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Cybutryne 18.4 < 0 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 86.2 < MDL 
Cyprodinil 89.1 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
DEET < MDL 98.4 < MDL < MDL < MDL < MDL < MDL < MDL 87.6 < MDL < MDL 92.1 < MDL 
Diazepam 31.0 50.8 < 0 99.2 94.4 < MDL 96.5 < MDL 91.0 54.6 < MDL 99.0 96.1 
Dibutyl phosphate < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 98.0 < MDL 
Diclofenac < MDL < MDL < MDL 78.2 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Difenoconazole I < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 88.2 < MDL < MDL 95.0 < MDL 
Diuron < 0 34.9 < MDL < MDL < 0 < MDL 74.6 5.8 75.1 < MDL 42.5 83.2 < MDL 








































Table A5 ( continued ) 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
Fexofenadine 99.2 100.0 3.9 99.9 94.7 97.0 96.8 < MDL 96.9 99.4 84.1 96.3 65.1 
Fluconazole 32.1 26.4 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 55.0 < MDL < MDL 95.0 
Fludioxonil < MDL < MDL < MDL < MDL < MDL 97.7 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Flufenacet < MDL 94.4 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 97.0 < MDL 
Flusilazole < 0 < 0 < MDL < 0 < MDL 24.3 < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Flutriafol < MDL 7.9 < MDL 76.1 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Fuberidazole < 0 < 0 4.8 22.3 0.5 17.6 < 0 < 0 < 0 42.8 < 0 13.5 27.5 
Furosemide < 0 < 0 < 0 68.6 < MDL 69.5 < 0 < MDL 60.1 < MDL < 0 56.5 33.4 
Hexamethylcyclotrisiloxane 
< 0 < 0 1.1 4.6 4.4 < 0 < 0 < MDL < 0 81.1 < 0 < 0 18.7 
Hexazinone 3.5 5.2 < 0 36.1 < MDL 78.3 < 0 < MDL 8.9 15.7 < 0 41.1 27.8 
Imidacloprid < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Irbesartan < 0 1.9 < 0 77.7 < MDL 91.9 9.3 7.4 77.1 < MDL < 0 93.4 45.6 
Isoproturon 0.8 < 0 9.5 46.2 < 0 45.4 < 0 < MDL < 0 61.4 < 0 34.7 30.2 
Ketoprofen < MDL < 0 < MDL < 0 < MDL < 0 < MDL < MDL < MDL < MDL 61.8 < 0 < 0 
Lamotrigine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Levamisole < MDL < MDL < MDL 99.5 < MDL < MDL < MDL < MDL 95.7 < MDL < MDL < MDL < MDL 
Loratadine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 94.6 < MDL < MDL < MDL < MDL 
Losartan < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 89.7 < MDL < MDL 
Mandipropamid < MDL < MDL < MDL 99.0 97.0 < MDL 89.2 < MDL 98.5 < MDL 88.0 < MDL 97.7 
MCPA < MDL < MDL < MDL 99.9 < MDL < MDL < MDL < MDL < MDL < MDL 95.8 < MDL < MDL 
Mebendazole < MDL < MDL < MDL 98.8 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 98.5 
Mecoprop < MDL 90.6 < 0 99.2 99.1 < MDL 91.4 < MDL 95.6 < MDL 87.7 98.7 97.0 
Metalaxyl < MDL < MDL < MDL 99.8 98.6 < MDL 97.5 < MDL < MDL < MDL < MDL < MDL < MDL 
Methabenzthiazuron < MDL < MDL < MDL 99.8 99.8 < MDL < MDL < MDL 98.3 99.7 97.7 99.6 99.8 
Methadone < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 62.2 < MDL < MDL < MDL 
Metolachlor < MDL < MDL < MDL 99.9 98.7 < MDL 97.9 < MDL 72.3 < MDL < MDL < MDL < MDL 
Metoprolol < MDL < MDL < MDL 99.9 100.0 < MDL 99.3 < MDL 99.7 < MDL 99.6 98.1 99.9 
Metribuzin 92.5 97.1 < MDL 99.6 99.2 < MDL 96.4 < MDL 99.1 64.8 97.2 92.0 < MDL 
Metronidazole < MDL < MDL < MDL 95.8 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Metsulfuron methyl < MDL < MDL < MDL 100.0 96.7 < MDL < MDL < MDL 96.3 < MDL 95.3 < MDL < MDL 
Mirtazapine 59.0 54.0 < MDL 99.3 < MDL 91.9 < MDL < MDL < MDL < MDL < MDL 86.2 < MDL 
Monobutyl Phthalate < MDL < MDL < MDL 85.1 80.6 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
N- 
Desmethylcitalopram 
< MDL < MDL 18.6 99.9 99.8 < MDL 99.7 < MDL 99.5 99.8 99.9 99.7 100.0 
Nicotine 40.8 20.9 < MDL 95.0 < MDL < MDL < MDL < MDL < MDL < MDL 62.0 64.8 < MDL 
Niflumic acid < MDL < MDL < MDL 87.7 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Ofloxacin 83.8 81.8 < MDL 100.0 99.9 < MDL 98.9 < MDL 99.9 < MDL 95.3 98.7 98.1 
Oxazepam < MDL < MDL < MDL 97.1 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Oxycodone 73.7 93.0 0.9 99.9 99.8 94.7 97.6 < MDL 99.3 < MDL 91.4 98.2 99.8 
Perfluorobutane 
sulfonic acid (PFBS) 
97.8 < MDL < MDL 99.6 < MDL < MDL < MDL < MDL < MDL 97.7 < MDL < MDL < MDL 
Perfluorodecanoic acid 
(PFDA) 
< MDL < MDL < MDL 95.8 < MDL < MDL < MDL < MDL < MDL 60.0 < MDL < MDL < MDL 








































Table A5 ( continued ) 
Compound China #1 China #2 Sweden Spain Czech Republic Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
Perfluoroheptanoic 
acid (PFHpA) 
< MDL 99.0 < MDL 100.0 99.4 < MDL 98.4 < MDL 98.9 98.7 95.0 98.6 99.5 
Perfluorohexane 
sulfonic acid (PFHxS) 
< MDL < MDL < MDL 93.9 < MDL < MDL < MDL < MDL < MDL 89.7 < MDL < MDL < MDL 
Perfluorohexanoic acid 
(PFHxA) 
< MDL < MDL < MDL 98.7 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Perfluorononanoic acid 
(PFNA) 
94.1 < MDL < MDL 98.0 99.7 < MDL 98.2 < MDL 99.2 < MDL 94.9 94.7 89.6 
Perfluorooctane 
sulfonamide (FOSA) 
57.6 < MDL < MDL 96.8 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Perfluorooctane 
sulfonic acid (PFOS) 
< MDL < MDL < MDL 99.5 97.0 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Perfluorooctanoic acid 
(PFOA) 
< MDL < MDL < MDL 98.8 96.3 < MDL 90.7 < MDL 89.2 < MDL < MDL < MDL < MDL 
Perfluoropentanoic 
acid (PFPeA) 
< MDL < MDL < MDL < MDL < MDL 95.0 < MDL < MDL 95.6 84.3 94.2 97.0 < MDL 
Perfluoroundecanoic 
acid (PFUnDA) 
< MDL < MDL < MDL 99.6 < MDL < MDL < MDL < MDL 89.4 < MDL < 0 < MDL < MDL 
Prochloraz < MDL < MDL 6.3 99.7 95.3 < MDL 92.6 < MDL < MDL < MDL < MDL 98.1 < MDL 
Progesterone < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 98.2 < MDL < MDL 
Propamocarb < MDL < MDL < MDL 98.8 < MDL < MDL 67.8 < MDL 72.8 < MDL < MDL < MDL < MDL 
Propiconazole < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 99.4 
Propranolol < MDL < MDL < MDL < MDL 96.3 < MDL < MDL < MDL 85.3 < MDL < MDL < MDL < MDL 
Prothioconazole- 
desthio 
< MDL 91.2 < MDL 99.4 97.5 < MDL 95.0 < MDL 89.1 94.0 85.5 95.0 97.9 
Pyraclostrobin 99.3 98.2 < 0 100.0 99.5 < 0 99.6 < MDL 100.0 92.9 99.9 99.7 99.9 
Pyroxsulam < MDL < MDL < MDL < MDL 98.7 < MDL < MDL < MDL 97.2 98.4 < MDL 95.9 98.9 
Roxithromycin < MDL < MDL < MDL 99.2 87.4 < MDL < MDL < MDL 78.4 < MDL < MDL 98.3 99.2 
Sotalol < MDL < MDL < 0 100.0 99.9 92.8 99.9 < MDL 98.1 99.0 98.2 99.7 97.9 
Sucralose 96.4 98.6 < 0 98.3 77.2 98.8 98.8 < MDL 98.6 99.4 97.4 87.9 99.8 
Sulfamethoxazole 90.5 67.0 < MDL 98.4 89.4 82.4 93.9 < MDL 99.1 < MDL 90.2 98.4 72.4 
TCEP < MDL < MDL < 0 100.0 99.7 < MDL 99.2 < MDL 98.4 96.4 97.3 99.6 97.1 
Telmisartan 47.7 42.9 13.5 89.0 66.6 77.9 52.1 < MDL 47.0 86.5 39.4 63.4 73.5 
Terbuthylazine 70.7 99.7 < 0 91.1 89.7 11.2 95.0 < 0 90.3 < 0 95.7 78.8 94.7 
Terbutryn < MDL < MDL < MDL 97.5 < MDL 99.0 < MDL < MDL < MDL < MDL < MDL 91.7 < MDL 
Theobromine < MDL < MDL < MDL 96.0 < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Thiabendazole < 0 0.4 < MDL < MDL < MDL 77.3 55.8 < MDL < MDL < MDL 74.8 < MDL 66.3 
Thiamethoxam < MDL < MDL < MDL 99.9 99.0 < MDL < MDL < MDL < MDL 97.5 < MDL 97.5 98.9 
Tramadol < MDL 96.9 < MDL 94.9 < MDL 99.2 < MDL < MDL < MDL 91.5 < MDL < MDL 92.1 
Triadimefon 92.5 82.8 < MDL 95.9 63.4 97.6 < MDL < 0 95.5 56.0 76.2 95.2 47.0 
Triflusulfuron-methyl 77.1 55.3 < MDL 88.8 < MDL 72.2 < MDL < MDL < MDL < MDL < MDL 95.8 < MDL 
Triisopropanolamine < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL < MDL 
Valsartan 93.9 82.5 < MDL < MDL < MDL 92.6 < MDL < MDL < MDL < MDL 54.4 89.8 71.3 
Venlafaxine 99.4 99.6 < MDL < MDL < MDL 98.4 < MDL < MDL < MDL < MDL < MDL < MDL 97.5 
Average - Total 55.2 56.6 9.1 89.0 82.0 76.8 77.4 2.3 83.3 73.4 69.2 84.0 81.6 
Average - Pesticide 55.6 61.5 24.1 93.4 74.1 96.4 90.3 3.3 87.5 67.4 66.2 88.4 87.3 
Average - PFAS 0.6 1.7 2.6 36.8 1.7 40.9 1.5 3.7 24.3 50.3 8.8 34.2 26.2 
Average - 
Pharmaceutical 
80.5 81.0 3.2 98.2 96.3 79.4 95.1 < MDL 94.0 89.1 89.2 95.2 97.0 
Average - Misc 72.3 73.9 0.0 94.9 84.0 80.9 75.4 0.0 92.9 86.5 39.4 63.4 73.5 
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Table A6 
List of suspects (n = 500) screened for in the raw water and drinking water. The list was created using SusTool ( Dürig et al., 2019 ). 












67596-04-7 CC( = C)C( = O)OCC[N + ](C)(C)CC(O)CCl 250.120996 
(E)-3-Formyl-2,4,4-trichloro-2-butenoic acid 115340-67-5 OC( = O)C(Cl) = C(C = O)C(Cl)Cl 215.914776 
(p-Ammoniophenyl)ethyl(2-hydroxyethyl)ammonium 
sulphate 
4327-84-8 Nc1ccc(CCNCCO)cc1 180.126263 
(Propylcarbonylthioethyl)trimethylammonium iodide 1866-16-6 CCCC( = O)SCC[N + ](C)(C)C 190.126559 
(R)-N-Methylsalsolinol 53622-84-7 CC1c2cc(O)c(O)cc2CCN1C 193.110279 
(R)-S-(2-amino-2-carboxyethyl)-L-homocysteine 56-88-2 NC(CSCCC(N)C(O) = O)C(O) = O 222.067428 
?-hydroxyhippuric acid 16555-77-4 OC( = O)C(O)NC( = O)c1ccccc1 195.053159 




68928-62-1 CC( = C)C( = O)OCC[N + ](C)(C)CC(C)O 216.159969 
[R(R ∗ ,R ∗]-2-amino-1-[p- 
(methylsulphonyl)phenyl]propane-1,3-diol 
51458-28-7 CS( = O)( = O)c1ccc(cc1)C(O)C(N)CO 245.072179 
1-(2,4-Dinitrophenyl)pyridinium chloride 4185-69-7 [O-][N + ]( = O)c1cc(ccc1-[n + ]1ccccc1)[N + ]([O-]) = O 246.051482 
1-(2-Aminoethyl)piperazine 140-31-8 NCCN1CCNCC1 129.126597 





C1N2CN3C[N + ]1(CN(C2)C3)CC = CC[N + ]12CN3CN(C1)CN(C2)C3 
334.259342 
1,1-Diethoxy-2-methylbutane 3658-94-4 NC1 = NC( = O)C2N = C(COP(O)( = O)OP(O)(O) = O)CNC2 = N1 355.008289 
1,1 ′ -Oxybis-2-propanol 110-98-5 CC(O)COCC(C)O 134.094295 
1,2,4-Benzenetrisulfonic acid, 5,6-dihydroxy-, trisodium 
salt 
112935-85-0 Oc1c(cc(c(c1O)S(O)( = O) = O)S(O)( = O) = O)S(O)( = O) = O 349.907225 




65945-33-7 C = Cc1ccccc1CN(CCN)CCN 219.173547 
1,2-Propylene glycol 57-55-6 CC(O)CO 76.05243 
1,3,5-Triazine-1,3,5(2H,4H,6H)-triethanol 4719-04-4 OCCN1CN(CN(C1)CCO)CCO 219.158292 
1,3-Benzenedimethanamine 1477-55-0 NCc1cc(CN)ccc1 136.100048 
1,3-Benzenedisulfonic acid, 4-hydroxy- 96-77-5 Oc1ccc(cc1S(O)( = O) = O)S(O)( = O) = O 253.955495 
1,3-Dimethylol-5,5-dimethylhydantoin 6440-58-0 CC1(C)C( = O)N(CO)C( = O)N1CO 188.079708 
1,4-BENZENDIOL, 2-(PHENYLMETHYL)- 1706-73-6 Oc1cc(Cc2ccccc2)c(O)cc1 200.08373 
1,4-Diazabicyclo[2.2.2]octane 280-57-9 C1CN2CCN1CC2 112.100048 
16ALPHA-HYDROXYESTRONE 566-76-7 CC12CCC3C(CCc4cc(O)ccc43)C1CC(O)C2 = O 286.156895 
16-Ketoestradiol 566-75-6 CC12CCC3C(CCc4cc(O)ccc43)C1CC( = O)C2O 286.156895 
17-Alpha-estradiol 57-91-0 c1c(O)cc2CCC3C4CCC(O)C4(C)CCC3c2c1 272.17763 
17-Beta-estradiol 50-28-2 CC12CCC3C(CCc4cc(O)ccc43)C1CCC2O 272.17763 
1-Amino-2-propanol 78-96-6 CC(O)CN 75.068414 
1-Methoxy-4-(1,2,2,2-tetrachloroethyl)benzene 51495-87-5 COc1ccc(cc1)C(Cl)C(Cl)(Cl)Cl 271.932923 
1-Propanaminium, 
3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-coco acyl 
derivs., chlorides, sodium salts 
61789-39-7 C[N + ](C)(CCCN)CC(O) = O 161.129003 
1-Propanesulfonic acid, 2-hydroxy-3-(2-propenyloxy)-, 
monosodium salt 
52556-42-0 C = CCOCC(O)CS(O)( = O) = O 196.040545 
1-Propanol, 3,3 ′ ,3 ′ ’-phosphinylidynetris- 51805-42-6 OCCCP( = O)(CCCO)CCCO 224.117747 
2-(2,7-Dichloro-6-hydroxy-3-oxo-3H-xanthen-9- 
yl)benzoic acid 
76-54-0 Oc1cc2Oc3cc(O)c(Cl)cc3C3(OC( = O)c4ccccc34)c2cc1Cl 399.990529 
2-(4,5-Dibromo-3,6-dihydroxy-2,7- 
dinitroxanthen-9-yl)-benzoic acid, disodium salt 
548-24-3 [O-][N + ]( = O)c1cc2C(c3ccccc3C(O) = O) = C3C = C(C( = O)C(Br) = 
C3Oc2c(Br)c1O)[N + ]([O-]) = O 
577.859655 
2-(4-Hydroxybenzyl)phenol 2467-03-0 Oc1ccc(Cc2ccccc2O)cc1 200.08373 
2-(Hydroxymethyl)-2-nitro-1,3-propanediol 126-11-4 [O-][N + ]( = O)C(CO)(CO)CO 151.048074 
2,2,2-[Methylidynetris(thio)]trisacetic acid 34914-39-1 OC( = O)CSC(SCC(O) = O)SCC(O) = O 285.96395 
2,2 ′ -[[3-Methyl-4-[[4-[[2- 
(sulphooxy)ethyl]sulphonyl]phenyl]azo]phenyl]imino] 
bisethyl bis(hydrogen sulphate), sodium salt 
94157-82-1 Cc1cc(ccc1N = Nc1ccc(cc1)S( = O)( = O)CCOS(O)( = O) = O) 
N(CCOS(O)( = O) = O)CCOS(O)( = O) = O 
647.021937 
2,2-Bis(4-hydroxyphenyl)-1,1,1-trichloroethane 2971-36-0 Oc1ccc(cc1)C(c1ccc(O)cc1)C(Cl)(Cl)Cl 315.982461 
2,3-DICHLOROPROPIONIC ACID 565-64-0 OC( = O)C(Cl)CCl 141.958834 
2,3-Dihydroxyfumaric acid 133-38-0 OC(C( = O)C(O) = O)C(O) = O 148.00079 
2,3-NAPHTHALENEDIOL, 6-ETHYL- 136944-43-9 CCc1cc2cc(O)c(O)cc2cc1 188.08373 
2,4,4 ′ -Trihydroxybenzophenone 1470-79-7 Oc1cc(O)ccc1C( = O)c1ccc(O)cc1 230.05791 
2,4,6-Tris(dimethylaminomethyl)phenol 90-72-2 CN(C)Cc1cc(CN(C)C)c(O)c(CN(C)C)c1 265.215412 
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67762-72-5 CC( = C)CC1CC( = O)N(CCNCCNCCNCCN)C1 = O 325.247775 
2-Amino-2-methylpropan-1-ol 124-68-5 CC(C)(N)CO 89.084064 
2-Chloro-4-phenylphenol 92-04-6 Oc1cc(Cl)c(cc1)-c1ccccc1 204.034192 
2-Chloro-6-hydroxynaphthalene 40604-49-7 Oc1cc2ccc(Cl)cc2cc1 178.018542 
2-chloro-9-[3-(dimethylamino)propyl]thioxanthen-9-ol 4295-65-2 CN(C)CCCC1(O)c2ccccc2Sc2ccc(Cl)cc12 333.095411 
2-Deoxyguanosine-5-Triphosphate 2564-35-4 NC1Nc2c([n]c[n]2C2CC(O)C(COP(O)( = O)OP(O)( = O)OP(O) 
(O) = O)O2)C( = O)N = 1 
506.995751 
2-Deoxyinosine 890-38-0 OC1CC(OC1CO)[n]1c[n]c2c1NC = NC2 = O 252.085856 
2-Ethyl-2-(hydroxymethyl)-1,3-propanediol 77-99-6 CCC(CO)(CO)CO 134.094295 
2-Furanmethanol, 2-formate 13493-97-5 CC1OCC(O)C(O1)C(O)C(O)C = O 206.07904 
2-hydroxy-5-carboxymethylmuconate semialdehyde 2461-62-3 OC( = O)C( = O)C = CC(CC(O) = O)C = O 200.03209 
2-Hydroxy-estradiol 362-05-0 CC12CCC3C(CCc4cc(O)c(O)cc43)C1CCC2O 288.172545 
2-Hydroxyethanesulfonic acid maleate, disodium 51678-73-0 OC( = O)C = CC( = O)OCCS(O)( = O) = O 223.999075 
2-Keto-3-deoxy-6-phosphogluconate 27244-54-8 OC( = O)C( = O)CC(O)C(O)COP(O)(O) = O 258.014072 
2-Methoxyestradiol 362-07-2 CC12CCC3C(CCc4cc(O)c(cc43)OC)C1CCC2O 302.188195 
2-Propenoic acid, polymer with 2-methyl-2-[(1-oxo-2- 
propen-1-yl)amino]-1-propanesulfonic acid 
40623-75-4 CCC(C)(NC( = O)C = C)S(O)( = O) = O 207.056529 
3-(2-Aminoethyl)indol-5-ol 50-67-9 NCCc1c[nH]c2ccc(O)cc21 176.094963 
3-(2-Chloro-phenoxy)-propane-1,2-diol 5112-21-0 OCC(O)COc1ccccc1Cl 202.039672 
3-(Dimethylamino)propylamine 109-55-7 CN(C)CCCN 102.115698 
3-(Trimethoxysilyl)-N-[3-(trimethoxysilyl)propyl]propan- 
1-amine 
82985-35-1 CO[Si](CCCNCCC[Si](OC)(OC)OC)(OC)OC 341.168993 
3-(Trimethoxysilyl)propan-1-amine 13822-56-5 CO[Si](CCCN)(OC)OC 179.097771 
3,3,3-Trichloro-2-hydroxy-propionic acid 599-01-9 OC(C(O) = O)C(Cl)(Cl)Cl 191.914776 
3,3 ′ -Dichloro-5,5 ′ -dinitro-2,2 ′ -biphenol 15595-24-1 [O-][N + ]( = O)c1cc(Cl)c(O)c(c1)-c1cc(cc(Cl)c1O)[N + ]([O-]) = O 343.960292 
3,3 ′ -Dimethylbisphenol A 79-97-0 CC(C)(c1cc(C)c(O)cc1)c1cc(C)c(O)cc1 256.14633 
3,4-Dihydroxyphenyllactic acid 23028-17-3 OC(Cc1cc(O)c(O)cc1)C(O) = O 198.052825 
3,6,9,12-Tetraoxahexadecan-1-ol 1559-34-8 CCCCOCCOCCOCCOCCO 250.178025 
3-[(6-Deoxy-?-L-mannopyranosyl)oxy]-5,7-dihydroxy-2- 
(3,4,5-trihydroxyphenyl)-4H-benzopyran-4-one 
17912-87-7 CC1OC(OC2C( = O)c3c(cc(O)cc3O)OC = 2c2cc(O)c(O)c(O)c2) 
C(O)C(O)C1O 
464.09548 
3-Benzylsydnone-4-acetamide 14504-15-5 NC( = O)Cc1c(O)o[n][n + ]1Cc1ccccc1 234.087867 
3-Deazaadenosine 6736-58-9 Nc1[n]ccc2c1[n]c[n]2C1OC(CO)C(O)C1O 266.101506 
3-Deoxyestradiol 2529-64-8 CC12CCC3C(CCc4ccccc43)C1CCC2O 256.182715 
3-HYDROXY-4-OXO-4H-PYRAN-2,6-DICARBOXYLIC ACID 497-59-6 OC( = O)C1 = CC( = O)C( = O)C(O1)C(O) = O 199.995705 
3-Hydroxykynurenine 484-78-6 Nc1c(cccc1O)C( = O)CC(N)C(O) = O 224.079708 
3-Ketolactose 15990-62-2 OC(CO)C(OC1OC(CO)C(O)C( = O)C1O)C(O)C(O)C = O 340.100565 
3-O-Ethylascorbic acid 86404-04-8 CCOC1C(OC( = O)C1 = O)C(O)CO 204.06339 
4-((Dimethylamino)methyl)phenol 103-87-7 CN(C)Cc1ccc(O)cc1 151.099714 
4-(4-Acetylpiperazin-4-yl)phenol 67914-60-7 CC( = O)N1CCN(CC1)c1ccc(O)cc1 220.121178 
4(G)-alpha-glucopyranosyl-rutin 130603-71-3 CC1OC(OCC2OC(OC3C( = O)c4c(cc(O)cc4O)OC = 3c3cc(O) 
c(O)cc3)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O 
772.206215 
4,4 ′ -(3H-2,1-benzoxathiol-3-ylidene)bis[2-chlorophenol] 
S,S-dioxide 
4430-20-0 Oc1ccc(cc1Cl)C1(OS( = O)( = O)c2ccccc12)c1cc(Cl)c(O)cc1 421.978249 
4,4 ′ -(Oxydiethylene)bis(morpholine) 6425-39-4 C1COCCN1CCOCCN1CCOCC1 244.178693 
4,4 ′ -Biphenyldiol 92-88-6 Oc1ccc(cc1)-c1ccc(O)cc1 186.06808 
4,4 ′ -Dihydoxybenzophenone 611-99-4 Oc1ccc(cc1)C( = O)c1ccc(O)cc1 214.062995 
4,4 ′ -Dihydroxydiphenyl ether 1965-09-9 Oc1ccc(cc1)Oc1ccc(O)cc1 202.062995 
4,4-Dithiobis[2-aminobutyric] acid 462-10-2 NC(CCSSCCC(N)C(O) = O)C(O) = O 268.055148 
4,4-Iminodianiline 537-65-5 Nc1ccc(cc1)Nc1ccc(N)cc1 199.110947 
4,4 ′ -Oxydianiline 101-80-4 Nc1ccc(cc1)Oc1ccc(N)cc1 200.094963 
4,4 ′ -Propane-1,1-diyldiphenol 1576-13-2 CCC(c1ccc(O)cc1)c1ccc(O)cc1 228.11503 
4,4 ′ -Thiodibenzene-1,3-diol 97-29-0 Oc1cc(O)c(cc1)Sc1ccc(O)cc1O 250.02998 
4-[(4-Amino-3-methylphenyl)amino]-phenol, reaction 
products with sodium sulfide (Na2(Sx)) 
1327-57-7 Cc1cc(ccc1N)Nc1ccc(O)cc1 214.110613 
4-[(4-Iminocyclohexa-2,5-dien-1-ylidene)benzyl]aniline 
monohydrochloride 
3442-83-9 Nc1ccc(cc1)C(c1ccccc1) = C1C = CC( = N)C = C1 272.131348 
4-Amino-4 ′ -hydroxybiphenyl 1204-79-1 Nc1ccc(cc1)-c1ccc(O)cc1 185.084064 




84080-70-6 COC( = O)CON = C(C( = O)CCl)C(O) = O 237.004016 
4-Chloro-4 ′ -biphenylol 28034-99-3 Oc1ccc(cc1)-c1ccc(Cl)cc1 204.034192 
4-Cyclohexylphenol 1131-60-8 Oc1ccc(cc1)C1CCCCC1 176.120115 
4-Hydroxybenzophenone 1137-42-4 Oc1ccc(cc1)C( = O)c1ccccc1 198.06808 
4-Hydroxy-estradiol 5976-61-4 CC12CCC3C(CCc4c3ccc(O)c4O)C1CCC2O 288.172545 
4-Hydroxyphenylpyruvic acid 156-39-8 OC( = O)C( = O)Cc1ccc(O)cc1 180.04226 
4-Phenylphenol 92-69-3 Oc1ccc(cc1)-c1ccccc1 170.073165 
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4-phenylpiracetam 77472-70-9 NC( = O)CN1CC(CC1 = O)c1ccccc1 218.105528 
5-(3-Dimethylaminopropyl)-10,11- 
dihydrodibenzo[a,d]cyclohepten-5-ol 
1159-03-1 CN(C)CCCC1(O)c2ccccc2CCc2ccccc12 295.193614 
5-Amino-3-sulfosalicylic acid 6201-87-2 Nc1cc(c(O)c(c1)C(O) = O)S(O)( = O) = O 232.999409 
5-Bromo-4-chloroindol-3-yl-?-D-galactopyranoside 7240-90-6 OCC1OC(Oc2c[nH]c3ccc(Br)c(Cl)c23)C(O)C(O)C1O 406.977127 
5-Bromouridine 957-75-5 OCC1OC(C(O)C1O)N1C = C(Br)C( = O)NC1 = O 321.980049 
5-Fluorouridine 316-46-1 OCC1OC(C(O)C1O)N1C = C(F)C( = O)NC1 = O 262.060116 
5H-Thiachromine-8-ethanol, 2,7-dimethyl- 92-35-3 CC1 = C(CCO)SC2 = Nc3[n]c(C)[n]cc3CN12 262.088831 
6,6-Dihydroxy-3,3-diarsene-1,2-diyldianilinium dichloride 139-93-5 Nc1cc(ccc1O)[As] = [As]c1cc(N)c(O)cc1 365.933066 
6a,7-dihydro-3,4,6a,10-tetrahydroxybenz[b]indeno[1,2- 
d]pyran-9(6H)-one 
475-25-2 Oc1ccc2c(OCC3(O)CC4 = CC( = O)C( = O)CC4 = C32)c1O 300.06339 
6-Alpha-hydroxy-estradiol 1229-24-9 CC12CCC3C(CC(O)c4cc(O)ccc43)C1CCC2O 288.172545 
6-Azacytidine 3131-60-0 NC1C = NN(C2OC(CO)C(O)C2O)C( = O)N = 1 244.080771 
6-AZAURIDINE 54-25-1 OCC1OC(C(O)C1O)N1N = CC( = O)NC1 = O 245.064787 
6-Phosphonoglucono-delta-lactone 2641-81-8 OC1C(COP(O)(O) = O)OC( = O)C(O)C1O 258.014072 
7-Aminonaphthalene-1,3,6-trisulphonic acid 118-03-6 Nc1cc2c(cc(cc2cc1S(O)( = O) = O)S(O)( = O) = O)S(O)( = O) = O 382.943944 
7-Thia-8-oxoguanosine 122970-40-5 NC1 = NC( = O)C2SC( = O)N(C3OC(CO)C(O)C3O)C2 = N1 316.047756 
8-Azidoadenosine 4372-67-2 Nc1[n]c[n]c2c1[n]c(N = [N + ] = N)[n]2C1OC(CO)C(O)C1O 309.105977 
8-Bromo-cAMP 23583-48-4 Nc1[n]c[n]c2c1[n]c(Br)[n]2C1OC2COP(O)( = O)OC2C1O 406.963033 
8-Hydroxyguanosine 3868-31-3 NC1 = NC( = O)C2NC( = O)N(C3OC(CO)C(O)C3O)C2 = N1 299.086585 
9-Deazainosine 89458-19-5 OCC1OC(C(O)C1O)c1c[nH]c2C( = O)N = CNc21 267.085522 
Acetarsol 97-44-9 CC( = O)Nc1cc(ccc1O)[As](O)(O) = O 274.977493 
Acetophenazine 2751-68-0 CC( = O)c1cc2c(cc1)Sc1ccccc1N2CCCN1CCN(CCO)CC1 411.198047 
ACETRYPTINE 3551-18-6 CC( = O)c1cc2c(CCN)c[nH]c2cc1 202.110613 
Acetylpromazine 61-00-7 CN(C)CCCN1c2cc(ccc2Sc2ccccc12)C(C) = O 326.145283 
ACONINE 509-20-6 CCN1CC2(COC)C3C(OC)C4C1C3(C1CC3(O)C(OC)C(O)C4(O) 
C1C3O)C(CC2O)OC 
499.278134 
Acrylic acid 79-10-7 C = CC(O) = O 72.02113 
Adenosine 5-(trihydrogen diphosphate) 58-64-0 Nc1[n]c[n]c2c1NCN2C1OC(COP(O)( = O)OP(O)(O) = O)C(O)C1O 429.045069 
Adenosine 5 ′ -(trihydrogen diphosphate), monosodium 
salt 
1172-42-5 Nc1[n]c[n]c2c1[n]c[n]2C1OC(COP(O)( = O) 
OP(O)(O) = O)C(O)C1O 
427.029419 
Adenosine Phosphosulfate 485-84-7 Nc1[n]c[n]c2c1[n]c[n]2C1OC(COP(O)( = O)OS(O) 
( = O) = O)C(O)C1O 
427.019902 
Adesulfone sodium 144-75-2 OS( = O)CNc1ccc(cc1)S( = O)( = O)c1ccc(cc1)NCS(O) = O 404.017048 
Alcohols, C13-15, ethoxylated 64425-86-1 CC1C(CCc2cccc(O)c21)N(CCC)CCC 261.209264 
ALENTEMOL 112891-97-1 CCCN(CCC)C1Cc2cc(O)cc3cccc(C1)c23 283.193614 
Alginic acid 9005-32-7 COC1C(OC(OC2C(OC(OC)C(O)C2O)C(O) = O)C(O)C1O)C(O) = O 398.106045 
Allantoin 97-59-6 NC( = O)NC1NC( = O)NC1 = O 158.043991 
Alloxantin 76-24-4 OC1(C( = O)NC( = O)NC1 = O)C1(O)C( = O)NC( = O)NC1 = O 286.018566 
Alpha-amanitin 23109-05-9 CCC(C)C1NC( = O)CNC( = O)C2Cc3c4ccc(O)cc4[nH]c3S( = O) 
CC(NC( = O)CNC1 = O)C( = O)NC(CC(N) = O)C( = O)N1CC(O) 
CC1C( = O)NC(C(C)C(O)CO)C( = O)N2 
918.35417 
Alpha-D-glucose 1,6-bisphosphate 10139-18-1 OC1C(OP(O)(O) = O)OC(COP(O)(O) = O)C(O)C1O 339.996054 
Alpha-D-glucose-1-phosphate 59-56-3 OCC1OC(OP(O)(O) = O)C(O)C(O)C1O 260.029722 
Amidephrine mesylate 1421-68-7 CNCC(O)c1cc(ccc1)NS(C)( = O) = O 244.088163 
Aminoimidazole ribotide 25635-88-5 Nc1c[n]c[n]1C1OC(COP(O)(O) = O)C(O)C1O 295.056939 
Amiterol 54063-25-1 CC(CC)NCC(O)c1ccc(N)cc1 208.157563 
AMMONIUM ZIRCONIUM HYDROXY CITRATE 149564-62-5 OC( = O)CC(O)(CC( = O)OO)C(O) = O 208.02192 
Amopyroquine 550-81-2 Oc1ccc(cc1CN1CCCC1)Nc1cc[n]c2cc(Cl)ccc21 353.129489 
Amygdalin 29883-15-6 N#CC(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O) 
c1ccccc1 
457.158414 
Anthrarobin 577-33-3 Oc1ccc2c(cc3ccccc3c2O)c1O 226.062995 
Aphidicolin 38966-21-1 CC12CCC(O)C(C)(CO)C1CCC1CC3CC21CCC3(O)CO 338.24571 
Arbutin 497-76-7 Oc1ccc(cc1)OC1OC(CO)C(O)C(O)C1O 272.089605 
Ascorbic acid 2-O-glucoside 129499-78-1 OC(CO)C1OC( = O)C(OC2OC(CO)C(O)C(O)C2O)C1 = O 338.084915 
ASPARTOCIN 4117-65-1 CC(C)CC(NC( = O)C1CCCN1C( = O)C1CSSCC(N)C( = O) 
NC(Cc2ccc(O)cc2)C( = O)NC(C(C)CC)C( = O)NC(CC(N) = O)C( = O) 
NC(CC(N) = O)C( = O)N1)C( = O)NCC(N) = O 
992.420808 
Asperuloside 14259-45-1 CC( = O)OCC1 = CC2OC( = O)C3 = COC(OC4OC(CO)C(O) 
C(O)C4O)C1C32 
414.116215 
Azidamfenicol 13838-08-9 N = [N + ] = NCC( = O)NC(CO)C(O)c1ccc(cc1)[N + ]([O-]) = O 296.099495 
Benaxibine 27661-27-4 OC( = O)c1ccc(cc1)NC1OCC(O)C(O)C1O 269.089939 
Benzenemethanaminium, 
ar-ethenyl-N-(2-hydroxyethyl)-N,N-dimethyl-, chloride, 
polymer with diethenylbenzene 
63181-94-2 C[N + ](C)(CCO)Cc1ccccc1C = C 206.154489 
Benzenesulfonamide,3-F-4-[3-HOPr-thio]- 108966-74-1 NS( = O)( = O)c1cc(F)c(cc1)SCCCO 265.024262 
benzyl(3-chloro-2-hydroxypropyl)dimethylammonium 
Chloride 
67304-25-0 C[N + ](C)(CC(O)CCl)Cc1ccccc1 228.115516 
Benzylmorphine 14297-87-1 CN1CCC23C4C = CC(O)C2Oc2c3c(CC14)ccc2OCc1ccccc1 375.183444 
Bergenin 477-90-7 COc1c(O)cc2C( = O)OC3C(OC(CO)C(O)C3O)c2c1O 328.079435 
Beta-mercaptolactate cysteine disulfide 18841-42-4 NC(CSSCC(O)C(O) = O)C(O) = O 241.007864 
Biflorin 89701-85-9 CC1 = CC( = O)c2c(cc(O)c(C3OC(CO)C(O)C(O)C3O)c2O)O1 354.095085 
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Bipenamol 79467-22-4 NCc1ccccc1Sc1ccccc1CO 245.087434 
Bis(2-hydroxyethyl)methyloctylammonium 
toluene-p-sulphonate 
58767-50-3 CCCCCCCC[N + ](C)(CCO)CCO 232.227654 
Bis(4-hydroxyphenyl)methane 620-92-8 Oc1ccc(Cc2ccc(O)cc2)cc1 200.08373 
Bisphenol A 80-05-7 CC(C)(c1ccc(O)cc1)c1ccc(O)cc1 228.11503 
Bisphenol B 77-40-7 CCC(C)(c1ccc(O)cc1)c1ccc(O)cc1 242.13068 
Bisphenol E 2081-08-5 CC(c1ccc(O)cc1)c1ccc(O)cc1 214.09938 
Bithionoloxide 844-26-8 Oc1c(cc(Cl)cc1Cl)S( = O)c1cc(Cl)cc(Cl)c1O 369.879173 
BOTIACRINE 4774-53-2 OCC1OC(O)C(OC( = O)c2cc(O)c(O)c(O)c2)C(OC( = O)c2cc 
(O)c(O)c(O)c2)C1O 
484.08531 
Bufotenine 487-93-4 CN(C)CCc1c[nH]c2ccc(O)cc12 204.126263 
Busulfan 55-98-1 CS( = O)( = O)OCCCCOS(C)( = O) = O 246.02318 
Butanedioic acid, [(ethoxythioxomethyl)thio]- 22119-15-9 CCOC( = S)SC(CC(O) = O)C(O) = O 237.996965 
Butanedioic acid, 2,3-dihydroxy- R-(R ∗ ,R ∗) -, m 608-89-9 CCOC( = O)C(O)C(O)C(O) = O 178.04774 
C.I. Basic Red 9 479-73-2 Nc1ccc(cc1)C(c1ccc(N)cc1) = C1C = CC( = N)C = C1 287.142247 
C6-galactose mustard 105618-02-8 OC1OC(CN(CCCl)CCCl)C(O)C(O)C1O 303.064028 
Caftaric acid 67879-58-7 OC(C(OC( = O)C = Cc1cc(O)c(O)cc1)C(O) = O)C(O) = O 312.048135 
Carboxymethyl cellulose 9000-11-7 OC1C(COCC(O) = O)OC(O)C(O)C1O 238.06887 
Cartap 15263-53-3 CN(C)C(CSC(N) = O)CSC(N) = O 237.060567 
Chloralose 15879-93-3 OCC(O)C1OC2OC(OC2C1O)C(Cl)(Cl)Cl 307.962121 
Chloramphenicol sodium succinate 982-57-0 [O-][N + ]( = O)c1ccc(cc1)C(O)C(COC( = O)CCC(O) = O) 
NC( = O)C(Cl)Cl 
422.028372 
Chloroacetic acid 79-11-8 OC( = O)CCl 93.982157 
Chlorogenic acid 327-97-9 OC( = O)C1(O)CC(O)C(O)C(C1)OC( = O)C = Cc1cc(O)c(O)cc1 354.095085 
Cianidanol 154-23-4 OC1Cc2c(cc(O)cc2O)OC1c1cc(O)c(O)cc1 290.07904 
CINAPROXEN 89163-44-0 CC( = O)NC(CSC( = O)C(C)c1cc2ccc(cc2cc1)OC)C(O) = O 375.114044 
Citric acid, monoester with glycerol 36291-32-4 OCC(O)COC( = O)CC(O)(CC(O) = O)C(O) = O 266.063785 
CLIROPAMINE 109525-44-2 Cc1ccc(cc1O)C(O)C(C)NCCCc1ccccc1 299.188529 
CLOFEVERINE 54340-63-5 CCCCC( = O)c1cc(F)c(O)c(Br)c1 274.000469 
Copper diethylamine oxyquinoline sulfonate 13007-93-7 Oc1c2[n]cccc2c(cc1S(O)( = O) = O)S(O)( = O) = O 304.966394 
Cordycepin triphosphate 73-04-1 Nc1[n]c[n]c2c1[n]c[n]2C1OC(COP(O)( = O) 
OP(O)( = O)OP(O)(O) = O)CC1O 
491.000836 
Corilagin 23094-69-1 Oc1c2-c3c(cc(O)c(O)c3O)C( = O)OCC3OC(OC( = O)c4cc 
(O)c(O)c(O)c4)C(O)C(OC( = O)c2cc(O)c1O)C3O 
634.08062 
Crisnatol 96389-68-3 CC(CO)(CO)NCc1cc2c3ccccc3ccc2c2ccccc21 345.172879 
Cyclocytidine 31698-14-3 N = C1C = CN2C3OC(CO)C(O)C3OC2 = N1 225.074957 
Cyclouridine 3736-77-4 OC1C2OC3 = NC( = O)C = CN3C2OC1CO 226.058973 
Cytidine-5-Diphosphate 63-38-7 NC1C = CN(C2OC(COP(O)( = O)OP(O)(O) = O)C(O)C2O) 
C( = O)N = 1 
403.018186 
D-(-)threo-2-amino-1-(p-nitrophenyl)propane-1,3-diol 716-61-0 NC(CO)C(O)c1ccc(cc1)[N + ]([O-]) = O 212.079708 
DACINOSTAT 404951-53-7 ONC( = O)C = Cc1ccc(CN(CCO)CCc2c[nH]c3ccccc23)cc1 379.189592 
DACOPAFANT 125372-33-0 NC( = O)c1cc[n]2C(SCc21)c1c[n]ccc1 245.062282 
D-arabino-2-hexulosonic acid, methyl ester 21063-40-1 COC( = O)C( = O)C(O)C(O)C(O)CO 208.058305 
DATELLIPTIUM CHLORIDE 105118-14-7 Cc1c2[nH]c3ccc(O)cc3c2c(C)c2c[n + ](CCN(CC)CC)ccc12 362.223237 
Deaminodicarba-Gly-oxytocin 33605-67-3 CC(C)CC(NC( = O)CNC( = O)C1CCCCCC( = O)NC(Cc2ccc(O)cc2) 
C( = O)NC(C(C)CC)C( = O)NC(CCC(N) = O)C( = O)NC(CC(N) = O) 
C( = O)N1)C( = O)NCC(N) = O 
915.481419 
Delsoline 509-18-2 CCN1CC2(CCC(O)C34C2C(OC)C(O)(C31)C1(O)CC(OC) 
C2CC4C1C2OC)COC 
467.288304 
Demoxytocin 113-78-0 CC(C)CC(NC( = O)C1CCCN1C( = O)C1CSSCCC( = O)NC(Cc2ccc 
(O)cc2)C( = O)NC(C(C)CC)C( = O)NC(CCC(N) = O)C( = O) 
NC(CC(N) = O)C( = O)N1)C( = O)NCC(N) = O 
991.425559 
Deoxyuridine triphosphate 1173-82-6 OP(O)( = O)OP(O)( = O)OP(O)( = O)OCC1OC(CC1O)N1C = CC( = O) 
NC1 = O 
467.973619 
Desethylhydroxychloroquine 4298-15-1 CC(CCCNCCO)Nc1cc[n]c2cc(Cl)ccc21 307.145139 
Desmopressin 16679-58-6 N1(CCC[C@@H]1C( = O)N[C@@H](C(NCC(N) = O) = O)CCCNC(N) 
= N)C([C@@H]1CSSCCC(N[C@@H](C(N[C@@H](C( = O)N[C@@H] 
(CCC( = O)N)C( = O)N[C@@H](C(N1) = O)CC(N) = O) 
Cc1ccccc1) = O)Cc1ccc(cc1)O) = O) = O 
1068.42696 
Dexelvucitabine 134379-77-4 NC1 = NC( = O)N(C = C1F)C1C = CC(CO)O1 227.07062 
Dezocine 53648-55-8 CC12CCCCCC(Cc3ccc(O)cc13)C2N 245.177964 
D-fructose 1-(dihydrogen phosphate) 15978-08-2 OCC(O)C(O)C(O)C( = O)COP(O)(O) = O 260.029722 
D-fructose 6-(dihydrogen phosphate) 643-13-0 OC1COC(O)(COP(O)(O) = O)C(O)C1O 260.029722 
D-Fructose, 3-O-.alpha.-D-glucopyranosyl- 547-25-1 OC1COC(O)(CO)C(OC2OC(CO)C(O)C(O)C2O)C1O 342.116215 
-D-Galactopyranoside, 5-bromo-4-chloro-1H-indol-3-yl 
6-deoxy- 
17016-46-5 CC1OC(Oc2c[nH]c3ccc(Br)c(Cl)c23)C(O)C(O)C1O 390.982212 
D-Galacturonic acid 685-73-4 OC(C = O)C(O)C(O)C(O)C(O) = O 194.042655 
D-Glucitol 50-70-4 OC(CO)C(O)C(O)C(O)CO 182.07904 
D-gluco-Heptonic acid, (2?)-, ester with boric acid 
(H3BO3), sodium salt 
58450-10-5 OCC(O)C(O)C(O)C(O)C(OB(O)O)C(O) = O 270.07583 
D-gluconic acid 6-(dihydrogen phosphate) 921-62-0 OC(COP(O)(O) = O)C(O)C(O)C(O)C(O) = O 276.024637 
D-gluconic acid, cyclic 4,5-ester with boric acid, calcium 
salt (2:1) 
5743-34-0 OCC1OB(O)OC1C(O)C(O)C(O) = O 222.0547 
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D-Glucose 50-99-7 OCC1OC(O)C(O)C(O)C1O 180.06339 
Dhurrin 499-20-7 N#CC(OC1OC(OO)C(O)C(O)C1O)c1ccc(O)cc1 313.079769 
Diazolidinyl urea 78491-02-8 OCNC( = O)N(CO)C1C( = O)N(CO)C( = O)N1CO 278.086251 
Dichlorophen 97-23-4 Oc1ccc(Cl)cc1Cc1cc(Cl)ccc1O 268.005784 
Dichlorprop 120-36-5 CC(Oc1ccc(Cl)cc1Cl)C(O) = O 233.985049 
Diethanolamine 111-42-2 OCCNCCO 105.078979 
Diethylene glycol 111-46-6 OCCOCCO 106.062995 
Diethylenetriamine 111-40-0 NCCNCCN 103.110947 
Digallic acid 536-08-3 OC( = O)c1cc(OC( = O)c2cc(O)c(O)c(O)c2)c(O)c(O)c1 322.032485 
Dihydroequilin 3563-27-7 CC12CCC3c4ccc(O)cc4CC = C3C1CCC2O 270.16198 
Dihydroxymethoxychlor olefin 14868-03-2 Oc1ccc(cc1)C(c1ccc(O)cc1) = C(Cl)Cl 280.005784 
Dimaprit 65119-89-3 CN(C)CCCSC(N) = N 161.098667 
Dimethylaminoethanol 108-01-0 CN(C)CCO 89.084064 
Dimethylolurea 140-95-4 OCNC( = O)NCO 120.053493 
Diphemethoxidine 13862-07-2 OCCN1CCCCC1C(c1ccccc1)c1ccccc1 295.193614 
Disodium 3,4,5,6-tetraoxocyclohex-1-en-1,2-ylene dioxide 523-21-7 OC1C( = O)C( = O)C( = O)C( = O)C1 = O 169.98514 
Disodium 
3-hydroxy-4-nitrosonaphthalene-2,7-disulphonate 
525-05-3 Oc1c(N = O)c2ccc(cc2cc1S(O)( = O) = O)S(O)( = O) = O 332.961309 
Disodium 3-hydroxynaphthalene-2,7-disulfonate 135-51-3 Oc1cc2ccc(cc2cc1S(O)( = O) = O)S(O)( = O) = O 303.971145 
Disodium ethylenediaminediacetate 38011-25-5 OC( = O)CNCCNCC(O) = O 176.079708 
DOPA sulfate 96253-55-3 NC(Cc1cc(OS(O)( = O) = O)c(O)cc1)C(O) = O 277.025624 
Dopaquinone 4430-97-1 NC(CC1 = CC( = O)C( = O)C = C1)C(O) = O 195.053159 
Dothiepin 113-53-1 CN(C)CCC = C1c2ccccc2CSc2ccccc21 295.139469 
Droxidopa 23651-95-8 NC(C(O)c1ccc(O)c(O)c1)C(O) = O 213.063724 




Ecopipam 112108-01-7 CN1CCc2cc(Cl)c(O)cc2C2C1CCc1ccccc12 313.123341 
Ellagic acid 476-66-4 Oc1cc2c3-c4c(OC2 = O)c(O)c(O)cc4C( = O)Oc3c1O 302.00627 
Elliptinium 58337-34-1 Cc1c2[nH]c3ccc(O)cc3c2c(C)c2c[n + ](C)ccc12 277.134088 
Emiglitate 80879-63-6 CCOC( = O)c1ccc(cc1)OCCN1CC(O)C(O)C(O)C1CO 355.163104 
Endrin aldehyde 7421-93-4 O = CC1CC2C3C1C1(Cl)C4(Cl)C2C4(Cl)C3(Cl)C1(Cl)Cl 377.870627 
EO 9 114560-48-4 C[n]1c(C = CCO)c(CO)c2c1C( = O)C = C(C2 = O)N1CC1 288.111008 
Epilactose 50468-56-9 OC(CO)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(O)C = O 342.116215 
Eptifibatide 188627-80-7 NC( = O)C1CSSCCC( = O)NC(CCCCNC(N) = N)C( = O)NCC( = O) 
NC(CC(O) = O)C( = O)NC(Cc2c[nH]c3ccccc23)C( = O) 
N2CCCC2C( = O)N1 
831.315614 
Erythrose 4-phosphate 585-18-2 OC(C = O)C(O)COP(O)(O) = O 200.008592 
Esculamine 2908-75-0 CC1 = CC( = O)Oc2c1cc(O)c(O)c2CN(CCO)CCO 309.121239 
Estriol 50-27-1 CC12CCC3C(CCc4cc(O)ccc43)C1CC(O)C2O 288.172545 
Estrone 53-16-7 CC12CCC3C(CCc4cc(O)ccc43)C1CCC2 = O 270.16198 
ETANTEROL 93047-39-3 CC(Cc1ccc(O)cc1)NCC(O)c1cc(N)cc(CO)c1 316.178693 
Ethanedithioamide, N,N’-bis(2-hydroxyethyl)- 120-86-5 OCCNC( = S)C( = S)NCCO 208.034018 
Ethanolamine 141-43-5 NCCO 61.052764 
Ethidium chloride (ET) 602-52-8 CC[n + ]1c(c2cc(N)ccc2c2ccc(N)cc12)-c1ccccc1 314.165722 
Ethylene glycol 107-21-1 OCCO 62.03678 
Ethylenebis[tris(2-cyanoethyl)phosphonium] dibromide 10310-38-0 N#CCC[P + ](CC[P + ](CCC#N)(CCC#N)CCC#N)(CCC#N)CCC#N 414.185068 
Ethylenediamine 107-15-3 NCCN 60.068748 
Exifone 52479-85-3 Oc1ccc(C( = O)c2cc(O)c(O)c(O)c2)c(O)c1O 278.042655 
Felypressin 56-59-7 N1([C@@H](C(N[C@@H](C(NCC(N) = O) = O)CCCCN) = O)CCC1)C 
([C@@H]1NC([C@@H](NC([C@@H](NC([C@@H] 
(Cc2ccccc2)NC([C@@H](NC([C@@H](CSSC1)N) = O)Cc1ccccc1) 
= O) = O)CCC(N) = O) = O)CC(N) = O) = O) = O 
1039.43679 
Fenalcomine 34616-39-2 CC(Cc1ccccc1)NCCOc1ccc(cc1)C(O)CC 313.204179 
Fenchlorphos 299-84-3 COP( = S)(Oc1cc(Cl)c(Cl)cc1Cl)OC 319.899733 
Fenoldopam 67227-56-9 Oc1c(Cl)c2CCNCC(c2cc1O)c1ccc(O)cc1 305.081871 
Fenticlor 97-24-5 Oc1ccc(Cl)cc1Sc1cc(Cl)ccc1O 285.962204 
Fepradinol 63075-47-8 CC(C)(CO)NCC(O)c1ccccc1 209.141579 
FERRIC (59 FE) CITRATE 54063-42-2 OC( = O)CC(O)(C(O) = O)C(O) = O 178.011355 
Flurocitabine 37717-21-8 N = C1N = C2OC3C(OC(CO)C3O)N2C = C1F 243.065535 
Formaldehyde, polymer with 1,3-benzenediol, 
[1,1 ′ -biphenyl]-ar,ar’-diol and [1,1 ′ -biphenyl]triol 
65876-95-1 Oc1ccc(-c2ccccc2)c(O)c1O 202.062995 
Formic acid 64-18-6 OC = O 46.00548 
FOSCOLIC ACID 2398-95-0 CC(O)(C(O) = O)P(O)( = O)C(C)(O)C(O) = O 242.019157 
FRAKEFAMIDE 188196-22-7 CC(NC( = O)C(N)Cc1ccc(O)cc1)C( = O) 
NC(Cc1ccc(F)cc1)C( = O)NC(Cc1ccccc1)C(N) = O 
563.254398 
Fuculose 1-phosphate 16562-58-6 CC1OC(OP(O)(O) = O)C(O)C(O)C1O 244.034807 
Fulvic acid 479-66-3 CC1(O)CC2Oc3cc(O)c(O)c(c3C( = O)C = 2CO1)C(O) = O 308.05322 
Gallic acid 149-91-7 OC( = O)c1cc(O)c(O)c(O)c1 170.021525 
Gamma-glutamylcysteine 636-58-8 NC(CCC( = O)NC(CS)C(O) = O)C(O) = O 250.062343 
Gemcitabine 95058-81-4 NC1C = CN(C2OC(CO)C(O)C2(F)F)C( = O)N = 1 263.071763 
Ginkgolide-A 15291-75-5 CC(C)(C)C1CC2OC( = O)C34OC5OC( = O)C(O)C51C32CC1OC 
( = O)C(C)C41O 
408.142035 
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Ginkgolide-C 15291-76-6 CC(C)(C)C1C(O)C2OC( = O)C34OC5OC( = O)C(O)C51C32C 
(O)C1OC( = O)C(C)C41O 
440.131865 
Ginkgolide-J 107438-79-9 CC(C)(C)C1C(O)C2OC( = O)C34OC5OC( = O)C(O)C51C32CC1OC 
( = O)C(C)C41O 
424.13695 
Ginkgolide-M 15291-78-8 
CC(C)(C)C1C(O)C2OC( = O)C34OC5OC( = O)C(O)C51C32C(O)C1OC 
( = O)C(C)C41 
424.13695 
Gluconolactone 90-80-2 OCC1OC( = O)C(O)C(O)C1O 178.04774 
Glucose 6-(disodium phosphate) 3671-99-6 OC(COP(O)(O) = O)C(O)C(O)C(O)C = O 260.029722 
Glucose-6-Phosphate 56-73-5 OC1OC(COP(O)(O) = O)C(O)C(O)C1O 260.029722 
GLUFOSFAMIDE 132682-98-5 OCC1OC(OP( = O)(NCCCl)NCCCl)C(O)C(O)C1O 382.046344 
Glycerol 56-81-5 OC(CO)CO 92.047345 
Glycerol, propoxylated 25791-96-2 OC(COC(OCCC(O)CO)OCCC(O)CO)CO 314.157685 
Glycine 56-40-6 NCC(O) = O 75.032029 
Glycine, N,N’-(1,2-dithioxo-1,2-ethanediyl)bis- 95-99-8 OC( = O)CNC( = S)C( = S)NCC(O) = O 235.992548 
Glycolic acid 79-14-1 OCC(O) = O 76.016045 
Guanosine 118-00-3 NC1NC( = O)c2[n]c[n](C3OC(CO)C(O)C3O)c2N = 1 283.09167 
Guanosine-5-Diphosphate 146-91-8 NC1Nc2c([n]c[n]2C2OC(COP(O)( = O)OP(O)(O) 
= O)C(O)C2O)C( = O)N = 1 
443.024334 
Helicin 618-65-5 OCC1OC(Oc2ccccc2C = O)C(O)C(O)C1O 284.089605 
Hematoxylin 517-28-2 Oc1cc2C3c4ccc(O)c(O)c4OCC3(O)Cc2cc1O 302.07904 
Heptanoic acid, 2,2,3,3,4,4,5,5,6,6,7,7-dodecafl 1546-95-8 OC( = O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)(F)C(F)F 345.986316 
Hexahydro-1,3,5-tris(2-hydroxypropyl)-s-triazine 25254-50-6 CC(O)CN1CN(CN(C1)CC(C)O)CC(C)O 261.205242 
Hexamethylolmelamine 531-18-0 OCN(CO)c1[n]c([n]c([n]1)N(CO)CO)N(CO)CO 306.128784 
Hexanedioic acid 124-04-9 OC( = O)CCCCC(O) = O 146.05791 
Homocitric acid 3562-74-1 OC( = O)C(O)(CC(O) = O)CCC(O) = O 206.042655 
Hydromorphinol 2183-56-4 CN1CCC23C4Oc5c2c(CC1C3(O)CCC4O)ccc5O 303.147059 
Hydroxyethylcellulose 9004-62-0 OCC1OC(O)C(OCCO)C(O)C1OC1OC(COCCO)C(O)C(COCCO)C1O 488.21051 
HYDROXYPYRIDINE TARTRATE 7008-17-5 OC( = O)C(O)C(O)C( = O)Oc1cccc[n]1 227.042989 
Hydroxystilbamidine Isethionate 533-22-2 NC( = N)C1C = CC(C = C1) = CC = C1C = CC( = CC1 = O)C(N) = N 280.132411 
Inosine 5-(trihydrogen diphosphate) 86-04-4 OP(O)( = O)OP(O)( = O)OCC1OC(C(O)C1O)[n]1c[n]c2c1NC 
= NC2 = O 
428.013435 
Isochorismic Acid 22642-82-6 C = C(OC1C = CC = C(C1O)C(O) = O)C(O) = O 226.04774 
Isopropyl citrate 83966-24-9 CC(C)OC( = O)C(O)(CC(O) = O)CC(O) = O 234.073955 
Isoquercitrin 21637-25-2 OCC(O)C1OC(OC2C( = O)c3c(cc(O)cc3O)OC = 2c2cc(O)c(O)cc2) 
C(O)C1O 
464.09548 
Isoquinoline-6,7-diol, 1,2,3,4-tetrahydro-2-meth 63937-92-8 CN1Cc2cc(O)c(O)cc2CC1 179.094629 
Isovalerylglucuronide 88070-93-3 CC(C)CC( = O)OC1OC(C(O)C(O)C1O)C(O) = O 278.10017 
Keracyanin 18719-76-1 CC1OC(OCC2OC(Oc3cc4c(cc(O)cc4O)[o + ]c3- 
c3cc(O)c(O)cc3)C(O)C(O)C2O)C(O)C(O)C1O 
595.1663 
KETORFANOL 79798-39-3 Oc1cccc2CC3C4CCC( = O)CC4(CCN3CC3CC3)c21 311.188529 
Lactic acid 50-21-5 CC(O)C(O) = O 90.031695 
Lactobionic acid 96-82-2 OC(CO)C(OC1OC(CO)C(O)C(O)C1O)C(O)C(O)C(O) = O 358.11113 
Lactose 63-42-3 OC1OC(CO)C(OC2OC(CO)C(O)C(O)C2O)C(O)C1O 342.116215 
L-Arginine 74-79-3 NC( = N)NCCCC(N)C(O) = O 174.111676 
L-Ascorbic acid 50-81-7 OCC(O)C1OC( = O)C( = O)C1O 176.03209 
L-Cystine 56-89-3 NC(CSSCC(N)C(O) = O)C(O) = O 240.023848 
L-Dopa 59-92-7 NC(Cc1cc(O)c(O)cc1)C(O) = O 197.068809 
Levallorphan 152-02-3 C = CCN1CCC23CCCCC2C1Cc1ccc(O)cc31 283.193614 
L-Glutamic acid 56-86-0 NC(CCC(O) = O)C(O) = O 147.053159 
Lithium carbonate 554-13-2 O = C(O[Li])O[Li] 74.01675074 
Lodoxamide 53882-12-5 N#Cc1cc(NC( = O)C(O) = O)c(Cl)c(c1)NC( = O)C(O) = O 310.994514 
Losigame 112856-44-7 COC1 = CC( = O)OC1C(O)c1ccccc1Cl 254.034587 
L-Tartaric acid 87-69-4 OC( = O)C(O)C(O)C(O) = O 150.01644 
L-Threonine 72-19-5 CC(O)C(N)C(O) = O 119.058244 
Maleic acid 110-16-7 OC( = O)C = CC(O) = O 116.01096 
Maleylacetoacetic acid 5698-52-2 OC( = O)CC( = O)CC( = O)C = CC(O) = O 200.03209 
Maltodextrin 9050-36-6 OCC(O)C(O)C(O)C(O)C = O 180.06339 
MDL 11,939 107703-78-6 OC(C1CCN(CCc2ccccc2)CC1)c1ccccc1 295.193614 
MDL 28574 121104-96-9 CCCC( = O)OC1CN2CCC(O)C2C(O)C1O 259.141974 
Melamine 108-78-1 Nc1[n]c(N)[n]c(N)[n]1 126.065394 
Melaminylthioarsenate 89141-50-4 Nc1[n]c(Nc2ccc(cc2)[As](SCCN)SCCN)[n]c(N)[n]1 428.054651 
MEPROTIXOL 4295-63-0 COc1cc2c(cc1)Sc1ccccc1C2(O)CCCN(C)C 329.144949 
Methanaminium, N-[4-[[4-(dimethylamino)phenyl] 
[4-[(2-hydroxyethyl)amino]phenyl]methylene] 
-2,5-cyclohexadien-1-ylidene]-N-methyl-, acetate (salt) 
82171-32-2 CN(C)c1ccc(cc1)C(c1ccc(cc1)NCCO) = C1C = CC(C = C1) 
= [N + ](C)C 
388.238887 
Methanesulfonic acid 75-75-2 CS(O)( = O) = O 95.988115 
Methoxyacetic acid 625-45-6 COCC(O) = O 90.031695 
Methyl cellulose 9004-67-5 COCC1OC(O)C(O)C(O)C1O 194.07904 
Methyl o-methoxyhippuric acid 27796-49-2 C[N + ](C)(CCO)CCCC( = O)c1ccccc1 236.165054 
Monomethyl phosphate 812-00-0 COP(O)(O) = O 111.992547 
Monoxerutin 23869-24-1 CC1OC(OCC2OC(OC3 = C(Oc4cc(cc(O)c4C3 = O)OCCO)c3cc 
(O)c(O)cc3)C(O)C(O)C2O)C(O)C(O)C1O 
654.179605 
Morphine 57-27-2 CN1CCC23C4Oc5c2c(CC1C3C = CC4O)ccc5O 285.136494 
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Morphine methylbromide 125-23-5 C[N + ]1(C)CCC23C4Oc5c2c(CC1C3C = CC4O)ccc5O 300.159969 
Morphine-6-glucuronide 20290-10-2 CN1CCC23C4Oc5c2c(CC1C3C = CC4OC1OC(C(O)C(O)C1O)C(O) 
= O)ccc5O 
461.168584 
Morpholine 110-91-8 C1COCCN1 87.068414 
Mucic acid 526-99-8 OC( = O)C(O)C(O)C(O)C(O)C(O) = O 210.03757 
Myricetin 529-44-2 Oc1cc2OC(c3cc(O)c(O)c(O)c3)C( = O)C( = O)c2c(O)c1 318.03757 
N-(3-acetyl-5-fluoro-2-hydroxyphenyl)-1H-tetrazole-5- 
carboxamide 
70977-46-7 CC( = O)C1 = CC(F) = CC( = NC( = O)C2NNNN = 2)C1 = O 265.061118 
N-(3-Chloroallyl)hexaminium chloride 4080-31-3 ClC = CC[N + ]12CN3CN(C1)CN(C2)C3 215.106348 
N-(4-pyridinylmethyl)-4-pyridinemethanamine, 
2-hydroxy-1,2,3-propanetricarboxylate 
1539-39-5 C(NCc1cc[n]cc1)c1cc[n]cc1 199.110947 
N-(4-sodiooxyphenyl)-p-benzoquinone monoimine 5418-32-6 Oc1ccc(cc1)N = C1C = CC( = O)C = C1 199.063329 
N,N,N’,N’-Tetrakis(2-Hydroxypropyl)ethylenediamine 102-60-3 CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O 292.236208 
N,N’-Bis[3-(trimethoxysilyl)propyl]ethane-1,2-diamine 68845-16-9 CO[Si](CCCNCCNCCC[Si](OC)(OC)OC)(OC)OC 384.211192 
N,N-Diethylethanolamine 100-37-8 CCN(CCO)CC 117.115364 
N-[3-(Trimethoxysilyl)propyl]ethane-1,2-diamine 1760-24-3 CO[Si](CCCNCCN)(OC)OC 222.13997 
N-1-hydroxymethyl-2,3-dihydroxypropyl-2,2,5,5- 
tetramethylpyrrolidin-1-oxyl-3-carboxamide 
97546-74-2 CC1(C)CC(C( = O)NC(CO)C(O)CO)C(C)(C)N1O 290.184173 
N-Acetyl-P-Nitrophenylserinol 15376-53-1 CC( = O)NC(CO)C(O)c1ccc(cc1)[N + ]([O-]) = O 254.090273 
Nadolol 42200-33-9 CC(C)(C)NCC(O)COc1cccc2CC(O)C(O)Cc21 309.194009 
Nalmefene 55096-26-9 C = C1CCC2(O)C3Cc4ccc(O)c5OC1C2(CCN3CC1CC1)c45 339.183444 
Neoarsphenamine 457-60-3 Nc1cc(ccc1O)[As] = [As]c1cc(NCS(O) = O)c(O)cc1 443.910616 
Neopterin 2009-64-5 NC1Nc2[n]cc([n]c2C( = O)N = 1)C(O)C(O)CO 253.081105 
Nifuratrone 19561-70-7 [O-][N + ]( = O)c1ccc(C = [N + ]([O-])CCO)o1 200.043323 
Nitrocellulose 9004-70-0 [O-][N + ]( = O)OC1C(O[N + ]([O-]) = O)C(O)OC(CO[N + ]([O- 
]) = O)C1O 
315.018627 
NITROGEN 93037-13-9 NC1Nc2c([n]c(Br)[n]2C2OC(CO)C(OP(O)(O) = O)C2O) 
C( = O)N = 1 
440.968513 
N-Methyldiethanolamine 105-59-9 CN(CCO)CCO 119.094629 
N-methylserotonin 1134-01-6 CNCCc1c[nH]c2ccc(O)cc12 190.110613 
N’-Nitrosonornicotine-1-N-oxide 78246-24-9 [O-][n + ]1cc(ccc1)C1CCCN1N = O 193.085127 
Norcodeine 467-15-2 COc1ccc2CC3NCCC45C(Oc1c42)C(O)C = CC53 285.136494 
Normorphine 466-97-7 Oc1ccc2CC3NCCC45C(Oc1c42)C(O)C = CC53 271.120844 
NSC 224131 51321-79-0 OC( = O)CC(NC( = O)CP(O)(O) = O)C(O) = O 255.014406 
NULL 119179-66-7 Oc1cc2OC( = O)C = C(c2cc1Cl)C(F)(F)F 263.980106 
ODAPIPAM 131796-63-9 CN1CC(c2cc(O)c(Cl)cc2CC1)c1cccc2CCOc21 329.118256 
OMAPATRILAT 167305-00-2 OC( = O)C1CCCC2SCCC(NC( = O)C(S)Cc3ccccc3)C( = O)N12 408.117748 
Oteracil 937-13-3 OC( = O)c1[n]c(O)[n]c(O)[n]1 157.012357 
Oxalosuccinic acid 1948-82-9 OC( = O)C( = O)C(CC(O) = O)C(O) = O 190.011355 
Oxalyl dichloride 79-37-8 O = C(Cl)C( = O)Cl 125.927534 
OXONAZINE 5580-22-3 C = CC[N + ]([O-])(CC = C)c1[n]c(N)[n]c(N)[n]1 222.122909 
Oxytocin 50-56-6 N3C( = O)C(NC( = O)C(CSSCC(C( = O)N2C(C( = O) 
NC(C( = O)NCC( = O)N)CC(C)C)CCC2)NC( = O)C(NC( = O)C(CCC( = O)N) 
NC( = O)C3C(CC)C)CC( = O)N)N)Cc1ccc(cc1)O 
1006.43646 
p-(1-phenylethyl)phenol 1988-89-2 CC(c1ccccc1)c1ccc(O)cc1 198.104465 
PANCRATISTATIN 96203-70-2 Oc1c2OCOc2cc2C3C(NC( = O)c12)C(O)C(O)C(O)C3O 325.079769 
Panobinostat 404950-80-7 Cc1[nH]c2ccccc2c1CCNCc1ccc(C = CC( = O)NO)cc1 349.179027 
Peldesine 133432-71-0 NC1Nc2c(Cc3c[n]ccc3)c[nH]c2C( = O)N = 1 241.09636 
Pentaerythritol 115-77-5 OCC(CO)(CO)CO 136.07356 
Persilic acid 4444-23-9 OS( = O)( = O)c1cc(O)c(cc1O)S(O)( = O) = O 269.95041 
Phalloidin 17466-45-4 CC(O)C1NC( = O)C(C)NC( = O)C(CC(C)(O)CO)NC( = O)C2Cc3c4 
ccccc4[nH]c3SCC(NC1 = O)C( = O)N1CC(O)CC 
1C( = O)NC(C)C( = O)N2 
788.316327 
Phenanthridinium, 3,8-diamino-5-methyl-6-phenyl- 518-67-2 C[n + ]1c(c2cc(N)ccc2c2ccc(N)cc12)-c1ccccc1 300.150072 
PHENOL, 2-CHLORO-4-CYCLOHEXYL- 3964-61-2 Oc1ccc(cc1Cl)C1CCCCC1 210.081142 
Phenol, 4-((phenylmethyl)amino)- 103-14-0 Oc1ccc(cc1)NCc1ccccc1 199.099714 
Phenol, 4,4 ′ -(3H-2,1-benzoxathiol- 
3-ylidene)bis[2,6-dinitro-, S,S-dioxide 
57564-54-2 [O-][N + ]( = O)c1cc(cc(c1O)[N + ]([O- 
]) = O)C1(OS( = O)( = O)c2ccccc12)c1cc(c(O)c(c1)[N + ]([O- 
]) = O)[N + ]([O-]) = O 
533.996511 
Phenol, 4,4 ′ -iminobis- 1752-24-5 Oc1ccc(cc1)Nc1ccc(O)cc1 201.078979 
PHENOLPHTHALOL 81-92-5 OCc1ccccc1C(c1ccc(O)cc1)c1ccc(O)cc1 306.125595 
Pholcodine 509-67-1 CN1CCC23C4C = CC(O)C2Oc2c3c(CC14)ccc2OCCN1CCOCC1 398.220558 
Phosmethylan 83733-82-8 CCCC( = O)N(CSP( = S)(OC)OC)c1ccccc1Cl 367.023248 
Phosphonic acid, 
[[(2-hydroxyethyl)imino]bis(methylene)]bis- 
5995-42-6 OCCN(CP(O)(O) = O)CP(O)(O) = O 249.016728 
Phosphonic acid, [[bis(2-hydroxyethyl)amino]methyl]-, 
diethyl ester 
2781-11-5 CCOP( = O)(CN(CCO)CCO)OCC 255.123561 
Phosphorothioic acid, O-(dichloro(methylthio)phe 60238-56-4 CSc1ccc(OP( = S)(OC)OC)c(Cl)c1Cl 331.926426 
Picrotoxin 124-87-8 CC(C)(O)C1C2C( = O)OC1C1OC( = O)C34OC3CC2(O)C41C 310.105255 
Piridoxylate 24340-35-0 Cc1[n]cc(CO)c(CO)c1OC(O)C(O) = O 243.074289 
Plasma protein fraction 55963-80-9 C = COCC(COP(O)(O) = O)OC = O 226.024242 
Pluronic F-127 9003-11-6 CC(COCCO)OCCO 164.10486 
Poly[oxy(methyl-1,2-ethanediyl)], ?-hydro-?-hydroxy-, 
ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1), 
2-hydroxy-3-mercaptopropyl ether 
72244-98-5 OCCCOCC(COCCCO)(COCCCO)COCCCO 368.24102 
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Polyoxin 11113-80-7 NC(C = O)C1OC(C(O)C1O)N1C = C(C( = O)NC1 = O)C(O) = O 315.070267 
Polyoxyethylene sorbitol tetraoleate 63089-86-1 OCCOC(COCCO)C(OCCO)C(OCCO)C(COCCO)OCCO 446.23633 
Polyoxypropylenediamine 9046-10-0 CC(COCCCN)COCCN 190.168128 
Potassium dichloroisocyanurate 2244-21-5 OC1 = NC( = O)N(Cl)C( = O)N1Cl 196.939496 
potassium 
N-ethyl-N-[(nonafluorobutyl)sulphonyl]glycinate 
67584-51-4 CCN(CC(O) = O)S( = O)( = O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F 385.003031 
Potassium sorbate / Sorbistat-K 24634-61-5 O[K]C( = O)C = CC = CC 151.016136 
Potassium citrate 6100-05-6 O = C(CC(C(O) = O)(CC(O) = O)O)O 192.027005 
Primapterin 2582-88-9 CC(O)C(O)c1c[n]c2C( = O)N = C(N)Nc2[n]1 237.08619 
Propionic acid 79-09-4 CCC(O) = O 74.03678 
Propyl gallate 121-79-9 CCCOC( = O)c1cc(O)c(O)c(O)c1 212.068475 
Psilocin 520-53-6 CN(C)CCc1c[nH]c2cccc(O)c12 204.126263 
Puberulic Acid 99-23-0 OC( = O)C1 = CC( = O)C( = O)C(O)C(O) = C1 198.01644 
Purpurogallin 569-77-7 Oc1c(O)cc2C = CCC( = O)C( = O)c2c1O 220.037175 
Pyrazofurin 30868-30-5 NC( = O)c1[n][nH]c(C2OC(CO)C(O)C2O)c1O 259.080437 
Pyridine-2-thiol 1-oxide, sodium salt 3811-73-2 n1( = O)c(S[Na])cccc1 148.9911292 
Pyridoxine-5-Phosphate 447-05-2 Cc1[n]cc(COP(O)(O) = O)c(CO)c1O 249.040226 
Pyrisuccideanol 33605-94-6 Cc1[n]cc(COC( = O)CCC( = O)OCCN(C)C)c(CO)c1O 340.163438 
Pyrithioxine 1098-97-1 Cc1[n]cc(CSSCc2c[n]c(C)c(O)c2CO)c(CO)c1O 368.086448 
Quercetin-3-glucoside 482-35-9 OCC1OC(OC2C( = O)c3c(cc(O)cc3O)OC = 2c2cc 
(O)c(O)cc2)C(O)C(O)C1O 
464.09548 
Ractopamine hydrochloride 90274-24-1 CC(CCc1ccc(O)cc1)NCC(O)c1ccc(O)cc1 301.167794 
Ribavirin 36791-04-5 NC( = O)c1[n][n](c[n]1)C1OC(CO)C(O)C1O 244.080771 
Ribavirin Monophosphate 40925-28-8 NC( = O)c1[n][n](c[n]1)C1OC(COP(O)(O) = O)C(O)C1O 324.047103 
Rribose 1-phosphate 14075-00-4 OCC1OC(OP(O)(O) = O)C(O)C1O 230.019157 
Ribose-5-phosphate 3615-55-2 OC(C(O)COP(O)(O) = O)C(O)C = O 230.019157 
Ribose-5-Phosphate 4151-19-3 OCC( = O)C(O)C(O)COP(O)(O) = O 230.019157 
Risedronic acid 105462-24-6 OC(Cc1c[n]ccc1)(P(O)(O) = O)P(O)(O) = O 283.001078 
Robinin 301-19-9 CC1OC(Oc2cc(O)c3C( = O)C(OC4OC(COC5OC(C)C(O)C(O)C5O) 
C(O)C(O)C4O) = C(Oc3c2)c2ccc(O)cc2)C(O)C(O)C1O 
740.216385 
Rutin trihydrate 153-18-4 CC1OC(OCC2OC(OC3C( = O)c4c(cc(O)cc4O)OC = 3c3cc 
(O)c(O)cc3)C(O)C(O)C2O)C(O)C(O)C1O 
610.15339 
Salidroside 10338-51-9 Oc1ccc(CCOC2OC(CO)C(O)C(O)C2O)cc1 300.120905 
Sedoheptulose 7-phosphate 2646-35-7 OCC( = O)C(O)C(O)C(O)C(O)COP(O)(O) = O 290.040287 
Sepiapterin 17094-01-8 CC(O)C( = O)C1CNC2 = NC(N) = NC( = O)C2N = 1 237.08619 
SEVITROPIUM MESILATE 88199-75-1 C[N + ]1(C)C2CC(CC1C1OC21)OC1c2ccccc2CSc2ccccc21 380.168424 
SILTENZEPINE 98374-54-0 OCCN(CC( = O)N1c2ccc(Cl)cc2NC( = O)c2ccccc12)CCO 389.114234 
Sinalbin 20196-67-2 Oc1ccc(CC( = NOS(O)( = O) = O)SC2OC(CO)C(O)C(O)C2O)cc1 425.045039 
SKF 77434 104422-04-0 C = CCN1CC(c2cc(O)c(O)cc2CC1)c1ccccc1 295.157229 
SKF 81297 71636-61-8 Oc1c(Cl)c2CCNCC(c2cc1O)c1ccccc1 289.086956 
SKF 83566 99295-33-7 CN1CC(c2cc(O)c(Br)cc2CC1)c1ccccc1 331.057175 
SKF 83959 hydrobromide 67287-95-0 Cc1cc(ccc1)C1CN(C)CCc2c(Cl)c(O)c(O)cc21 317.118256 
Sodium 2-(2,4,5-trichlorophenoxy)ethyl sulfate 3570-61-4 OS( = O)( = O)OCCOc1cc(Cl)c(Cl)cc1Cl 319.907976 
Sodium 3,5-dichloro-2-hydroxybenzenesulphonate 54970-72-8 Oc1c(Cl)cc(Cl)cc1S(O)( = O) = O 241.920734 
Sodium 4-(3,5-dichloro-4-oxocyclohexa-2,5- 
dienylideneamino)phenoxide 
620-45-1 Oc1ccc(cc1)N = C1C = C(Cl)C( = O)C(Cl) = C1 266.985383 
Sodium 6,7-dihydroxynaphthalene-2-sulphonate 135-53-5 OS( = O)( = O)c1cc2cc(O)c(O)cc2cc1 240.009245 
Sodium alginate 9005-38-3 OC1OC(C(O)C(O)C1O)C(O) = O 194.042655 
SOLPECAINOL 68567-30-6 CC(COc1ccccc1)NC(CO)C(O)c1ccccc1 301.167794 
Sucralose 56038-13-2 OCC1OC(OC2(CCl)OC(CCl)C(O)C2O)C(O)C(O)C1Cl 396.014551 
Sucrose 57-50-1 OC1C(OC(CO)C(O)C1O)OC1(CO)OC(CO)C(O)C1O 342.116215 
Sulmarin 29334-07-4 CC1 = CC( = O)Oc2cc(OS(O)( = O) = O)c(cc21)OS(O)( = O) = O 351.95589 
Sydnophen 22293-47-6 CC(Cc1ccccc1)[N + ]1 = CC( = N)ON1 204.113687 
Tagetitoxin 87913-21-1 CC( = O)OC1C2OC(CSC2(O)C(N) = O)(C(OP(O)(O) = O) 
C1N)C(O) = O 
416.02907 
Taxifolin 480-18-2 OC1C(Oc2cc(O)cc(O)c2C1 = O)c1cc(O)c(O)cc1 304.058305 
TCPSA 65600-62-6 OS( = O)( = O)CC(Cl) = C(Cl)Cl 223.886846 
Terbutaline 23031-25-6 CC(C)(C)NCC(O)c1cc(O)cc(O)c1 225.136494 
Tetraacetylethylenediamine 10543-57-4 CC( = O)N(CCN(C(C) = O)C(C) = O)C(C) = O 228.111008 
Tetraethylenepentamine 112-57-2 NCCNCCNCCNCCN 189.195345 
tetrahydro-1,3,4,6-tetrakis(hydroxymethyl)imidazo[4,5- 
d]imidazole-2,5(1H,3H)-dione 
5395-50-6 OCN1C2C(N(CO)C( = O)N2CO)N(CO)C1 = O 262.091336 
Tetrahydro-1,3,6-thiadiazepine-2,7-dithione 5782-83-2 S = C1NCCNC( = S)S1 177.969308 
Tetrasodium iminidisuccinate 144538-83-0 OC( = O)CC(NC(CC(O) = O)C(O) = O)C(O) = O 249.048469 
Tetronic 701 11111-34-5 CC(CN(CC(C)OCCO)CCN(CC(C)OCCO)CC(C)OCCO)OCCO 468.341068 
Tetroquinone 319-89-1 OC1C( = O)C( = O)C(O)C( = O)C1 = O 172.00079 
Theaflavin 4670-05-7 OC1C = C(C2Oc3cc(O)cc(O)c3CC2O)C2 = CC( = CC 
( = O)C( = O)C2C = 1O)C1Oc2cc(O)cc(O)c2CC1O 
564.12678 
Theaflavin-3-gallate 28543-07-9 OC1Cc2c(cc(O)cc2O)OC1C1C = C2C(C( = O)C( = O)C = 1)C(O) = 
C(O)C = C2C1Oc2cc(O)cc(O)c2CC1OC( = O)c1cc(O)c(O)c(O)c1 
716.13774 
THIACETARSAMIDE SODIUM 14433-82-0 NC( = O)c1ccc(cc1)[As](SCC(O) = O)SCC(O) = O 376.937283 
Tiaramide 32527-55-2 OCCN1CCN(CC1)C( = O)CN1c2cc(Cl)ccc2SC1 = O 355.075739 
( continued on next page ) 
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Table A6 ( continued ) 
Name CAS# Smiles Monoisotopic 
Mass (Da) 
TIFLOREX 53993-67-2 CCNC(C)Cc1cc(ccc1)SC(F)(F)F 263.095553 
Tiron 149-45-1 Oc1cc(cc(c1O)S(O)( = O) = O)S(O)( = O) = O 269.95041 
Toyocamycin 606-58-6 Nc1[n]c[n]c2c1c(c[n]2C1OC(CO)C(O)C1O)C#N 291.096755 
trans-4-hydroxystilbene 6554-98-9 Oc1ccc(cc1)C = Cc1ccccc1 196.088815 
Trehalose-6-phosphate 4484-88-2 OCC1OC(OC2OC(COP(O)(O) = O)C(O)C(O)C2O)C(O)C(O)C1O 422.082547 
Triethanolamine 102-71-6 OCCN(CCO)CCO 149.105194 
Triethylene glycol 112-27-6 OCCOCCOCCO 150.08921 
Triethylenetetramine 112-24-3 NCCNCCNCCN 146.153146 
Trihydroxybiphenyl 29222-39-7 Oc1ccc(cc1)-c1cc(O)cc(O)c1 202.062995 
Triisopropanolamine 122-20-3 CC(O)CN(CC(C)O)CC(C)O 191.152144 
Trimethoquinol 18559-59-6 COc1c(cc(CC2NCCc3cc(O)c(O)cc32)cc1OC)OC 345.157624 
Trimethyl(2-propionylthioethyl)ammonium chloride 1866-73-5 CCC( = O)SCC[N + ](C)(C)C 176.110909 




1667-99-8 Cc1cc(cc(c1O)C(O) = O)C(c1c(Cl)c(ccc1Cl)S(O)( = O) = O) = C1C = 





63817-39-0 Cc1ccccc1Nc1[n]c(F)[n]c(Nc2cc(NC(N) = O)c(cc2)N = 
Nc2cc3c(cc(cc3cc2S(O)( = O) = O)S(O)( = O) = O)S(O)( = O) = O)[n]1 
747.063579 
Trisodium citrate 68-04-2 OC( = O)C(O)(CC(O) = O)CC(O) = O 192.027005 
Trisodium ethylenediaminetriacetate 19019-43-3 OC( = O)CNCCN(CC(O) = O)CC(O) = O 234.085188 
Tritac 1861-44-5 CC(O)COCc1c(Cl)c(Cl)ccc1Cl 267.982461 
Tromethamine 77-86-1 NC(CO)(CO)CO 121.073894 
Troxerutin 7085-55-4 CC1OC(OCC2OC(OC3C( = O)c4c(cc(cc4O)OCCO)OC = 
3c3cc(OCCO)c(cc3)OCCO)C(O)C(O)C2O)C(O)C(O)C1O 
742.232035 
Tubercidin 69-33-0 Nc1[n]c[n]c2c1cc[n]2C1OC(CO)C(O)C1O 266.101506 
UK-373911 291305-06-1 CNC1CCC(c2ccc(cc21)S(N)( = O) = O)c1cc(Cl)c(Cl)cc1 384.046602 
Urea 57-13-6 NC(N) = O 60.032363 
Uridine-5-diphosphate 58-98-0 OP(O)( = O)OP(O)( = O)OCC1OC(C(O)C1O)N1C = CC( = O)NC1 = O 404.002202 
Urochloralic Acid 97-25-6 OC1C(O)C(OC(OCC(Cl)(Cl)Cl)C1O)C(O) = O 323.957036 
Vacciniin 90-75-5 OC1OC(COC( = O)c2ccccc2)C(O)C(O)C1O 284.089605 
Vanillactic acid 2475-56-1 COc1cc(CC(O)C(O) = O)ccc1O 212.068475 
Xanthosine 146-80-5 OCC1OC(C(O)C1O)[n]1c[n]c2c1NC( = O)NC2 = O 284.075686 
Xanthosine monophosphate 523-98-8 OC1C(COP(O)(O) = O)OC(C1O)[n]1c[n]c2c1NC( = O)NC2 = O 364.042018 
Xylitol 87-99-0 OC(C(O)CO)C(O)CO 152.068475 
Zelandopam 139233-53-7 Oc1c2CNCC(c2ccc1O)c1cc(O)c(O)cc1 273.100109 
Zincpyrithione 13463-41-7 c2(n(cccc2) = O)S[Zn]Sc1n(cccc1) = O 315.931863 







































All 208 detected features (175 unique suspects) in the raw (section a) and drinking water (section b) samples from all DWTPs (n = 13). 0 = No detection in the triplicate, 1 = one detection, 2 = two detections, “number”= average 






























































+ 3,07 180,1263 0 0 0 3125 0 0 0 0 0 0 0 0 0 
(R)-N-Methylsalsolinol - 3,30 193,1103 0 3062 0 0 0 0 0 0 0 0 0 0 0 
(R)-S-(2-amino-2- 
carboxyethyl)-L-homocysteine 
+ 4,77 222,0674 9344 24548 0 5947 0 0 0 0 10635 27311 0 0 4170 
?-Hydroxy-o-tolyl 
?-D-glucopyranoside 
- 0,60 286,1053 2315 2541 4223 0 2908 2 1 5782 1 10018 3087 5066 5453 
[R(R ∗ ,R ∗]-2-amino-1-[p- 
(methylsulphonyl)phenyl]propane- 
1,3-diol 




- 0,51 246,0515 1 0 0 2070 3035 0 0 0 1 1 0 0 0 
1,3-Benzenedimethanamine + 2,73 136,1000 4071 0 0 0 0 0 0 0 0 0 0 0 0 
1,3-Benzenedisulfonic acid, 
4-hydroxy- 
- 5,02 253,9555 1187 0 0 0 0 0 0 0 0 0 0 0 0 
1,4-BENZENDIOL, 
2-(PHENYLMETHYL)- 
+ 8,61 200,0837 0 0 0 3392 0 0 0 0 0 0 0 0 0 
17-Alpha-estradiol - 3,26 272,1776 0 0 0 0 0 0 0 0 2473 0 0 0 0 
17-Alpha-estradiol + 12,53 272,1776 0 0 0 281112 0 0 0 0 0 0 0 0 41704 
1-methoxy-4-(1,2,2,2- 
tetrachloroethyl)benzene 
- 4,52 271,9329 0 0 0 3052 0 0 0 0 0 1844 0 0 2872 
1-Propanol, 
3,3 ′ ,3 ′ ’-phosphinylidynetris- 
+ 0,65 224,1177 0 0 0 0 0 0 161169 0 0 1 0 0 0 
1-Propanol, 
3,3 ′ ,3 ′ ’-phosphinylidynetris- 
+ 12,38 224,1177 0 0 0 6143 0 0 0 0 0 1 0 0 0 
2-(4-Hydroxybenzyl)phenol + 8,61 200,0837 0 0 0 3392 0 0 0 0 0 0 0 0 0 
2,4,4 ′ - 
Trihydroxybenzophenone 
- 2,35 230,0579 0 0 2234 0 0 0 0 1 0 0 0 0 0 
2,4,4 ′ - 
Trihydroxybenzophenone 










+ 9,06 333,0954 0 0 2753 0 0 0 0 0 0 0 0 2556 0 








































Table A7 ( continued ) 
a) 



















































2-Deoxyinosine + 5,08 252,0859 0 0 0 21647 8693 9211 1 0 2 0 2 8264 2 
2-Furanmethanol, 2-formate + 2,82 206,0790 0 0 0 14860 8166 0 8419 0 1 0 2 10344 12495 
3-(2-Aminoethyl)indol-5-ol + 2,15 176,0950 110827 195846 50619 170670 70393 18583 37364 1 68690 168520 55028 112031 132329 




- 0,47 199,9957 0 0 1 0 1533 0 0 5822 1 2446 0 1 0 
3-O-Ethylascorbic acid - 0,51 204,0634 1 0 1 0 1 0 0 3030 0 2 0 1 2 
4- 
((Dimethylamino)methyl)phenol 
+ 1,55 151,0997 0 5377 0 1 0 0 0 0 0 1 0 0 0 
4- 
((Dimethylamino)methyl)phenol 
+ 1,24 151,0997 0 3678 0 0 0 0 0 0 0 0 0 0 0 
4,4 ′ -Dihydroxydiphenyl ether - 3,71 202,0630 0 0 0 1325 0 0 0 0 0 17300 0 0 0 
4,4-Dithiobis[2-aminobutyric] 
acid 
- 0,50 268,0551 0 0 1467 0 2 0 0 2 0 2 0 1 0 
4,4-Iminodianiline + 8,50 199,1109 2584 13165 0 7147 0 0 0 0 26479 3254 0 135201 0 
4,4 ′ -Propane-1,1-diyldiphenol - 4,43 228,1150 0 0 0 4693 0 0 0 0 0 0 0 0 4890 
4,4 ′ -Thiodibenzene-1,3-diol - 4,79 250,0300 1574 5437 0 6426 0 0 0 0 3219 4664 0 2010 1707 
4-Amino-4 ′ -hydroxybiphenyl - 4,43 185,0841 0 0 0 0 0 0 0 0 0 1330 0 0 0 
4-Amino-4 ′ -hydroxybiphenyl + 2,84 185,0841 0 0 0 19784 0 0 1 0 0 0 0 0 0 
4-Benzylphenol - 3,34 184,0888 0 0 0 1465 0 0 0 0 0 0 0 0 1889 
4-Cyclohexylphenol - 2,62 176,1201 0 0 0 0 0 0 0 0 0 0 0 0 0 
4-Hydroxybenzophenone - 3,69 198,0681 0 3898 0 0 0 0 0 0 0 1 0 0 0 
4-hydroxyphenylpyruvic acid - 1,88 180,0423 2 0 0 5290 1 0 0 1 11299 2 1 8439 0 
4-Hydroxyphenylpyruvic acid - 1,98 180,0423 9548 2 3397 5290 3486 5329 1 1 11299 7051 2 8439 4380 
4-Phenylphenol - 3,86 170,0732 0 1 1499 11263 1185 1 1 3405 2846 2235 1230 2 1307 
5-Amino-3-sulfosalicylic acid - 8,68 232,9994 3097 1943 0 0 0 0 0 0 0 0 0 0 0 
5-Amino-3-sulfosalicylic acid - 3,35 232,9994 9679 49092 2 0 2919 0 2342 3082 5497 36130 1492 10550 52786 
5-Fluorouridine - 2,92 262,0601 0 0 0 0 0 0 0 0 0 0 1476 2 0 
5H-Thiachromine-8-ethanol, 
2,7-dimethyl- 








- 6,59 382,9439 0 0 0 0 0 0 0 0 0 0 0 0 0 
8-Hydroxyguanosine - 3,70 299,0866 0 0 0 0 0 0 0 0 0 2389 0 0 0 
9-Deazainosine + 4,74 267,0855 4790 0 0 0 0 0 0 0 0 0 0 0 0 
Acetophenazine + 3,96 411,1980 127037 103383 184825 205768 253364 0 29361 228174 2 2 66761 31841 32018 
Acetophenazine + 3,70 411,1980 1 103785 177210 109165 233448 0 0 2 2 2 66104 1 0 
ACETRYPTINE + 4,95 202,1106 77468 41154 0 0 0 130227 0 0 0 1 0 0 0 
Alcohols, C13-15, ethoxylated + 4,70 261,2093 0 0 0 0 0 0 0 0 0 0 0 0 19222 
Alginic acid - 6,26 398,1060 1455 0 0 0 0 0 0 0 0 0 0 0 0 
Alloxantin - 3,84 286,0186 0 0 0 0 0 0 0 0 0 0 0 0 0 
Aminoimidazole ribotide + 0,54 295,0569 4033 0 0 0 0 0 0 0 0 0 0 0 0 
Amiterol + 2,22 208,1576 8475 11556 0 9385 0 5418 0 0 0 1 2 3899 9704 
Amiterol + 3,28 208,1576 0 2 0 1 0 0 0 0 0 1 2 1 3898 
AMMONIUM ZIRCONIUM 
HYDROXY CITRATE 
+ 6,17 208,0219 0 0 0 5458 0 0 0 0 0 0 0 0 0 








































Table A7 ( continued ) 
a) 



















































Anthrarobin - 3,80 226,0630 2 2 0 2 2261 0 0 0 1612 8398 0 2 2 
Anthrarobin + 7,17 226,0630 0 0 0 0 0 0 0 0 0 5843 0 0 0 
Aphidicolin - 5,17 338,2457 0 0 0 0 0 0 0 0 0 5990 0 3447 0 
Aphidicolin - 5,37 338,2457 21572 20383 0 2 3244 0 0 0 0 0 0 0 0 
Aphidicolin - 6,05 338,2457 44456 28605 1537 11817 7872 0 0 1874 3557 2988 4848 9209 4666 
Aphidicolin + 10,27 338,2457 232039 123966 0 2 2 0 0 0 0 0 25479 0 0 
Arbutin + 0,65 272,0896 0 0 0 0 0 0 0 0 0 0 0 0 0 
Asperuloside - 0,60 414,1162 1 0 1 0 0 0 0 4260 0 2 0 1 0 
Asperuloside + 4,88 414,1162 13167 10537 38558 0 0 0 0 0 0 14779 9225 0 0 
Azidamfenicol - 5,70 296,0995 0 0 0 10120 0 0 0 0 0 0 0 0 0 
Benaxibine - 3,26 269,0899 0 0 0 1659 0 0 0 0 0 0 0 0 0 




- 4,43 228,1155 0 0 0 4693 0 0 0 0 0 0 0 0 4890 
Benzylmorphine + 9,18 375,1834 0 0 0 22393 1 0 0 0 0 0 0 0 16567 
Bergenin - 0,62 328,0794 0 0 0 0 0 0 0 0 0 0 0 0 0 
Biflorin - 0,62 354,0951 2 2 2 0 3479 1810 1 4935 1 4551 1 2258 1 
Bipenamol - 3,67 245,0874 0 1532 0 0 0 0 0 2332 0 0 0 2 0 
Butanedioic acid, 
[(ethoxythioxomethyl)thio]- 
- 0,64 237,9970 2594 0 0 1 0 0 0 1 3951 0 0 0 0 
Butanedioic acid, 
2,3-dihydroxy- R-(R ∗ ,R ∗) -, m 
- 0,51 178,0477 0 0 0 0 0 0 0 1929 0 0 0 0 1 
C6-galactose mustard + 7,79 303,0640 0 0 0 2643 0 0 0 0 0 0 0 0 0 
Caftaric acid + 10,06 312,0481 8918 28847 0 0 0 0 0 0 0 11395 0 0 0 
Carboxymethyl cellulose - 5,84 238,0689 0 0 0 2 0 2165 0 0 2 0 1 2 0 
Chloralose + 5,34 307,9621 6304 0 0 0 0 0 0 0 0 0 0 0 0 
Chlorogenic acid - 0,60 354,0951 2 2 3394 0 3479 1810 1 4935 1 4551 1 2258 1 
Cianidanol - 0,60 290,0790 0 1434 0 0 0 2 2 2 1 1 2 2 1119 
Cianidanol + 5,13 290,0790 0 0 0 0 0 4646 0 0 0 0 0 0 0 
Citric acid, monoester with 
glycerol 
+ 4,25 266,0638 0 0 0 21413 0 0 0 0 0 0 0 0 0 
Cyclouridine - 4,28 226,0590 3550 13127 0 1 0 0 0 1184 1787 2 1430 0 2601 
Desethylhydroxychloroquine + 9,83 307,1451 18667 64467 0 5303 4273 0 0 0 9997 13461 0 12961 34141 
Dexelvucitabine + 7,12 227,0706 9558 86174 0 0 0 0 0 0 0 0 0 0 0 
Dezocine + 9,43 245,1780 0 0 0 5583 0 0 0 0 0 0 0 0 0 
Dezocine + 6,91 245,1780 0 2275 0 0 0 0 0 0 0 0 0 0 0 
D-gluco-Heptonic acid, (2?)-, 
ester with boric acid (H3BO3), 
sodium salt 
- 0,51 270,0758 0 0 1887 0 2445 0 0 3769 0 2335 0 0 1 
D-gluconic acid 6-(dihydrogen 
phosphate) 
+ 7,77 276,0246 1 0 0 1 0 1 0 0 5414 0 2 0 1 
D-gluconic acid, cyclic 
4,5-ester with boric acid, 
calcium salt (2:1) 
+ 5,01 222,0547 35908 31196 0 0 0 13626 0 0 0 0 0 0 6559 
D-Glucose + 2,22 180,0634 0 0 0 2 12237 0 0 0 10178 9468 1 1 13814 
Dhurrin - 3,71 313,0798 2 6580 1 0 0 0 0 1 0 0 0 0 0 
Dhurrin + 4,60 313,0798 6530 0 0 0 0 0 0 0 0 0 0 0 0 
Dichlorprop - 4,30 233,9850 0 0 0 0 0 0 0 0 0 0 0 0 0 








































Table A7 ( continued ) 
a) 



















































Digallic acid - 0,47 322,0325 0 0 0 0 0 0 0 2 0 3072 0 0 0 
Dihydroequilin + 11,65 270,1620 0 0 0 0 0 0 0 0 0 0 0 0 3471 




- 5,60 332,9613 0 0 0 0 0 27987 0 0 0 0 0 0 0 
Disodium 
ethylenediaminediacetate 
+ 6,90 176,0797 119369 542418 38968 
6903020 
33305 0 48646 11119 26580 29597 27921 87130 255492 
DOPA sulfate - 3,47 277,0256 1843 8414 0 0 0 0 0 0 0 2 0 0 3544 
Dopaquinone - 3,76 195,0532 0 3181 0 0 0 0 0 0 0 0 0 0 2 
EO 9 - 3,89 288,1110 0 0 0 0 0 0 0 0 0 0 0 9822 0 
Epilactose - 7,37 342,1162 0 0 0 3111 0 0 4777 0 0 0 0 9785 0 
Eptifibatide + 7,86 831,3156 1 0 0 0 0 0 0 0 0 0 3538 0 0 
Estriol + 6,36 288,1725 30247 107539 41687 0 165177 2 11524 62434 12811 122367 0 152441 1 
Estriol + 5,76 288,1725 1 2 0 25257 26598 0 0 75710 27068 165110 0 0 25531 
ETANTEROL + 6,15 316,1787 0 0 0 0 0 0 0 0 0 0 0 0 0 
Ethidium chloride (ET) + 7,24 314,1657 0 0 0 0 0 0 0 0 0 0 0 0 22402 
Exifone - 3,29 278,0427 0 0 3330 0 0 0 0 2 0 8673 0 0 0 
Felypressin - 15,80 
1039,4368 
0 0 0 0 0 0 0 0 0 0 2 0 0 
Fenoldopam + 4,06 305,0819 0 0 0 8755 0 0 0 0 0 0 0 0 0 
Fepradinol + 6,83 209,1416 0 0 0 0 0 0 0 0 0 0 0 0 0 
Formaldehyde, polymer with 
1,3-benzenediol, 
[1,1 ′ -biphenyl]-ar,ar’-diol and 
[1,1 ′ -biphenyl]triol 
+ 5,39 202,0630 0 0 18315 0 0 0 0 12052 0 2 0 0 0 
Fulvic acid - 0,51 308,0532 0 0 1 0 1 0 0 2 0 3465 0 0 0 
Gamma-glutamylcysteine - 4,50 250,0623 0 16544 0 0 0 0 0 0 0 0 0 0 0 
Gamma-glutamylcysteine - 4,67 250,0623 0 16544 0 0 0 0 0 0 0 0 0 0 0 
Gamma-glutamylcysteine + 5,93 250,0623 0 1 0 4056 0 0 0 0 0 0 0 0 0 
Gemcitabine + 4,79 263,0718 3195 0 0 0 0 0 0 0 0 0 0 0 0 
Ginkgolide-A - 0,60 408,1420 2 3928 2 0 2 4368 2 7014 2155 6513 3139 4093 2610 
Ginkgolide-A + 2,13 408,1420 0 4379 0 6647 28820 0 0 0 0 8788 0 0 1 
Ginkgolide-C - 0,61 440,1319 1126 1 1 0 1 2 1 4338 1 2 2 1 1324 
Ginkgolide-J - 0,61 424,1369 2 2630 4201 0 4078 2 2 6325 2 5065 1961 3720 2138 
Ginkgolide-M - 0,60 424,1369 2 2630 4201 0 4078 2 2 6325 2 5065 1961 3720 2138 
Gluconolactone - 0,49 178,0477 0 0 0 0 0 0 0 1929 0 0 0 0 1 
GLUFOSFAMIDE - 6,19 382,0463 0 0 0 0 0 2171 0 0 0 0 0 0 0 
Glycine, N,N’-(1,2-dithioxo- 
1,2-ethanediyl)bis- 
- 2,44 235,9925 0 59361 0 0 0 0 0 0 0 0 0 0 0 
Guanosine + 5,41 283,0917 0 0 0 6270 0 0 0 0 0 0 0 0 0 
Helicin - 0,60 284,0896 2 1749 2 0 2145 1489 2 5063 1 6535 1386 3039 2416 
Heptanoic acid, 
2,2,3,3,4,4,5,5,6,6,7,7-dodecafl
- 5,39 345,9863 1187 4649 0 0 0 0 0 0 0 0 2 1 0 
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Hexamethylolmelamine + 0,66 306,1288 0 0 1 0 0 0 0 0 0 0 0 0 0 
Hexanedioic acid - 0,49 146,0579 0 0 0 0 0 0 0 2255 0 2487 1226 2 2 
Hydroxystilbamidine 
Isethionate 
+ 8,06 280,1324 0 0 32202 0 0 0 0 0 0 0 0 0 0 
Isochorismic Acid - 0,49 226,0477 0 0 0 0 1 0 0 1887 0 2249 0 0 0 
Isochorismic Acid + 3,32 226,0477 0 0 0 2869 0 0 0 0 0 0 0 0 0 
Isopropyl citrate + 5,98 234,0740 22278 0 0 0 0 0 0 0 0 0 0 0 0 
Isoquinoline-6,7-diol, 
1,2,3,4-tetrahydro-2-meth 
+ 5,23 179,0946 0 37012 0 0 0 0 0 0 0 0 0 0 0 
Lactobionic acid + 5,35 358,1111 16918 0 0 0 0 0 0 0 0 0 0 0 0 
Lactose - 7,37 342,1162 0 0 0 3111 0 0 4777 0 0 0 0 9785 0 
L-Dopa - 2,69 197,0688 1 10415 0 0 0 0 0 0 0 2662 0 0 2480 
Levallorphan + 7,16 283,1936 0 0 0 11410 0 0 0 0 0 0 0 0 0 
L-Glutamic acid + 6,90 147,0532 0 0 0 8553 0 0 0 0 0 0 0 0 0 
Lodoxamide - 5,46 310,9945 0 0 0 2466 0 0 0 0 0 0 0 0 0 
Maleylacetoacetic acid - 3,13 200,0321 1792 1 0 0 0 0 0 0 0 0 0 0 0 
Maltodextrin + 2,49 180,0634 0 0 2 0 0 0 0 0 0 0 0 6710 0 







+ 8,59 388,2389 0 0 0 1 0 0 0 0 0 0 0 0 129267 
Morphine + 6,93 285,1365 0 0 0 0 0 0 0 0 0 0 0 0 0 
Morphine methylbromide + 4,92 300,1600 0 2 0 
1353631 
0 0 0 0 0 0 0 0 1 
N-(3-Chloroallyl)hexaminium 
chloride 
+ 7,51 215,1063 0 0 0 16204 0 0 0 0 0 0 0 0 0 
N,N,N’,N’-Tetrakis(2- 
Hydroxypropyl)ethylenediamine 
- 4,18 292,2362 0 0 0 3258 0 0 0 0 0 0 0 0 0 
Nadolol - 4,51 309,1940 0 0 0 0 0 0 0 0 0 0 0 0 0 
Nitrocellulose - 3,45 315,0186 4006 7386 0 0 0 0 0 0 0 10159 0 0 0 
Nitrocellulose + 4,94 315,0186 2797 4391 0 0 0 0 0 0 0 3774 0 0 0 
N’-Nitrosonornicotine-1-N- 
oxide 
+ 4,86 193,0851 1 2 2 0 3382 0 0 0 0 0 2 0 0 
Norcodeine + 9,24 285,1365 0 0 0 29209 2 0 0 0 0 12238 0 0 4390 
Normorphine - 2,89 271,1208 0 0 0 0 0 0 0 0 0 1814 0 0 0 
OXONAZINE - 3,87 222,1229 2 0 0 2 1 0 0 0 1 2 0 2 0 
p-(1-phenylethyl)phenol - 5,97 198,1045 0 1 0 2040 0 0 0 0 0 11078 0 0 5477 
PANCRATISTATIN - 3,75 325,0798 0 1513 0 0 0 0 0 0 0 0 0 0 0 
Phenanthridinium, 3,8- 
diamino-5-methyl-6-phenyl- 
+ 6,90 300,1501 2 2 0 0 0 0 1 0 13208 0 2 0 2 
Phenol, 4,4 ′ -iminobis- + 6,05 201,0790 0 2 0 0 0 0 0 0 2 0 1 0 37252 
PHENOLPHTHALOL + 9,56 306,1256 3331 2 2 5818 2813 0 0 0 0 2 0 6498 2 
Phosphonic acid, [[(2- 
hydroxyethyl)imino]bis(methylene)]bis- 
+ 4,41 249,0167 0 6086 0 0 0 0 0 0 0 0 0 0 0 
Picrotoxin - 3,83 310,1053 28351 5204 0 4591 1 0 0 1 2 0 1 0 0 








































Table A7 ( continued ) 
a) 



















































Picrotoxin + 0,67 310,1053 0 0 1 0 0 0 0 0 0 0 0 0 0 
Plasma protein fraction - 2,89 226,0242 8774 20853 0 0 0 0 1 2517 6055 0 2 2 3707 
Potassium citrate - 0,51 192,0270 0 0 0 0 1 0 3966 2 0 0 1 0 0 
Propyl gallate - 4,37 212,0685 0 0 0 0 0 0 0 0 2535 0 0 0 0 
Puberulic acid - 0,49 198,0164 2 0 2449 0 3042 2 0 6519 1 6872 1 2137 2 
Purpurogallin - 1,54 220,0372 0 0 0 0 0 0 0 0 2148 2 0 0 0 
Purpurogallin - 2,52 220,0372 0 0 1 0 1 0 0 0 0 7867 0 0 0 
Pyrazofurin + 4,58 259,0804 0 0 0 0 1 1 0 1 1 0 1 0 0 
Ractopamine hydrochloride - 6,09 301,1678 1 1893 7164 0 0 0 0 0 0 0 0 0 0 
Ribavirin monophosphate - 0,50 324,0471 0 0 0 0 2 0 0 2445 0 3443 0 0 0 
Ribavirin monophosphate + 6,71 324,0471 1 2 0 1 0 0 0 1 2 2 1 1 1 
Risedronic acid - 10,06 283,0011 0 0 0 0 0 0 0 0 0 1033 0 0 0 
Robinin - 8,10 740,2164 0 0 0 2407 0 0 0 0 0 0 0 0 1129 
Salidroside - 0,60 300,1209 2369 2886 2 0 3202 2224 2 6963 2 9196 3103 5141 4717 
Salidroside + 0,65 300,1209 0 0 0 0 0 0 0 0 0 0 0 0 0 
Sedoheptulose 7-phosphate + 3,13 290,0403 0 0 0 8372 0 0 0 0 0 0 0 0 0 
SEVITROPIUM MESILATE + 9,95 380,1684 0 0 0 24280 2 0 0 0 0 0 0 0 0 
SKF 77434 + 10,43 295,1572 0 0 0 0 0 14310 0 0 14713 2 0 0 0 
SKF 81297 + 4,28 289,0870 0 0 0 15081 2 1 0 0 0 0 0 0 0 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
- 4,06 241,9207 1 2052 0 0 0 0 0 0 0 0 0 0 0 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
- 2,47 241,9207 7662 0 0 0 0 0 0 0 0 1 0 0 0 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
- 4,26 241,9207 5733 3222 0 2 0 0 0 0 0 6609 0 0 0 
Sucralose - 2,98 396,0146 40578 29437 7619 138714 13755 12977 4776 0 5620 4762 3450 21107 64922 
Sydnophen - 2,94 204,1137 0 0 0 0 0 0 0 0 0 2 0 0 0 




+ 1,90 262,0913 3844 0 0 10680 2 0 0 0 1 0 0 0 2 
Tetrasodium iminidisuccinate + 2,72 249,0485 2 0 0 0 0 13073 0 0 0 0 0 0 0 
Tetronic 701 - 10,21 468,3411 0 0 0 0 0 0 0 2557 1100 818 0 0 0 
Tetronic 701 - 10,09 468,3411 2 1 2 2 0 2 2102 0 1100 818 1989 2495 2 
Theaflavin-3-gallate - 2,99 716,1377 1473 0 0 1 0 0 0 0 0 0 0 1 1 
Tiaramide + 8,11 355,0757 0 0 0 0 0 0 0 0 0 0 0 0 0 
TIFLOREX + 7,81 263,0956 6759 2679 0 0 0 0 0 0 0 0 0 0 0 
Triethylene glycol + 11,49 150,0892 0 0 0 13646 0 0 0 0 0 0 0 0 0 
Triisopropanolamine + 0,65 191,1521 14436 20308 1 169731 27905 34561 33146 0 33680 59141 20977 23783 254516 
Trisodium citrate - 0,51 192,0270 0 0 0 0 1 0 3966 2 0 0 1 0 0 
Vanillactic acid - 0,62 212,0685 2 0 0 0 2 0 0 3520 2 3715 2 2241 2761 
Vanillactic acid + 7,13 212,0685 0 2 0 2 0 1 2 0 10017 0 0 2 0 
Xanthosine + 5,46 284,0757 6038 2 0 0 0 6551 0 0 0 0 0 0 0 
Xanthosine + 7,61 284,0757 2770 3907 0 0 0 0 0 0 0 0 0 0 0 






















































































































+ 3,07 180,1263 0 0 0 0 0 0 0 0 0 0 0 0 0 
(R)-N-methylsalsolinol - 3,30 193,1103 0 0 0 0 0 0 0 0 0 0 0 0 0 
(R)-S-(2-amino-2- 
carboxyethyl)-L-homocysteine 
+ 4,77 222,0674 4155 20055 0 0 0 0 0 0 0 13844 0 0 0 
?-hydroxy-o-tolyl 
?-D-glucopyranoside 
- 0,60 286,1053 7622 8087 3918 1937 3884 2311 5238 5948 3491 6648 5504 6286 3842 
[R(R ∗ ,R ∗]-2-amino-1-[p- 
(methylsulphonyl)phenyl]propane- 
1,3-diol 




- 0,51 246,0515 0 0 0 0 0 0 0 1 0 0 0 0 0 
1,3-Benzenedimethanamine + 2,73 136,1000 0 0 0 0 0 0 0 0 0 0 0 0 0 
1,3-Benzenedisulfonic acid, 
4-hydroxy- 
- 5,02 253,9555 0 0 0 0 0 0 0 0 0 0 0 0 0 
1,4-BENZENDIOL, 
2-(PHENYLMETHYL)- 
+ 8,61 200,0837 0 0 0 0 0 0 0 0 0 0 0 0 0 
17-Alpha-estradiol - 3,26 272,1776 0 0 0 0 0 0 0 0 0 0 0 0 0 
17-Alpha-Estradiol + 12,53 272,1776 0 0 0 0 0 0 0 0 0 0 0 0 0 
1-Methoxy-4-(1,2,2,2- 
tetrachloroethyl)benzene 
- 4,52 271,9329 0 0 0 0 0 0 0 0 0 2 0 0 0 
1-Propanol, 
3,3 ′ ,3 ′ ’-phosphinylidynetris- 
+ 0,65 224,1177 0 0 2 0 3821 0 0 1 3788 0 0 2 0 
1-Propanol, 
3,3 ′ ,3 ′ ’-phosphinylidynetris- 
+ 12,38 224,1177 0 0 0 0 0 0 0 0 0 1 0 0 0 
2-(4-Hydroxybenzyl)phenol + 8,61 200,0837 0 0 0 0 0 0 0 0 0 0 0 0 0 
2,4,4 ′ - 
Trihydroxybenzophenone 
- 2,35 230,0579 0 0 2920 0 0 0 0 0 0 0 0 0 0 
2,4,4 ′ - 
Trihydroxybenzophenone 










+ 9,06 333,0954 0 0 2558 0 0 0 0 0 0 0 0 0 0 
2-Deoxyinosine + 5,08 252,0859 0 0 0 0 0 0 0 0 0 0 0 0 0 
2-Furanmethanol, 2-formate + 2,82 206,0790 0 0 0 0 0 0 0 0 0 0 0 0 0 
3-(2-Aminoethyl)indol-5-ol + 2,15 176,0950 110820 148073 52428 58866 28174 1 10654 2 19209 104601 19064 47630 34321 




- 0,47 199,9957 0 0 0 0 0 0 0 3954 0 2 0 0 0 








































Table A7 ( continued ) 
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3-O-Ethylascorbic acid - 0,51 204,0634 1 0 0 0 0 0 0 2421 0 2 0 1 0 
4- 
((Dimethylamino)methyl)phenol 
+ 1,55 151,0997 1 3186 0 0 0 0 0 0 0 0 0 0 0 
4- 
((Dimethylamino)methyl)phenol 
+ 1,24 151,0997 0 1 0 0 0 0 0 0 0 0 0 0 0 
4,4 ′ -Dihydroxydiphenyl ether - 3,71 202,0630 0 0 0 0 0 0 0 0 0 0 0 0 0 
4,4-Dithiobis[2-aminobutyric] 
acid 
- 0,50 268,0551 0 0 1477 0 0 0 0 2610 0 2 0 0 0 
4,4-Iminodianiline + 8,50 199,1109 0 0 0 0 0 0 0 0 0 0 0 0 0 
4,4 ′ -Propane-1,1-diyldiphenol - 4,43 228,1150 0 0 0 0 0 0 0 0 0 0 0 0 0 
4,4 ′ -Thiodibenzene-1,3-diol - 4,79 250,0300 0 1 0 0 0 0 0 0 0 0 0 0 0 
4-Amino-4 ′ -hydroxybiphenyl - 4,43 185,0841 0 0 0 0 0 0 0 0 0 0 0 0 0 
4-Amino-4 ′ -hydroxybiphenyl + 2,84 185,0841 0 0 0 0 0 0 0 0 0 0 0 0 0 
4-Benzylphenol - 3,34 184,0888 0 0 0 0 0 0 0 0 0 0 0 0 0 
4-Cyclohexylphenol - 2,62 176,1201 1 1 2556 0 0 0 0 0 0 0 0 1 0 
4-Hydroxybenzophenone - 3,69 198,0681 0 0 0 0 0 0 0 0 0 0 0 0 0 
4-Hydroxyphenylpyruvic acid - 1,88 180,0423 0 0 1 0 0 0 0 2 12921 1 0 2 1 
4-Hydroxyphenylpyruvic acid - 1,98 180,0423 5422 3597 5507 5572 4160 3224 4155 0 12912 27288 3729 5311 2932 
4-Phenylphenol - 3,86 170,0732 1 0 1672 0 0 0 2 4108 2489 2293 1405 0 0 
5-Amino-3-sulfosalicylic acid - 8,68 232,9994 1552 0 0 0 0 0 0 0 0 0 0 0 0 
5-Amino-3-sulfosalicylic acid - 3,35 232,9994 7347 29545 2830 0 0 0 0 3291 0 19182 0 0 6072 
5-Fluorouridine - 2,92 262,0601 0 0 0 0 0 0 0 0 0 2091 0 0 0 
5H-Thiachromine-8-ethanol, 
2,7-dimethyl- 








- 6,59 382,9439 0 0 0 1991 0 0 0 0 0 0 0 0 0 
8-Hydroxyguanosine - 3,70 299,0866 0 0 0 0 0 0 0 0 0 0 0 0 0 
9-Deazainosine + 4,74 267,0855 0 0 0 0 0 0 0 0 0 0 0 0 0 
Acetophenazine + 3,96 411,1980 0 2 0 0 0 0 0 0 1 1 0 1 0 
Acetophenazine + 3,70 411,1980 0 0 0 0 1 0 0 0 0 0 0 0 0 
ACETRYPTINE + 4,95 202,1106 0 0 0 76341 1 0 0 0 0 0 0 0 0 
Alcohols, C13-15, ethoxylated + 4,70 261,2093 0 0 0 0 0 0 0 0 0 0 0 0 0 
Alginic acid - 6,26 398,1060 0 0 0 0 0 0 0 0 0 0 0 0 0 
Alloxantin - 3,84 286,0186 0 0 0 0 0 0 0 0 0 5002 0 0 0 
Aminoimidazole ribotide + 0,54 295,0569 0 0 0 0 0 0 0 0 0 0 0 0 0 
Amiterol + 2,22 208,1576 8093 13206 0 0 0 2 0 0 0 4100 7839 0 5330 
Amiterol + 3,28 208,1576 0 1 0 0 0 0 0 0 0 1 2 0 1 
AMMONIUM ZIRCONIUM 
HYDROXY CITRATE 
+ 6,17 208,0219 0 0 0 0 0 0 0 0 0 0 0 0 0 
Anthrarobin - 3,80 226,0630 0 0 0 0 0 0 0 0 0 0 0 0 0 
Anthrarobin + 7,17 226,0630 0 0 0 0 0 0 0 0 0 0 0 0 0 
Aphidicolin - 5,17 338,2457 0 0 0 0 0 0 0 0 0 0 0 0 0 
Aphidicolin - 5,37 338,2457 0 0 0 0 0 0 0 0 0 0 0 0 0 
Aphidicolin - 6,05 338,2457 0 0 1 0 0 0 0 2 0 0 0 0 0 
Aphidicolin + 10,27 338,2457 0 0 0 0 0 0 0 0 0 0 0 0 0 
Arbutin + 0,65 272,0896 0 2686 0 0 0 0 0 0 0 0 0 0 0 
Asperuloside - 0,60 414,1162 2 1 0 1 1 1 1 2 2 2 0 2 0 
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Asperuloside + 4,88 414,1162 6971 9155 2 0 0 0 0 0 0 0 0 0 0 
Azidamfenicol - 5,70 296,0995 0 0 0 7115 1 0 0 0 3044 0 2 0 3371 
Benaxibine - 3,26 269,0899 0 0 0 0 0 0 0 0 0 0 0 0 0 




- 4,43 228,1155 0 0 0 0 0 0 0 0 0 0 0 0 0 
Benzylmorphine + 9,18 375,1834 0 0 0 0 0 0 0 0 0 0 0 0 0 
Bergenin - 0,62 328,0794 0 0 0 0 2962 0 0 0 0 0 0 1 0 
Biflorin - 0,62 354,0951 2236 2537 3395 0 5858 1 2013 2 1164 2373 2 1 1 
Bipenamol - 3,67 245,0874 0 0 0 0 0 0 0 0 0 0 0 0 0 
Butanedioic acid, 
[(ethoxythioxomethyl)thio]- 
- 0,64 237,9970 0 0 1 1 0 0 0 2 1 0 0 0 0 
Butanedioic acid, 
2,3-dihydroxy- R-(R ∗ ,R ∗) -, m 
- 0,51 178,0477 0 0 0 0 0 0 0 1313 0 0 0 0 0 
C6-galactose mustard + 7,79 303,0640 0 0 0 0 0 0 0 0 0 0 0 0 0 
Caftaric acid + 10,06 312,0481 0 0 0 0 0 0 0 0 0 0 0 0 0 
Carboxymethyl cellulose - 5,84 238,0689 0 0 0 0 0 0 0 0 0 0 0 0 0 
Chloralose + 5,34 307,9621 2270 0 0 0 0 0 0 0 0 0 0 0 0 
Chlorogenic acid - 0,60 354,0951 2236 2537 3395 0 5858 1 2013 2 1164 2373 2 1 1 
Cianidanol - 0,60 290,0790 0 0 0 0 0 0 0 1 0 0 0 0 0 
Cianidanol + 5,13 290,0790 0 0 0 0 0 0 0 0 0 0 0 0 0 
Citric acid, monoester with 
glycerol 
+ 4,25 266,0638 0 0 0 0 0 0 0 0 0 0 0 0 0 
Cyclouridine - 4,28 226,0590 0 0 0 0 0 0 0 1545 0 0 0 0 0 
Desethylhydroxychloroquine + 9,83 307,1451 4812 17360 0 0 0 0 0 0 0 4692 0 0 0 
Dexelvucitabine + 7,12 227,0706 0 0 0 0 0 0 0 0 0 0 0 0 0 
Dezocine + 9,43 245,1780 0 0 0 0 0 0 0 0 0 0 0 0 0 
Dezocine + 6,91 245,1780 0 0 0 0 0 0 0 0 0 0 0 0 0 
D-gluco-Heptonic acid, (2?)-, 
ester with boric acid (H3BO3), 
sodium salt 
- 0,51 270,0758 2 2416 2209 0 1984 0 0 2 0 2 0 1 0 
D-gluconic acid 6-(dihydrogen 
phosphate) 
+ 7,77 276,0246 1 1 1 0 1 1 1 2 1 0 0 0 0 
D-gluconic acid, cyclic 
4,5-ester with boric acid, 
calcium salt (2:1) 
+ 5,01 222,0547 0 0 0 0 2 0 0 0 0 0 0 0 0 
D-Glucose + 2,22 180,0634 1 0 0 0 0 0 0 0 0 0 0 0 0 
Dhurrin - 3,71 313,0798 2125 4884 1 0 0 0 0 3379 0 0 0 0 0 
Dhurrin + 4,60 313,0798 0 0 0 0 0 0 0 0 0 0 0 0 0 
Dichlorprop - 4,30 233,9850 0 0 0 0 0 0 0 0 0 3744 0 0 0 
Digallic acid - 0,47 322,0325 0 0 0 0 0 0 0 0 0 0 0 0 0 
Dihydroequilin + 11,65 270,1620 0 0 0 0 0 0 0 0 3656 0 0 0 6498 




- 5,60 332,9613 0 0 0 0 0 0 0 0 0 0 0 0 0 
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+ 6,90 176,0797 38597 269091 43694 655750 16781 0 7979 12698 7508 12985 12445 16842 42599 
DOPA sulfate - 3,47 277,0256 2 6010 0 0 0 0 0 0 0 1 0 0 0 
Dopaquinone - 3,76 195,0532 1 2819 0 0 0 0 0 0 0 0 0 0 0 
EO 9 - 3,89 288,1110 0 1 0 0 0 0 0 0 0 9521 0 2 25441 
Epilactose - 7,37 342,1162 0 0 0 0 0 0 0 0 0 0 0 0 0 
Eptifibatide + 7,86 831,3156 0 0 0 0 0 0 0 0 0 1 2270 0 0 
Estriol + 6,36 288,1725 145844 34241 1 0 2 0 0 134768 0 231287 0 1 0 
Estriol + 5,76 288,1725 145881 116957 0 0 0 0 0 133701 0 229650 4405 0 0 
ETANTEROL + 6,15 316,1787 0 0 0 0 0 0 0 0 6275 0 0 0 0 
Ethidium chloride (ET) + 7,24 314,1657 0 0 0 2 0 0 0 0 0 0 0 0 2 
Exifone - 3,29 278,0427 0 0 1 0 0 0 0 0 0 0 0 0 0 
Felypressin - 15,80 
1039,4368 
0 0 0 0 0 0 0 0 0 1 1213 1 1 
Fenoldopam + 4,06 305,0819 0 0 0 0 0 0 0 0 0 0 0 0 0 
Fepradinol + 6,83 209,1416 0 0 0 2505 0 0 0 0 0 0 0 0 0 
Formaldehyde, polymer with 
1,3-benzenediol, 
[1,1 ′ -biphenyl]-ar,ar’-diol and 
[1,1 ′ -biphenyl]triol 
+ 5,39 202,0630 0 0 40288 0 0 0 0 2 0 0 0 0 0 
Fulvic acid - 0,51 308,0532 0 0 0 0 0 0 0 1 0 1 0 0 0 
Gamma-glutamylcysteine - 4,50 250,0623 0 0 0 0 0 0 0 0 0 0 0 0 0 
Gamma-glutamylcysteine - 4,67 250,0623 0 0 0 0 0 0 0 0 0 0 0 0 0 
Gamma-glutamylcysteine + 5,93 250,0623 0 4615 0 4333 0 0 0 0 0 0 0 0 0 
Gemcitabine + 4,79 263,0718 0 0 0 0 0 0 0 0 0 0 0 0 0 
Ginkgolide-A - 0,60 408,1420 3176 4470 2 1437 8098 3122 2512 2 2231 2680 2217 4578 2 
Ginkgolide-A + 2,13 408,1420 0 0 0 0 0 0 0 0 0 0 0 0 0 
Ginkgolide-C - 0,61 440,1319 2 2 2 2 3817 1131 1627 2 1471 2 996 2204 1 
Ginkgolide-J - 0,61 424,1369 3111 3347 4508 2 6574 2217 2640 7060 2161 2589 1898 3719 2 
Ginkgolide-M - 0,60 424,1369 3111 3347 4508 2 6574 2217 2640 7060 2161 2589 1898 3719 2 
Gluconolactone - 0,49 178,0477 0 0 0 0 0 0 0 1313 0 0 0 0 0 
GLUFOSFAMIDE - 6,19 382,0463 0 0 0 0 0 0 0 0 0 0 0 0 0 
Glycine, N,N’-(1,2-dithioxo- 
1,2-ethanediyl)bis- 
- 2,44 235,9925 0 44400 0 0 0 0 0 0 0 0 0 0 0 
Guanosine + 5,41 283,0917 0 0 0 0 0 0 0 0 0 0 0 0 0 
Helicin - 0,60 284,0896 3984 5131 4104 2 3985 1464 2 5640 2 3966 1812 4403 2 
Heptanoic acid, 
2,2,3,3,4,4,5,5,6,6,7,7-dodecafl
- 5,39 345,9863 2581 5223 0 2298 2 0 0 5644 5500 0 1 2 0 
Hexamethylolmelamine + 0,66 306,1288 1 2978 0 1 0 0 0 0 0 0 0 1 0 
Hexanedioic acid - 0,49 146,0579 2 0 0 0 0 0 0 2 0 2 1413 0 2 
Hydroxystilbamidine 
Isethionate 
+ 8,06 280,1324 0 0 34283 0 0 0 0 0 0 0 0 0 0 
Isochorismic acid - 0,49 226,0477 0 0 0 0 0 0 0 1898 0 2 0 0 0 
Isochorismic acid + 3,32 226,0477 0 0 0 0 0 0 0 0 0 0 0 0 0 
Isopropyl citrate + 5,98 234,0740 0 0 0 0 0 0 0 0 0 0 0 0 0 
Isoquinoline-6,7-diol, 
1,2,3,4-tetrahydro-2-meth 
+ 5,23 179,0946 0 22065 0 0 0 0 0 0 0 0 0 0 0 
Lactobionic acid + 5,35 358,1111 0 0 0 0 0 0 0 0 0 0 0 0 0 
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Lactose - 7,37 342,1162 0 0 0 0 0 0 0 0 0 0 0 0 0 
L-Dopa - 2,69 197,0688 0 0 0 0 0 0 0 0 0 0 0 0 0 
Levallorphan + 7,16 283,1936 0 0 0 0 0 0 0 0 0 0 0 0 0 
L-Glutamic acid + 6,90 147,0532 0 0 0 0 0 0 0 0 0 0 0 0 0 
Lodoxamide - 5,46 310,9945 0 0 0 0 0 0 0 0 0 0 0 0 0 
Maleylacetoacetic acid - 3,13 200,0321 0 0 0 0 0 0 0 0 0 0 0 0 0 
Maltodextrin + 2,49 180,0634 0 0 13056 0 0 0 0 0 0 0 0 0 0 







+ 8,59 388,2389 0 0 0 0 0 0 0 0 0 0 0 0 0 
Morphine + 6,93 285,1365 0 1 0 0 0 0 0 0 0 0 0 0 2407 
Morphine methylbromide + 4,92 300,1600 0 1 0 2 0 0 0 0 0 0 0 0 0 
N-(3-Chloroallyl)hexaminium 
chloride 
+ 7,51 215,1063 0 0 0 0 0 0 0 0 0 0 0 0 0 
N,N,N’,N’-Tetrakis(2- 
Hydroxypropyl)ethylenediamine 
- 4,18 292,2362 0 0 0 0 0 0 0 0 0 0 0 0 0 
Nadolol - 4,51 309,1940 0 0 0 0 0 0 0 0 0 2 0 0 1294 
Nitrocellulose - 3,45 315,0186 3037 5698 0 0 0 0 0 0 0 4943 0 0 0 
Nitrocellulose + 4,94 315,0186 2559 3474 0 0 0 0 0 0 0 1 0 0 0 
N’-Nitrosonornicotine-1-N- 
oxide 
+ 4,86 193,0851 0 2 0 0 0 0 0 0 0 0 0 0 0 
Norcodeine + 9,24 285,1365 0 0 0 0 0 0 0 0 0 0 0 0 0 
Normorphine - 2,89 271,1208 0 0 0 0 0 0 0 0 0 0 0 0 0 
OXONAZINE - 3,87 222,1229 1 7584 1 1915 0 0 0 1 0 2 0 0 0 
p-(1-phenylethyl)phenol - 5,97 198,1045 0 0 0 0 0 0 0 0 0 0 0 0 0 
PANCRATISTATIN - 3,75 325,0798 0 1164 0 0 0 0 0 0 0 0 0 0 0 
Phenanthridinium, 3,8- 
diamino-5-methyl-6-phenyl- 
+ 6,90 300,1501 17406 1 0 1 2 0 2904 0 2614 0 2 1 1 
Phenol, 4,4 ′ -iminobis- + 6,05 201,0790 0 1 0 0 0 0 0 0 0 0 0 0 0 
PHENOLPHTHALOL + 9,56 306,1256 0 0 2 0 0 0 0 0 0 0 0 0 0 
Phosphonic acid, [[(2- 
hydroxyethyl)imino]bis(methylene)]bis- 
+ 4,41 249,0167 4322 2 0 0 0 0 0 0 0 0 0 0 0 
Picrotoxin - 3,83 310,1053 1 1 0 0 0 0 0 0 0 0 0 0 0 
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Picrotoxin + 0,67 310,1053 2 3335 1 0 0 0 0 0 0 0 0 0 0 
Plasma protein fraction - 2,89 226,0242 0 0 0 0 0 0 0 1 0 0 0 0 0 
Potassium citrate - 0,51 192,0270 0 0 0 0 0 0 0 0 0 0 0 0 0 
Propyl gallate - 4,37 212,0685 0 0 0 0 0 0 0 0 0 0 0 0 0 
Puberulic acid - 0,49 198,0164 0 0 1308 0 0 0 0 3971 0 2 0 0 0 
Purpurogallin - 1,54 220,0372 0 0 0 0 0 0 0 0 0 5399 0 0 0 
Purpurogallin - 2,52 220,0372 0 0 0 0 0 0 0 0 0 0 0 0 0 
Pyrazofurin + 4,58 259,0804 0 6258 0 0 1 0 0 0 0 1 1 1 0 
Ractopamine hydrochloride - 6,09 301,1678 0 1 7483 0 0 0 0 0 0 0 0 0 0 
Ribavirin Monophosphate - 0,50 324,0471 0 0 0 0 0 0 0 0 0 0 0 0 0 
Ribavirin Monophosphate + 6,71 324,0471 2 1 1 2 1 1 0 65854 0 1 1 1 1 
Risedronic acid - 10,06 283,0011 0 0 0 0 0 0 0 0 0 0 0 0 0 
Robinin - 8,10 740,2164 0 0 0 0 0 0 0 0 0 0 0 0 0 
Salidroside - 0,60 300,1209 7541 8785 2 1 4403 2883 5177 7319 3535 6100 4807 6221 3652 
Salidroside + 0,65 300,1209 0 2727 0 0 0 0 0 0 0 0 0 0 0 
sedoheptulose 7-phosphate + 3,13 290,0403 0 0 0 0 0 0 0 0 0 0 0 0 0 
SEVITROPIUM MESILATE + 9,95 380,1684 0 0 0 0 0 0 0 0 0 0 0 0 0 
SKF 77434 + 10,43 295,1572 0 0 0 0 0 0 0 0 0 0 0 0 0 
SKF 81297 + 4,28 289,0870 0 0 0 0 0 0 0 0 0 0 0 0 0 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
- 4,06 241,9207 0 0 0 0 0 0 0 0 0 0 0 0 0 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
- 2,47 241,9207 0 0 0 0 0 0 0 0 0 0 0 0 0 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
- 4,26 241,9207 2 1383 0 0 0 0 0 0 0 0 0 0 0 
Sucralose - 2,98 396,0146 40081 27049 9049 18897 6526 3511 3049 0 3809 2042 2483 12067 30967 
Sydnophen - 2,94 204,1137 1 2311 0 0 0 0 0 1 0 0 0 1 0 




+ 1,90 262,0913 0 0 0 0 0 0 0 0 0 0 0 0 0 
Tetrasodium iminidisuccinate + 2,72 249,0485 0 0 0 0 0 0 0 0 0 0 0 0 0 
Tetronic 701 - 10,21 468,3411 0 0 0 0 0 0 0 2 0 0 0 0 0 
Tetronic 701 - 10,09 468,3411 1 0 1565 2 1594 2 1 0 0 0 2 2579 1 
Theaflavin-3-gallate - 2,99 716,1377 1 1 0 0 0 0 0 0 0 0 0 0 0 
Tiaramide + 8,11 355,0757 0 0 0 0 0 0 0 0 0 0 0 2589 0 
TIFLOREX + 7,81 263,0956 0 0 0 0 0 0 0 0 0 0 0 0 0 
Triethylene glycol + 11,49 150,0892 0 0 0 0 0 0 0 0 0 0 0 0 0 
Triisopropanolamine + 0,65 191,1521 0 0 2650 2 5676 0 0 0 0 0 0 2 1 
Trisodium citrate - 0,51 192,0270 0 0 0 0 0 0 0 0 0 0 0 0 0 
Vanillactic acid - 0,62 212,0685 1875 1674 0 0 0 0 0 1 1392 3367 1887 2 1 
Vanillactic acid + 7,13 212,0685 0 0 0 0 0 0 0 0 0 0 0 0 0 
Xanthosine + 5,46 284,0757 0 0 0 0 0 0 0 0 0 0 0 0 0 
Xanthosine + 7,61 284,0757 0 0 0 0 0 0 0 0 0 0 0 0 0 
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N/D N/D N/D 96.8 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
(R)-N-Methylsalsolinol N/D 96.7 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
(R)-S-(2-amino-2-carboxyethyl)-L- 
homocysteine 
55.5 18.3 N/D 98.3 N/D N/D N/D N/D 99.1 49.3 N/D N/D 97.6 
?-hydroxy-o-tolyl 
?-D-glucopyranoside 
0.0 0.0 7.2 N/D 0.0 N/D N/D 0.0 N/D 33.6 0.0 0.0 29.5 
[R(R ∗ .R ∗]-2-amino-1-[p- 
(methylsulphonyl)phenyl]propane- 
1,3-diol 
N/D N/D N/D 99.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
1-(2,4-dinitrophenyl)pyridinium 
chloride 
N/D N/D N/D 95.2 96.7 N/D N/D N/D N/D N/D N/D N/D N/D 
1,3-Benzenedimethanamine 97.5 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
1,3-Benzenedisulfonic acid, 
4-hydroxy- 
91.6 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
1,4-BENZENDIOL, 
2-(PHENYLMETHYL)- 
N/D N/D N/D 97.1 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
17-alpha-Estradiol N/D N/D N/D N/D N/D N/D N/D N/D 96.0 N/D N/D N/D N/D 
17-alpha-Estradiol N/D N/D N/D 100.0 N/D N/D N/D N/D N/D N/D N/D N/D 99.8 
1-methoxy-4-(1,2,2,2- 
tetrachloroethyl)benzene 
N/D N/D N/D 96.7 N/D N/D N/D N/D N/D 94.6 N/D N/D 96.5 
1-Propanol, 
3,3 ′ ,3 ′ ’-phosphinylidynetris- 
N/D N/D N/D N/D N/D N/D 99.9 N/D N/D N/D N/D N/D N/D 
1-Propanol, 
3,3 ′ ,3 ′ ’-phosphinylidynetris- 
N/D N/D N/D 98.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
2-(4-Hydroxybenzyl)phenol N/D N/D N/D 97.1 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
2,4,4 ′ -Trihydroxybenzophenone N/D N/D 0.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 









N/D N/D 7.1 N/D N/D N/D N/D N/D N/D N/D N/D 96.1 N/D 
2-Deoxyinosine N/D N/D N/D 99.5 98.8 98.9 N/D N/D N/D N/D N/D 98.8 N/D 
2-Furanmethanol, 2-formate N/D N/D N/D 99.3 98.8 N/D 98.8 N/D N/D N/D N/D 99.0 99.2 
3-(2-aminoethyl)indol-5-ol 0.0 24.4 0.0 65.5 60.0 99.5 71.5 N/D 72.0 37.9 65.4 57.5 74.1 




N/D N/D N/D N/D 93.5 N/D N/D 32.1 N/D 95.9 N/D N/D N/D 
3-O-Ethylascorbic acid N/D N/D N/D N/D N/D N/D N/D 20.1 N/D N/D N/D N/D N/D 
4-((Dimethylamino)methyl)phenol N/D 40.7 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
4-((Dimethylamino)methyl)phenol N/D 97.3 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
4,4 ′ -Dihydroxydiphenyl ether N/D N/D N/D 92.5 N/D N/D N/D N/D N/D 99.4 N/D N/D N/D 
4,4-dithiobis[2-aminobutyric] acid N/D N/D 0.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
4,4-iminodianiline 96.1 99.2 N/D 98.6 N/D N/D N/D N/D 99.6 96.9 N/D 99.9 N/D 
4,4 ′ -Propane-1,1-diyldiphenol N/D N/D N/D 97.9 N/D N/D N/D N/D N/D N/D N/D N/D 98.0 
4,4 ′ -Thiodibenzene-1,3-diol 93.6 98.2 N/D 98.4 N/D N/D N/D N/D 96.9 97.9 N/D 95.0 94.1 
4-Amino-4 ′ -hydroxybiphenyl N/D N/D N/D N/D N/D N/D N/D N/D N/D 92.5 N/D N/D N/D 
4-Amino-4 ′ -hydroxybiphenyl N/D N/D N/D 99.5 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
4-Benzylphenol N/D N/D N/D 93.2 N/D N/D N/D N/D N/D N/D N/D N/D 94.7 
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4-cyclohexylphenol N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
4-Hydroxybenzophenone N/D 97.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
4-hydroxyphenylpyruvic acid N/D N/D N/D 98.1 N/D N/D N/D N/D 0.0 N/D N/D 98.8 N/D 
4-hydroxyphenylpyruvic acid 43.2 N/D 0.0 0.0 0.0 39.5 N/D N/D 0.0 0.0 N/D 37.1 33.1 
4-Phenylphenol N/D N/D 0.0 99.1 91.6 N/D N/D 0.0 12.5 0.0 0.0 N/D 92.3 
5-Amino-3-sulfosalicylic acid 49.9 94.9 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
5-Amino-3-sulfosalicylic acid 24.1 39.8 N/D N/D 96.6 N/D 95.7 0.0 98.2 46.9 93.3 99.1 88.5 
5-Fluorouridine N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 93.2 N/D N/D 
5H-Thiachromine-8-ethanol, 
2,7-dimethyl- 








N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
8-hydroxyguanosine N/D N/D N/D N/D N/D N/D N/D N/D N/D 95.8 N/D N/D N/D 
9-Deazainosine 97.9 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Acetophenazine 99.9 99.9 99.9 100.0 100.0 N/D 99.7 100.0 N/D N/D 99.9 99.7 99.7 
Acetophenazine N/D 99.9 99.9 99.9 100.0 N/D N/D N/D N/D N/D 99.8 N/D N/D 
ACETRYPTINE 99.9 99.8 N/D N/D N/D 99.9 N/D N/D N/D N/D N/D N/D N/D 
Alcohols, C13-15, ethoxylated N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 99.5 
Alginic acid 93.1 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Alloxantin N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Aminoimidazole ribotide 97.5 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Amiterol 4.5 0.0 N/D 98.9 N/D 98.2 N/D N/D N/D N/D N/D 97.4 45.1 
Amiterol N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 97.4 
AMMONIUM ZIRCONIUM HYDROXY 
CITRATE 
N/D N/D N/D 98.2 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Anthrarobin N/D N/D N/D N/D 95.6 N/D N/D N/D 93.8 98.8 N/D N/D N/D 
Anthrarobin N/D N/D N/D N/D N/D N/D N/D N/D N/D 98.3 N/D N/D N/D 
Aphidicolin N/D N/D N/D N/D N/D N/D N/D N/D N/D 98.3 N/D 97.1 N/D 
Aphidicolin 99.5 99.5 N/D N/D 96.9 N/D N/D N/D N/D N/D N/D N/D N/D 
Aphidicolin 99.8 99.7 93.5 99.2 98.7 N/D N/D 94.7 97.2 96.7 97.9 98.9 97.9 
Aphidicolin 100.0 99.9 N/D N/D N/D N/D N/D N/D N/D N/D 99.6 N/D N/D 
Arbutin N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Asperuloside N/D N/D N/D N/D N/D N/D N/D 97.7 N/D N/D N/D N/D N/D 
Asperuloside 47.1 13.1 99.7 N/D N/D N/D N/D N/D N/D 99.3 98.9 N/D N/D 
Azidamfenicol N/D N/D N/D 29.7 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Benaxibine N/D N/D N/D 94.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D 




N/D N/D N/D 97.9 N/D N/D N/D N/D N/D N/D N/D N/D 98.0 
Benzylmorphine N/D N/D N/D 99.6 N/D N/D N/D N/D N/D N/D N/D N/D 99.4 
Bergenin N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Biflorin N/D N/D N/D N/D 0.0 94.5 N/D 98.0 N/D 47.9 N/D 95.6 N/D 
Bipenamol N/D 93.5 N/D N/D N/D N/D N/D 95.7 N/D N/D N/D N/D N/D 
Butanedioic acid, 
[(ethoxythioxomethyl)thio]- 
96.1 N/D N/D N/D N/D N/D N/D N/D 97.5 N/D N/D N/D N/D 
Butanedioic acid, 2,3-dihydroxy- 
R-(R ∗ ,R ∗) -, m 
N/D N/D N/D N/D N/D N/D N/D 31.9 N/D N/D N/D N/D N/D 
C6-galactose mustard N/D N/D N/D 96.2 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Caftaric acid 98.9 99.7 N/D N/D N/D N/D N/D N/D N/D 99.1 N/D N/D N/D 
Carboxymethyl cellulose N/D N/D N/D N/D N/D 95.4 N/D N/D N/D N/D N/D N/D N/D 
Chloralose 64.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Chlorogenic acid N/D N/D 0.0 N/D 0.0 94.5 N/D 98.0 N/D 47.9 N/D 95.6 N/D 
Cianidanol N/D 93.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 91.1 
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Cianidanol N/D N/D N/D N/D N/D 97.8 N/D N/D N/D N/D N/D N/D N/D 
Citric acid, monoester with 
glycerol 
N/D N/D N/D 99.5 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Cyclouridine 97.2 99.2 N/D N/D N/D N/D N/D 0.0 94.4 N/D 93.0 N/D 96.2 
Desethylhydroxychloroquine 74.2 73.1 N/D 98.1 97.7 N/D N/D N/D 99.0 65.1 N/D 99.2 99.7 
Dexelvucitabine 99.0 99.9 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Dezocine N/D N/D N/D 98.2 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Dezocine N/D 95.6 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
D-gluco-Heptonic acid, (2?)-, ester 
with boric acid (H3BO3), sodium 
salt 
N/D N/D 0.0 N/D 18.9 N/D N/D 97.3 N/D 95.7 N/D N/D N/D 
D-gluconic acid 6-(dihydrogen 
phosphate) 
N/D N/D N/D N/D N/D N/D N/D N/D 98.2 N/D N/D N/D N/D 
D-gluconic acid, cyclic 4,5-ester 
with boric acid, calcium salt (2:1) 
99.7 99.7 N/D N/D N/D 99.3 N/D N/D N/D N/D N/D N/D 98.5 
D-Glucose N/D N/D N/D N/D 99.2 N/D N/D N/D 99.0 98.9 N/D N/D 99.3 
Dhurrin N/D 25.8 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Dhurrin 98.5 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Dichlorprop N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Digallic acid N/D N/D N/D N/D N/D N/D N/D N/D N/D 96.7 N/D N/D N/D 
Dihydroequilin N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 0.0 




N/D N/D N/D N/D N/D 99.6 N/D N/D N/D N/D N/D N/D N/D 
Disodium 
ethylenediaminediacetate 
67.7 50.4 0.0 90.5 49.6 N/D 83.6 0.0 71.8 56.1 55.4 80.7 83.3 
DOPA sulfate 94.6 28.6 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 97.2 
Dopaquinone N/D 11.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
EO 9 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 99.0 N/D 
Epilactose N/D N/D N/D 96.8 N/D N/D 97.9 N/D N/D N/D N/D 99.0 N/D 
Eptifibatide N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 35.8 N/D N/D 
Estriol 0.0 68.2 99.8 N/D 99.9 N/D 99.1 0.0 99.2 0.0 N/D 99.9 N/D 
Estriol N/D N/D N/D 99.6 99.6 N/D N/D 0.0 99.6 0.0 N/D N/D 99.6 
ETANTEROL N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Ethidium chloride (ET) N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 99.6 
Exifone N/D N/D 97.0 N/D N/D N/D N/D N/D N/D 98.8 N/D N/D N/D 
Felypressin N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Fenoldopam N/D N/D N/D 98.9 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Fepradinol N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Formaldehyde, polymer with 
1,3-benzenediol, 
[1,1 ′ -biphenyl]-ar,ar’-diol and 
[1,1 ′ -biphenyl]triol 
N/D N/D 0.0 N/D N/D N/D N/D 99.2 N/D N/D N/D N/D N/D 
Fulvic acid N/D N/D N/D N/D N/D N/D N/D N/D N/D 97.1 N/D N/D N/D 
Gamma-glutamylcysteine N/D 99.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Gamma-glutamylcysteine N/D 99.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Gamma-glutamylcysteine N/D N/D N/D 0.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Gemcitabine 96.9 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Ginkgolide-A N/D 0.0 N/D N/D N/D 28.5 N/D 98.6 0.0 58.9 29.4 0.0 96.2 
Ginkgolide-A N/D 97.7 N/D 98.5 99.7 N/D N/D N/D N/D 98.9 N/D N/D N/D 
Ginkgolide-C 91.1 N/D N/D N/D N/D N/D N/D 97.7 N/D N/D N/D N/D 92.4 
Ginkgolide-J N/D 0.0 0.0 N/D 0.0 N/D N/D 0.0 N/D 48.9 3.2 0.0 95.3 
Ginkgolide-M N/D 0.0 0.0 N/D 0.0 N/D N/D 0.0 N/D 48.9 3.2 0.0 95.3 
Gluconolactone N/D N/D N/D N/D N/D N/D N/D 31.9 N/D N/D N/D N/D N/D 
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GLUFOSFAMIDE N/D N/D N/D N/D N/D 95.4 N/D N/D N/D N/D N/D N/D N/D 
Glycine, N,N’-(1,2-dithioxo-1,2- 
ethanediyl)bis- 
N/D 25.2 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Guanosine N/D N/D N/D 98.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Helicin N/D 0.0 N/D N/D 0.0 1.7 N/D 0.0 N/D 39.3 0.0 0.0 95.9 
Heptanoic acid, 
2,2,3,3,4,4,5,5,6,6,7,7-dodecafl
0.0 0.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Hexamethylolmelamine N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Hexanedioic acid N/D N/D N/D N/D N/D N/D N/D 95.6 N/D 96.0 0.0 N/D N/D 
Hydroxystilbamidine Isethionate N/D N/D 0.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Isochorismic acid N/D N/D N/D N/D N/D N/D N/D 0.0 N/D 95.6 N/D N/D N/D 
Isochorismic acid N/D N/D N/D 96.5 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Isopropyl citrate 99.6 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Isoquinoline-6,7-diol, 
1,2,3,4-tetrahydro-2-meth 
N/D 40.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Lactobionic acid 99.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Lactose N/D N/D N/D 96.8 N/D N/D 97.9 N/D N/D N/D N/D 99.0 N/D 
L-Dopa N/D 99.0 N/D N/D N/D N/D N/D N/D N/D 96.2 N/D N/D 96.0 
Levallorphan N/D N/D N/D 99.1 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
L-Glutamic acid N/D N/D N/D 98.8 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Lodoxamide N/D N/D N/D 95.9 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Maleylacetoacetic acid 94.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Maltodextrin N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 98.5 N/D 







N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 99.9 
Morphine N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Morphine methylbromide N/D N/D N/D 100.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
N-(3-Chloroallyl)hexaminium 
chloride 
N/D N/D N/D 99.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
N,N,N’,N’-Tetrakis(2- 
Hydroxypropyl)ethylenediamine 
N/D N/D N/D 96.9 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Nadolol N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Nitrocellulose 24.2 22.9 N/D N/D N/D N/D N/D N/D N/D 51.3 N/D N/D N/D 
Nitrocellulose 8.5 20.9 N/D N/D N/D N/D N/D N/D N/D 97.4 N/D N/D N/D 
N’-Nitrosonornicotine-1-N-oxide N/D N/D N/D N/D 97.0 N/D N/D N/D N/D N/D N/D N/D N/D 
Norcodeine N/D N/D N/D 99.7 N/D N/D N/D N/D N/D 99.2 N/D N/D 97.7 
Normorphine N/D N/D N/D N/D N/D N/D N/D N/D N/D 94.5 N/D N/D N/D 
OXONAZINE N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
p-(1-phenylethyl)phenol N/D N/D N/D 95.1 N/D N/D N/D N/D N/D 99.1 N/D N/D 98.2 
PANCRATISTATIN N/D 23.1 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Phenanthridinium, 
3,8-diamino-5-methyl-6-phenyl- 
N/D N/D N/D N/D N/D N/D N/D N/D 80.2 N/D N/D N/D N/D 
Phenol, 4,4 ′ -iminobis- N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 99.7 
PHENOLPHTHALOL 97.0 N/D N/D 98.3 96.4 N/D N/D N/D N/D N/D N/D 98.5 N/D 
Phosphonic acid, [[(2- 
hydroxyethyl)imino]bis(methylene)]bis- 
N/D 98.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Picrotoxin 99.6 98.1 N/D 97.8 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Picrotoxin N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Plasma protein fraction 98.9 99.5 N/D N/D N/D N/D N/D 96.0 98.3 N/D N/D N/D 97.3 
Potassium citrate N/D N/D N/D N/D N/D N/D 97.5 N/D N/D N/D N/D N/D N/D 
Propyl gallate N/D N/D N/D N/D N/D N/D N/D N/D 96.1 N/D N/D N/D N/D 













































Sweden Spain Czech 
Republic 
Netherlands Switzerland Germany Italy #2 Vietnam Italy #1 Belgium Japan 
Puberulic acid N/D N/D 46.6 N/D 96.7 N/D N/D 39.1 N/D 98.5 N/D 95.3 N/D 
Purpurogallin N/D N/D N/D N/D N/D N/D N/D N/D 95.3 N/D N/D N/D N/D 
Purpurogallin N/D N/D N/D N/D N/D N/D N/D N/D N/D 98.7 N/D N/D N/D 
Pyrazofurin N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Ractopamine hydrochloride N/D 94.7 0.0 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Ribavirin monophosphate N/D N/D N/D N/D N/D N/D N/D 95.9 N/D 97.1 N/D N/D N/D 
Ribavirin monophosphate N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Risedronic acid N/D N/D N/D N/D N/D N/D N/D N/D N/D 90.3 N/D N/D N/D 
Robinin N/D N/D N/D 95.8 N/D N/D N/D N/D N/D N/D N/D N/D 91.1 
Salidroside 0.0 0.0 N/D N/D 0.0 0.0 N/D 0.0 N/D 33.7 0.0 0.0 22.6 
Salidroside N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Sedoheptulose 7-phosphate N/D N/D N/D 98.8 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
SEVITROPIUM MESILATE N/D N/D N/D 99.6 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
SKF 77434 N/D N/D N/D N/D N/D 99.3 N/D N/D 99.3 N/D N/D N/D N/D 
SKF 81297 N/D N/D N/D 99.3 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
N/D 95.1 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
98.7 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Sodium 3,5-dichloro-2- 
hydroxybenzenesulphonate 
98.3 57.1 N/D N/D N/D N/D N/D N/D N/D 98.5 N/D N/D N/D 
Sucralose 1.2 8.1 0.0 86.4 52.6 72.9 36.2 N/D 32.2 57.1 28.0 42.8 52.3 
Sydnophen N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 




97.4 N/D N/D 99.1 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Tetrasodium iminidisuccinate N/D N/D N/D N/D N/D 99.2 N/D N/D N/D N/D N/D N/D N/D 
Tetronic 701 N/D N/D N/D N/D N/D N/D N/D 96.1 90.9 87.8 N/D N/D N/D 
Tetronic 701 N/D N/D N/D N/D N/D N/D 95.2 N/D 90.9 87.8 95.0 0.0 N/D 
Theaflavin-3-gallate 93.2 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Tiaramide N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
TIFLOREX 98.5 96.3 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Triethylene glycol N/D N/D N/D 99.3 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Triisopropanolamine 99.3 99.5 N/D 99.9 79.7 99.7 99.7 N/D 99.7 99.8 99.5 99.6 100.0 
Trisodium citrate N/D N/D N/D N/D N/D N/D 97.5 N/D N/D N/D N/D N/D N/D 
Vanillactic acid N/D N/D N/D N/D N/D N/D N/D 97.2 N/D 9.4 N/D 95.5 96.4 
Vanillactic acid N/D N/D N/D N/D N/D N/D N/D N/D 99.0 N/D N/D N/D N/D 
Xanthosine 98.3 N/D N/D N/D N/D 98.5 N/D N/D N/D N/D N/D N/D N/D 
Xanthosine 96.4 97.4 N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Zelandopam N/D N/D N/D 94.5 N/D N/D N/D N/D N/D N/D N/D N/D N/D 
Number of detected features 57 60 23 65 33 21 15 32 30 54 22 34 45 




R. Tröger, H. Ren, D. Yin et al. Water Research 198 (2021) 117099 
Fig. A1. PCA biplot of raw water concentrations of individual CECs at all DWTPs (n = 13). The first two principal components (PCs) jointly explained 61% of the data variance 
(PC1: 39%, PC2: 22%). 
Fig. A2. PCA biplot of drinking water concentrations of individual CECs at all DWTPs (n = 13). The first two principal components (PCs) jointly explained 62% of the data 
variance (PC1: 48%, PC2: 14%). 
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R. Tröger, H. Ren, D. Yin et al. Water Research 198 (2021) 117099 
Fig. A3. Removal efficiency (%) plotted vs log K oc for all individual CECs at all individual DWTPs (n = 13). Dotted lines represent regression lines for each individual DWTP. 
For visibility, the DWTPs was divided in sub-figure a-c. 
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R. Tröger, H. Ren, D. Yin et al. Water Research 198 (2021) 117099 
Fig. A4. Removal efficiency (%) plotted vs log D for all individual CECs at all individual DWTPs (n = 13). Dotted lines represent regression lines for each individual DWTP. 
For visibility, the DWTPs was divided in sub-figure a-c. 
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